STUDYID|DOMAIN|USUBJID|EXSEQ|EXGRPID|EXREFID|EXSPID|EXLNKID|EXLNKGRP|EXTRT|EXCAT|EXSCAT|EXDOSE|EXDOSTXT|EXDOSU|EXDOSFRM|EXDOSFRQ|EXDOSRGM|EXROUTE|EXLOT|EXLOC|EXLAT|EXDIR|EXFAST|EXADJ|TAETORD|EPOCH|EXSTDTC|EXENDTC|EXSTDY|EXENDY|EXDUR|EXTPT|EXTPTNUM|EXELTM|EXTPTREF|EXRFTDTC
TRIAL STUDY 134XCP|EX|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1|||||||||||COULOMB|TABLET, SOLUBLE|EVERY 5 WEEKS||INTRACARTILAGINOUS||TRICUSPID VALVE, POSTERIOR ANNULUS|LATERAL|PERIVENTRICULAR|Y|||OBSERVATION|1968-11-29|1964-09-13|||1967-01-01|||1965-08-23||1967-09-25
TRIAL STUDY 134XCP|EX|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2|||||||||||MS/MMHG|CAPSULE, EXTENDED RELEASE|Q4D||INTRADURAL||TRAPEZOID BONE|IPSILATERAL|LATERAL|Y|||WASHOUT|1963-11-01|1970-06-24|||1967-07-04|||1972-11-30||1964-07-15
TRIAL STUDY 134XCP|EX|1117C221-3530-45CB-82B2-B831C4DAD86B|3|||||||||||DYN|SOLID|3 TIMES PER YEAR||AURICULAR (OTIC)||NASAL CAVITY|LEFT|TEMPORAL|Y|||SCREENING|1965-02-20|1970-03-24|||1963-07-10|||1969-07-31||1971-07-07
TRIAL STUDY 134XCP|EX|3ACFF838-5B16-4898-9640-A60C85096F64|4|||||||||||CY/CM|SUTURE|Q7H||INTRACAVERNOUS||DIGIT|LEFT|ANTEROLATERAL|U|||WASHOUT|1970-08-30|1964-06-20|||1972-10-09|||1961-07-03||1967-05-05
TRIAL STUDY 134XCP|EX|308F422A-B02B-4C76-86E7-834AAC127FE3|5|||||||||||UG/KG/H|INTRAUTERINE DEVICE|QHS||SOFT TISSUE||METACARPOPHALANGEAL JOINT 5|BILATERAL|DEEP|N|||OPEN LABEL TREATMENT|1964-02-11|1966-03-13|||1962-08-11|||1973-04-04||1968-05-04
TRIAL STUDY 134XCP|EX|34A3AA01-3595-42C2-95C3-44E3AF77B28D|6|||||||||||MONTHS|GRANULE, FOR SOLUTION|QAM||NASAL||CARPAL BONE|CONTRALATERAL|FORE|U|||BLINDED TREATMENT|1963-10-11|1968-11-19|||1973-03-24|||1973-07-06||1967-06-06
TRIAL STUDY 134XCP|EX|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|7|||||||||||GENEQ/ML|STICK|3 TIMES PER WEEK||INTRACORONAL, DENTAL||MALE GENITALIA|RIGHT|LOWER FLEXOR SURFACE|NA|||OBSERVATION|1967-01-18|1960-03-29|||1962-09-18|||1967-07-13||1960-05-16
TRIAL STUDY 134XCP|EX|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|8|||||||||||PFU/DOSE|TABLET, ORALLY DISINTEGRATING|Q21H||ELECTRO-OSMOSIS||OPTIC NERVE|UNILATERAL|INTERMEDIATE|Y|||WASHOUT|1967-10-26|1973-08-20|||1972-01-13|||1972-03-13||1965-06-23
TRIAL STUDY 134XCP|EX|ECA054C6-EA0F-4D7B-905C-849EA4592624|9|||||||||||OZ|OIL|4 TIMES PER WEEK||INTRATHORACIC||GASTROINTESTINAL TRACT, LOWER, WALL|LATERAL|OUTER|N|||RUN-IN|1973-06-17|1964-07-01|||1966-04-06|||1965-07-30||1971-01-01
TRIAL STUDY 134XCP|EX|83823CA3-1C1D-455E-BE49-DC5E3651A939|10|||||||||||CYLINDER|DRESSING|EVERY 7 WEEKS||EPIDURAL||GASTROINTESTINAL TRACT, LOWER|BILATERAL|INNER|Y|||TREATMENT|1963-02-22|1970-11-02|||1967-03-29|||1962-10-10||1964-04-15
TRIAL STUDY 134XCP|EX|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|11|||||||||||FRACTION OF 1|DRESSING|EVERY 6 WEEKS||INTRA-ABDOMINAL||RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|BILATERAL|POSTERIOR|U|||BASELINE|1969-01-30|1969-09-05|||1965-12-15|||1971-05-01||1965-09-27
TRIAL STUDY 134XCP|EX|9C24F018-315A-4B9C-B89B-F54CA26452E7|12|||||||||||KG/M2|INHALANT|Q4M||INTRA-AMNIOTIC||HEART, LEFT ATRIAL APPENDAGE|RIGHT|OUTER|U|||FOLLOW-UP|1967-03-14|1964-11-23|||1968-06-17|||1966-05-19||1971-05-16
TRIAL STUDY 134XCP|EX|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|13|||||||||||UCI|SPRAY|AD LIBITUM||INTRADERMAL||PARS COMPACTA|RIGHT|UPPER|Y|||LONG-TERM FOLLOW-UP|1968-03-07|1970-05-24|||1962-11-22|||1966-02-10||1968-03-12
TRIAL STUDY 134XCP|EX|8D48F229-F38B-4335-B8A7-0AA24C928707|14|||||||||||CY/CM|LIQUID, EXTENDED RELEASE|QPM||SUBCONJUNCTIVAL||SUBSTANTIA NIGRA|BILATERAL|INFERIOR|N|||LONG-TERM FOLLOW-UP|1960-01-19|1967-11-05|||1963-05-15|||1971-01-30||1961-10-07
TRIAL STUDY 134XCP|EX|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|15|||||||||||UG/L|SUPPOSITORY, EXTENDED RELEASE|Q15H||INTRATUBULAR||SKIN OF THE BENDING JOINT|UNILATERAL|LOWER FLEXOR SURFACE|U|||BLINDED TREATMENT|1967-12-13|1967-01-16|||1963-01-04|||1963-03-22||1961-05-08
TRIAL STUDY 134XCP|EX|C882CB1F-C0DE-4BE5-B762-611333949C74|16|||||||||||ELISA UNIT/DOSE|CAPSULE, GELATIN COATED|4 TIMES PER YEAR||INTRATYMPANIC||POSTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|ANTEROMEDIAL|NA|||CONTINUATION TREATMENT|1966-10-30|1964-12-28|||1965-03-10|||1961-11-02||1965-06-21
TRIAL STUDY 134XCP|EX|7F3C3801-607B-4141-AA83-383FDFFD7152|17|||||||||||M3|LOTION/SHAMPOO|Q15H||SUBCONJUNCTIVAL||SUBARACHNOID SPACE|LATERAL|FORE|Y|||FOLLOW-UP|1968-02-23|1972-04-08|||1961-11-03|||1961-03-11||1961-03-06
TRIAL STUDY 134XCP|EX|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|18|||||||||||NKAT/L|WAFER|EVERY 3 WEEKS||INTRAVENOUS DRIP||LUNG, LEFT UPPER LOBE|BILATERAL|LATERAL|U|||WASHOUT|1963-03-18|1963-11-22|||1964-11-18|||1966-08-27||1962-12-30
TRIAL STUDY 134XCP|EX|67025219-DBC0-4222-9D04-7F23EE3D5806|19|||||||||||UG/CM2|POWDER, DENTIFRICE|EVERY 5 WEEKS||INTRADURAL||ASCENDING AORTA|RIGHT|ANTEROMEDIAL|U|||SCREENING|1960-04-05|1962-05-18|||1967-06-06|||1969-02-04||1966-04-10
TRIAL STUDY 134XCP|EX|A865B860-E5F2-423D-8110-58EBF7E470F3|20|||||||||||DPM|CAPLET|3 TIMES PER MONTH||INTRADERMAL||MEDIASTINUM, MIDDLE|UNILATERAL|CENTRAL|NA|||RUN-IN|1963-12-23|1963-04-12|||1968-05-03|||1972-03-23||1966-12-12
TRIAL STUDY 134XCP|EX|E78B2C0E-81D6-4898-B78A-FE136029AEA4|21|||||||||||10^3 CFU|TABLET, MODIFIED RELEASE, SHORT DURATION|5 TIMES PER MONTH||INTRACORONARY||SKIN OF THE TRUNK|LEFT|POSTERIOR|U|||RUN-IN|1962-10-20|1960-02-28|||1972-10-24|||1971-01-12||1965-01-24
TRIAL STUDY 134XCP|EX|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|22|||||||||||BAU|GRANULE, FOR SOLUTION|3 TIMES PER CYCLE||INTRATESTICULAR||CECUM|UNILATERAL|SURFACE|U|||OBSERVATION|1961-04-16|1963-03-20|||1963-11-13|||1968-08-28||1960-12-17
TRIAL STUDY 134XCP|EX|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|23|||||||||||MJOULE/CM2|CAPSULE, COATED|Q22H||INTRAGINGIVAL||HAIR|LEFT|UPPER EXTENSOR SURFACE|U|||BLINDED TREATMENT|1969-11-14|1972-01-30|||1961-08-05|||1961-08-07||1970-11-25
TRIAL STUDY 134XCP|EX|55210E20-F6B9-446F-994D-2D9149E33BAF|24|||||||||||10^6 ORGANISMS/MG|TAMPON|TID||INTRADERMAL||FEMORAL ARTERY|LATERAL|VENTRAL|Y|||RUN-IN|1968-06-06|1963-02-21|||1971-04-20|||1970-01-24||1967-03-20
TRIAL STUDY 134XCP|EX|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|25|||||||||||CYCLE/MIN|TABLET, MODIFIED RELEASE, LONG DURATION|Q4H||INTRASPINAL||EPIDURAL SPACE|BILATERAL|FRONTAL|U|||CONTINUATION TREATMENT|1961-09-30|1966-11-10|||1960-07-13|||1964-11-22||1968-01-26
TRIAL STUDY 134XCP|EX|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|26|||||||||||PFU/ML|PELLET, IMPLANTABLE|3 TIMES PER MONTH||INTRASINAL||ANAL CANAL|UNILATERAL|LOWER FLEXOR SURFACE|U|||WASHOUT|1970-05-23|1962-12-29|||1964-11-10|||1972-08-17||1961-10-16
TRIAL STUDY 134XCP|EX|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|27|||||||||||CS|CAPSULE, FILM COATED, EXTENDED RELEASE|6 TIMES PER MONTH||INTRADUCTAL||MEDIASTINUM, SUPERIOR|BILATERAL|LOWER EXTENSOR SURFACE|U|||SCREENING|1968-03-31|1969-03-07|||1969-11-27|||1960-10-29||1970-02-25
TRIAL STUDY 134XCP|EX|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|28|||||||||||M|SALVE|Q16H||INTRAOVARIAN||PLACENTA|BILATERAL|ANTEROTEMPORAL|U|||TREATMENT|1973-01-08|1964-12-25|||1969-04-14|||1964-03-17||1973-03-30
TRIAL STUDY 134XCP|EX|CAD0ED37-954A-4935-8A7E-589EC108E141|29|||||||||||LOG EID 50/DOSE|OIL|QM||ELECTRO-OSMOSIS||THORACIC ARTERY|IPSILATERAL|BASAL|NA|||INDUCTION TREATMENT|1960-09-16|1960-09-05|||1969-08-22|||1961-10-12||1962-04-05
TRIAL STUDY 134XCP|EX|BC9A31E2-100C-4AC3-8910-A04309854590|30|||||||||||M/SEC|CAPSULE, DELAYED RELEASE|Q14H||INTRATHECAL||L2 VERTEBRA|LATERAL|FORE|U|||RUN-IN|1967-07-05|1962-11-20|||1970-03-19|||1963-07-29||1966-11-29
TRIAL STUDY 134XCP|EX|13A424BB-CC85-41EC-BDED-165A29532DFF|31|||||||||||MG/MOL|TABLET, COATED|EVERY 6 WEEKS||INTRAOVARIAN||ABDOMINAL REGION|LEFT|OCCIPITAL|Y|||BASELINE|1972-05-26|1971-09-04|||1962-11-16|||1971-03-24||1964-04-25
TRIAL STUDY 134XCP|EX|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|32|||||||||||CUP|CLOTH|EVERY WEEK||INTRAPULMONARY||UTERUS|RIGHT|UPPER FLEXOR SURFACE|Y|||FOLLOW-UP|1967-09-15|1972-07-06|||1973-03-30|||1969-11-23||1972-07-09
TRIAL STUDY 134XCP|EX|059FE504-DEE4-4E24-AA80-3C64264636BF|33|||||||||||DAGU|INJECTION, SUSPENSION, LIPOSOMAL|QPM||INTRAVENOUS||ABDUCTOR DIGITI QUINTI MUSCLE|LATERAL|ROSTRAL|NA|||INDUCTION TREATMENT|1966-09-02|1965-06-28|||1963-06-01|||1973-03-26||1966-11-18
TRIAL STUDY 134XCP|EX|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|34|||||||||||G|FOR SOLUTION|Q8H||INTRATYMPANIC||ANKLE JOINT ANTERIOR FLEXOR TENDONS|CONTRALATERAL|SUPERIOR|Y|||CONTINUATION TREATMENT|1962-08-03|1971-02-24|||1967-12-23|||1962-07-08||1972-08-01
TRIAL STUDY 134XCP|EX|69BCF810-6748-43AA-BDFC-64EE1536CB47|35|||||||||||PKAT/L|SWAB|Q13H||OPHTHALMIC||C2 VERTEBRA|CONTRALATERAL|POSTERIOR|NA|||FOLLOW-UP|1963-11-29|1960-01-22|||1962-11-21|||1965-11-04||1961-03-11
TRIAL STUDY 134XCP|EX|DCE71DE9-8DFB-4796-BC41-21930EC21925|36|||||||||||MG/H|INJECTABLE, LIPOSOMAL|5 TIMES PER WEEK||SUPRACHOROIDAL||GLOBUS PALLIDUS|CONTRALATERAL|UPPER EXTENSOR SURFACE|U|||FOLLOW-UP|1966-09-14|1961-06-25|||1973-08-20|||1971-07-26||1964-08-26
TRIAL STUDY 134XCP|EX|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|37|||||||||||UKAT|FILM, EXTENDED RELEASE|1 TIME PER WEEK||INTRASINAL||INTRATHORACIC LYMPH NODE|LATERAL|BASAL|NA|||TREATMENT|1972-04-05|1970-04-03|||1965-10-06|||1968-07-01||1967-10-30
TRIAL STUDY 134XCP|EX|97D06076-FE6B-4C77-BD5C-2E665F707C7A|38|||||||||||NMOL/L/MIN|FILM, EXTENDED RELEASE|Q5H||INTRACARTILAGINOUS||CALF MUSCULAR VEIN|BILATERAL|PROXIMAL VOLAR|Y|||TREATMENT|1961-04-14|1969-12-31|||1972-10-10|||1961-09-16||1960-08-22
TRIAL STUDY 134XCP|EX|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|39|||||||||||WEBER|DRUG DELIVERY SYSTEM|EVERY 6 WEEKS||INTRA-ARTERIAL||LATISSIMUS DORSI MUSCLE|LEFT|CAUDAL|N|||OPEN LABEL TREATMENT|1973-07-31|1972-11-21|||1970-09-05|||1970-11-17||1961-07-18
TRIAL STUDY 134XCP|EX|D5A1EB38-77EA-49A5-84CA-740A83D258AF|40|||||||||||CI/UG|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|5 TIMES PER DAY||INTRATHALAMIC||INTERATRIAL SEPTUM|BILATERAL|DISTAL VOLAR|NA|||TREATMENT|1970-06-22|1964-11-06|||1967-07-03|||1971-06-12||1961-03-12
TRIAL STUDY 134XCP|EX|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|41|||||||||||G/L|SUSPENSION/DROPS|EVERY 7 WEEKS||INTRACISTERNAL||URETHRAL SPHINCTER|LEFT|LATERAL|NA|||TREATMENT|1963-10-30|1966-11-21|||1972-05-19|||1960-02-16||1968-08-15
TRIAL STUDY 134XCP|EX|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|42|||||||||||KIU|INJECTABLE, LIPOSOMAL|5 TIMES PER MONTH||TRANSMAMMARY||CHEEK|UNILATERAL|DISTAL|Y|||LONG-TERM FOLLOW-UP|1973-08-15|1966-09-06|||1968-05-20|||1964-10-08||1964-05-01
TRIAL STUDY 134XCP|EX|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|43|||||||||||KA_U/DL|BLOCK|Q2H||INFILTRATION||ANTERIOR CINGULATE CORTEX|UNILATERAL|ROSTRAL|Y|||TREATMENT|1971-03-06|1968-10-21|||1971-12-27|||1973-03-23||1964-12-27
TRIAL STUDY 134XCP|EX|640DDEF5-748A-4F92-A13D-15D1C7CE0800|44|||||||||||MU/L|FOR SOLUTION|4 TIMES PER WEEK||UNASSIGNED||UTERINE ARTERY|LATERAL|FRONTAL|U|||OPEN LABEL TREATMENT|1966-11-03|1967-09-24|||1962-01-25|||1967-11-19||1960-06-07
TRIAL STUDY 134XCP|EX|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|45|||||||||||GRAVITATIONAL UNIT|KIT|5 TIMES PER DAY||NASAL||TEMPORAL BONE|RIGHT|PROXIMAL|N|||CONTINUATION TREATMENT|1973-05-11|1964-03-22|||1968-09-15|||1960-09-16||1963-09-18
TRIAL STUDY 134XCP|EX|EBC7BF7B-18C6-463C-8500-027B2A6966DB|46|||||||||||PG/L|TABLET, COATED PARTICLES|Q22H||TRANSPLACENTAL||FOOT|UNILATERAL|TEMPORAL|NA|||SCREENING|1962-05-26|1963-03-29|||1961-07-10|||1967-03-20||1972-05-15
TRIAL STUDY 134XCP|EX|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|47|||||||||||G/CAGE/DAY|SUSPENSION, EXTENDED RELEASE|AD LIBITUM||INTRAMEDULLARY||CARDIAC WALL|LATERAL|PROXIMAL|NA|||FOLLOW-UP|1962-03-02|1966-09-09|||1960-10-18|||1967-11-16||1967-06-26
TRIAL STUDY 134XCP|EX|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|48|||||||||||UG/MIN|GRANULE, EFFERVESCENT|Q19H||INTRABILIARY||PARS COMPACTA|CONTRALATERAL|HIND|N|||OPEN LABEL TREATMENT|1966-11-26|1969-09-05|||1960-02-09|||1962-12-04||1965-09-15
TRIAL STUDY 134XCP|EX|74741526-F925-4AA5-9BE3-F3B3884BEE68|49|||||||||||NMOL/G|INJECTION, SOLUTION|OCCASIONAL||PERCUTANEOUS||KIDNEY, UPPER LOBE|LATERAL|MEDIAL|Y|||FOLLOW-UP|1965-07-04|1962-06-19|||1960-01-21|||1968-03-14||1967-08-11
TRIAL STUDY 134XCP|EX|25088C28-0FA3-4005-90C3-CCF9C6FF5851|50|||||||||||UMOL/DAY|TABLET, EFFERVESCENT|Q14H||PERIARTICULAR||COSTOCHONDRAL JOINT 7|LEFT|PARIETO-OCCIPITAL|U|||BASELINE|1960-05-12|1968-04-17|||1962-08-05|||1964-07-28||1965-01-07
TRIAL STUDY 134XCP|EX|9BF13738-0A50-46E6-A3DA-AC956A361B97|51|||||||||||MMOL2/L2|GENERATOR|6 TIMES PER MONTH||INTRAMANDIBULAR||SKIN OF THE BUTTOCK|LATERAL|DORSOLATERAL|N|||RUN-IN|1966-04-16|1966-11-25|||1972-10-22|||1967-10-17||1972-03-27
TRIAL STUDY 134XCP|EX|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|52|||||||||||CI/L|GENERATOR|PA||INTRATESTICULAR||SEBACEOUS GLAND|LATERAL|NASAL|NA|||FOLLOW-UP|1966-01-05|1972-07-15|||1965-07-15|||1972-03-18||1962-12-15
TRIAL STUDY 134XCP|EX|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|53|||||||||||UKAT/L|PLASTER|Q5H||INTRACARDIAC||SUPRACLAVICULAR LYMPH NODE|LEFT|LOWER MEDIAL|U|||INDUCTION TREATMENT|1971-08-27|1969-01-24|||1962-06-14|||1968-07-24||1972-06-30
TRIAL STUDY 134XCP|EX|5AEA7EE9-1095-4967-B833-7665B6A71B31|54|||||||||||USEC|TABLET, FILM COATED|6 TIMES PER YEAR||INTRAGINGIVAL||L6 VERTEBRA|BILATERAL|PERIVENTRICULAR|N|||RUN-IN|1969-02-01|1960-02-04|||1966-03-03|||1967-11-28||1967-06-25
TRIAL STUDY 134XCP|EX|241CD521-D0BD-40BB-ABA2-B8C8E500B491|55|||||||||||LOG10 COPIES/ML|PLASTER|Q16H||TRANSDERMAL||HEPATIC LYMPH NODE|UNILATERAL|SUBCORTICAL|U|||LONG-TERM FOLLOW-UP|1971-11-26|1961-01-27|||1962-08-16|||1969-10-11||1964-01-12
TRIAL STUDY 134XCP|EX|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|56|||||||||||BOWL|OINTMENT, AUGMENTED|Q7H||IRRIGATION||SCAPHOID-CAPITATE JOINT|RIGHT|UPPER|U|||OPEN LABEL TREATMENT|1971-05-05|1970-11-15|||1962-10-05|||1966-11-05||1967-10-20
TRIAL STUDY 134XCP|EX|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|57|||||||||||IU/DL|STRIP|Q36H||TRANSMUCOSAL||SKIN OF THE KNEE|UNILATERAL|CRANIAL|N|||FOLLOW-UP|1972-01-29|1962-01-29|||1973-04-14|||1970-08-03||1969-09-29
TRIAL STUDY 134XCP|EX|FD609B1C-D1E7-4349-B036-DF0126D96A52|58|||||||||||MG/KG/H|DISC|Q15H||INTRAVENOUS DRIP||TRACHEA|LEFT|SURFACE|NA|||CONTINUATION TREATMENT|1970-03-24|1971-05-20|||1962-09-07|||1973-07-30||1967-09-02
TRIAL STUDY 134XCP|EX|DEB0593B-E3FD-471C-A800-43058AC5FD86|59|||||||||||U/M2|GEL, DENTIFRICE|EVERY AFTERNOON||INTRAVASCULAR||TIBIALIS ANTERIOR MUSCLE|IPSILATERAL|TIP|N|||BLINDED TREATMENT|1960-01-24|1967-06-17|||1960-01-22|||1961-05-10||1972-10-16
TRIAL STUDY 134XCP|EX|596BD728-2487-44E4-AFB1-8A4331EEDDF6|60|||||||||||POUCH|BEAD|3 TIMES PER MONTH||INTRASPINAL||BLOOD|LATERAL|MEDIAL|Y|||CONTINUATION TREATMENT|1963-07-11|1970-11-07|||1962-07-01|||1971-11-13||1973-09-04
TRIAL STUDY 134XCP|EX|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|61|||||||||||NKAT/G HB|FILM|Q10H||INTRACORONAL, DENTAL||RETROAURICULAR LYMPH NODE|CONTRALATERAL|PERIPHERAL|U|||BASELINE|1969-04-29|1966-03-25|||1972-12-23|||1971-11-13||1960-06-01
TRIAL STUDY 134XCP|EX|0365EB5F-7364-4B1F-8919-543D8D21B045|62|||||||||||UG/L|GRAFT|Q20H||SOFT TISSUE||THORACIC CAVITY|LATERAL|ANTEROMEDIAL|Y|||FOLLOW-UP|1964-11-22|1968-02-24|||1971-06-22|||1966-03-13||1964-11-29
TRIAL STUDY 134XCP|EX|364277A8-875C-4A6F-93C3-C913BB3C97CA|63|||||||||||%(W/W)|CAPSULE, GELATIN COATED|Q16H||TRANSPLACENTAL||GLENOID FOSSA|BILATERAL|FACIAL|NA|||RUN-IN|1963-06-22|1971-11-05|||1966-01-03|||1966-06-12||1971-04-06
TRIAL STUDY 134XCP|EX|B824951F-58EE-4003-A2AD-A91AADBBAC0D|64|||||||||||DAGU/ML|INSERT|Q36H||INTRAOSSEOUS||SUBCUTIS|CONTRALATERAL|MEDIAL|U|||FOLLOW-UP|1971-05-01|1972-04-28|||1973-07-02|||1968-06-01||1970-02-17
TRIAL STUDY 134XCP|EX|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|65|||||||||||MS2|GRANULE, FOR SUSPENSION|Q22H||RESPIRATORY (INHALATION)||DORSAL MOTOR NUCLEUS|LATERAL|OUTER|N|||INDUCTION TREATMENT|1962-09-19|1970-12-18|||1969-04-04|||1973-08-30||1962-07-02
TRIAL STUDY 134XCP|EX|A108F408-906C-4320-965A-D5D295BC5C31|66|||||||||||NMOL/DAY|LOTION, AUGMENTED|QAM||INTRAVENOUS DRIP||INFRATENTORIAL BRAIN|IPSILATERAL|SUPERFICIAL|Y|||BLINDED TREATMENT|1968-03-19|1970-12-22|||1962-11-09|||1972-02-14||1960-08-30
TRIAL STUDY 134XCP|EX|8E627D27-4855-4E1B-B823-1E14368973AF|67|||||||||||MOSM/KG|DIAPHRAGM|4 TIMES PER YEAR||NOT APPLICABLE||TONGUE|CONTRALATERAL|APICAL|Y|||OBSERVATION|1971-01-10|1963-04-24|||1960-04-30|||1967-05-27||1968-03-26
TRIAL STUDY 134XCP|EX|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|68|||||||||||BQ/ML|CAPSULE, DELAYED RELEASE PELLETS|QHS||INTRADISCAL||CORNEAL STROMA|UNILATERAL|PARIETO-OCCIPITAL|Y|||CONTINUATION TREATMENT|1967-08-28|1965-10-09|||1967-01-27|||1961-01-19||1964-11-25
TRIAL STUDY 134XCP|EX|483D89E1-45FD-41D4-B9E0-22FFB41D323A|69|||||||||||NM|PASTE, DENTIFRICE|QOD||INTRACORPORUS CAVERNOSUM||FEMORO-POPLITEAL PERIPHERAL ARTERY|BILATERAL|OUTER|NA|||SCREENING|1973-09-02|1961-10-03|||1964-10-28|||1963-10-17||1971-12-25
TRIAL STUDY 134XCP|EX|2CCBED9D-5F24-4ED8-B575-8523C820A227|70|||||||||||PMOL|FIBER, EXTENDED RELEASE|Q4H||INTRA-ARTICULAR||NERVE|LEFT|MEDIAL|U|||INDUCTION TREATMENT|1967-12-27|1969-02-28|||1971-05-17|||1969-06-04||1970-11-17
TRIAL STUDY 134XCP|EX|F4D6A28D-569F-4639-ACE2-10EB517128B2|71|||||||||||HENRY|GEL, METERED|QN||TOPICAL||TIBIALIS ANTERIOR MUSCLE|LEFT|ANTEROLATERAL|Y|||WASHOUT|1965-03-09|1966-06-04|||1970-03-10|||1964-02-20||1962-09-13
TRIAL STUDY 134XCP|EX|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|72|||||||||||MILE|CAPSULE, COATED, EXTENDED RELEASE|Q72H||INTRAPERITONEAL||BASILIC VEIN|CONTRALATERAL|ANTEROPOSTERIOR|N|||INDUCTION TREATMENT|1969-02-04|1972-11-30|||1965-06-13|||1965-05-05||1967-05-19
TRIAL STUDY 134XCP|EX|415EF35E-6D99-48F8-80A1-89A4CDC621B8|73|||||||||||DAYS|TABLET, FOR SUSPENSION|3 TIMES PER WEEK||SUBCUTANEOUS||CAPITATE-LUNATE JOINT|BILATERAL|VENTROLATERAL|Y|||TREATMENT|1964-05-07|1963-06-01|||1964-04-20|||1962-11-03||1971-02-02
TRIAL STUDY 134XCP|EX|AA0F6192-A377-43C6-8203-BDF7553AEA88|74|||||||||||IU/KG|SOLUTION, FOR SLUSH|Q11H||INTRASTOMAL||DISTAL PHALANX 2 OF THE HAND|LATERAL|CAUDAL|NA|||SCREENING|1962-04-11|1966-10-23|||1967-07-25|||1960-04-25||1972-04-28
TRIAL STUDY 134XCP|EX|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|75|||||||||||MEQ/DAY|GUM, CHEWING|5 TIMES PER DAY||SUPRACHOROIDAL||ARM SKIN|BILATERAL|OCCIPITAL|Y|||TREATMENT|1972-02-15|1968-10-24|||1963-04-04|||1962-07-17||1967-11-29
TRIAL STUDY 134XCP|EX|A848B1B5-679F-4C45-AD73-6506604C835E|76|||||||||||IU/ML|IMPLANT|EVERY 3 YEARS||URETERAL||OPTIC NERVE|IPSILATERAL|LOWER FLEXOR SURFACE|Y|||CONTINUATION TREATMENT|1967-08-13|1967-05-11|||1964-05-14|||1970-08-06||1960-07-18
TRIAL STUDY 134XCP|EX|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|77|||||||||||PMOL/10^9 CELLS|FIBER, EXTENDED RELEASE|7 TIMES PER WEEK||INTRAOSSEOUS||ABDUCENS NERVE|RIGHT|LOWER EXTENSOR SURFACE|Y|||RUN-IN|1966-11-11|1972-06-11|||1972-02-11|||1973-08-26||1969-06-01
TRIAL STUDY 134XCP|EX|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|78|||||||||||10^6 RNA COPIES/ML|CIGARETTE|CONTINUOUS||RESPIRATORY (INHALATION)||HAND|LATERAL|LOWER EXTENSOR SURFACE|NA|||BLINDED TREATMENT|1960-09-13|1960-06-03|||1962-08-21|||1962-02-11||1960-05-10
TRIAL STUDY 134XCP|EX|FC155F37-522F-4620-BBFF-4999D37C1379|79|||||||||||MG/MIN|PILL|Q8H||TRANSPLACENTAL||SUPERFICIAL FEMORAL ARTERY|UNILATERAL|INNER|N|||OBSERVATION|1960-04-05|1961-12-04|||1970-12-30|||1963-11-12||1965-04-04
TRIAL STUDY 134XCP|EX|20F817BC-4C89-4F6C-AA45-36CE786A73A8|80|||||||||||1/(S*KPA)|SOLUTION/ DROPS|EVERY 5 WEEKS||OROMUCOSAL||DUCTUS ARTERIOSUS|LEFT|SURFACE|NA|||SCREENING|1963-12-15|1965-12-07|||1966-10-02|||1972-08-24||1961-10-04
TRIAL STUDY 134XCP|EX|99058E64-9873-4CD5-BB31-28C08758A1B5|81|||||||||||PPTH|INJECTION|Q6M||INTRAMEDULLARY||PYRAMIDAL TRACTS, BRAINSTEM|LEFT|UPPER|Y|||FOLLOW-UP|1961-09-18|1970-03-19|||1965-12-24|||1969-03-21||1960-08-24
TRIAL STUDY 134XCP|EX|656B6693-1C1C-433B-84E3-77E89F0B543E|82|||||||||||IU/MMOL|INTRAUTERINE DEVICE|Q6M||INTRAPARENCHYMAL||SUBSTANTIA NIGRA|UNILATERAL|LOWER EXTENSOR SURFACE|N|||SCREENING|1961-07-16|1966-02-01|||1960-11-21|||1960-04-05||1964-04-13
TRIAL STUDY 134XCP|EX|43C443F9-AB0F-44BE-B28B-63A60EE09205|83|||||||||||VG/ML|ENEMA|7 TIMES PER WEEK||URETERAL||OCCIPITAL LYMPH NODE|UNILATERAL|INFERIOR|U|||FOLLOW-UP|1969-04-08|1973-01-14|||1969-10-22|||1962-11-26||1970-11-02
TRIAL STUDY 134XCP|EX|37FF91B1-CE3C-4587-85CE-F76B880D40E7|84|||||||||||UG/L|LIQUID, EXTENDED RELEASE|10 DAYS PER MONTH||OPHTHALMIC||COLON, RIGHT|BILATERAL|LOWER MEDIAL|U|||BLINDED TREATMENT|1963-09-24|1968-03-30|||1972-05-11|||1967-06-01||1965-11-27
TRIAL STUDY 134XCP|EX|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|85|||||||||||KIT|SUTURE|Q2M||INTRACORPORUS CAVERNOSUM||SINUS|LEFT|POSTERIOR|U|||OBSERVATION|1970-02-09|1966-09-05|||1967-12-25|||1964-09-15||1970-01-02
TRIAL STUDY 134XCP|EX|49017491-2C28-4F86-BF72-CF83651052F6|86|||||||||||UG/M2/MIN|LOTION/SHAMPOO|Q18H||INTRAPERITONEAL||SYMPATHETIC GANGLIA|CONTRALATERAL|TEMPORAL|U|||WASHOUT|1973-01-13|1962-08-03|||1960-02-27|||1961-09-14||1971-09-29
TRIAL STUDY 134XCP|EX|DAA65EE6-66ED-4354-935B-1347E1B572A5|87|||||||||||UG/DOSE|POWDER|BIM||INTRALESIONAL||L2 VERTEBRA|LATERAL|FACIAL|U|||OBSERVATION|1966-11-18|1972-01-20|||1962-09-02|||1972-11-09||1965-04-17
TRIAL STUDY 134XCP|EX|A440A3E5-F87D-4306-9195-3A842F0DDE33|88|||||||||||PT_BR|CAPSULE, GELATIN COATED|4 TIMES PER YEAR||INTRAGINGIVAL||NASAL SEPTUM|LEFT|VENTROLATERAL|N|||SCREENING|1968-11-11|1973-07-02|||1966-01-23|||1969-08-23||1961-11-20
TRIAL STUDY 134XCP|EX|48BBE085-BD68-451A-9700-6A1AB18D84EE|89|||||||||||RFU|SUSPENSION, EXTENDED RELEASE|4 TIMES PER YEAR||INTRACORONARY||FLEXOR POLLICIS LONGUS MUSCLE|BILATERAL|LOWER FLEXOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1963-08-16|1964-11-04|||1971-02-04|||1971-04-10||1965-03-02
TRIAL STUDY 134XCP|EX|F38055A2-11E2-437B-BD6A-662D81521F1D|90|||||||||||ENZYME U/G HB|DOUCHE|QD||INTRAPALATAL||AXIAL SKELETON|LATERAL|INTERMEDIATE|U|||BASELINE|1962-11-27|1969-06-28|||1965-11-10|||1967-10-19||1967-02-05
TRIAL STUDY 134XCP|EX|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|91|||||||||||KG/L|GRANULE, FOR SUSPENSION|Q48H||SUBCONJUNCTIVAL||FINGER|BILATERAL|ANTERIOR|N|||TREATMENT|1960-05-09|1965-10-28|||1960-07-23|||1965-05-04||1961-02-03
TRIAL STUDY 134XCP|EX|22B0F097-D571-4E65-9B58-BEF2C3482F05|92|||||||||||P|CORE, EXTENDED RELEASE|PRN||TRANSMAMMARY||SEMITENDINOSUS MUSCLE|BILATERAL|DISTAL|NA|||OPEN LABEL TREATMENT|1968-09-25|1962-05-11|||1966-09-25|||1961-03-06||1969-05-24
TRIAL STUDY 134XCP|EX|F56B6C70-0513-4032-A0BE-B961F6F2EF30|93|||||||||||MBP|STICK|4 TIMES PER YEAR||INTRATUMOR||CORONARY SINUS|IPSILATERAL|SUPERFICIAL|NA|||OBSERVATION|1965-04-19|1973-06-17|||1968-05-06|||1960-08-01||1972-01-12
TRIAL STUDY 134XCP|EX|8E385A66-25C9-417E-9298-FB87A73B661F|94|||||||||||AMPULE|TABLET, DELAYED RELEASE|THRICE||INTRABILIARY||COMMON FEMORAL VEIN|IPSILATERAL|DORSAL|NA|||FOLLOW-UP|1969-05-17|1969-09-07|||1964-04-08|||1968-01-26||1972-12-15
TRIAL STUDY 134XCP|EX|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|95|||||||||||NEBULE|SUPPOSITORY|Q20H||INTRAGINGIVAL||HEPATOBILIARY SYSTEM|LEFT|HIND|U|||INDUCTION TREATMENT|1970-06-30|1962-08-21|||1969-08-11|||1964-07-13||1962-06-26
TRIAL STUDY 134XCP|EX|D0AE2069-B430-4771-9A8C-0F5442DFCECE|96|||||||||||L/H/M2|PELLET, IMPLANTABLE|EVERY 4 WEEKS||INTRAOSSEOUS||BICEPS FEMORIS MUSCLE|BILATERAL|CRANIAL|NA|||BLINDED TREATMENT|1966-04-17|1968-08-08|||1966-08-19|||1966-02-06||1972-08-22
TRIAL STUDY 134XCP|EX|CF214007-AC24-4760-AEDE-F78CDE3D9351|97|||||||||||NSEC|GEL|EVERY WEEK||SUBCONJUNCTIVAL||CHOROID PLEXUS|UNILATERAL|CENTRAL|NA|||FOLLOW-UP|1969-02-07|1963-09-02|||1963-05-05|||1970-09-22||1967-02-27
TRIAL STUDY 134XCP|EX|E996BE19-2824-49D3-944F-B777F3D8E746|98|||||||||||FOZ_US|BAR, CHEWABLE|THRICE||ORAL GAVAGE||FOOT DIGIT 3|RIGHT|ANTEROTEMPORAL|U|||OPEN LABEL TREATMENT|1969-02-17|1967-10-30|||1970-03-29|||1972-01-23||1961-08-28
TRIAL STUDY 134XCP|EX|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|99|||||||||||/5X10^4 WBC|TABLET, DELAYED RELEASE|Q8H||INTRAGINGIVAL||URACHAL TRACT|UNILATERAL|FRONTAL|NA|||BASELINE|1972-03-17|1970-04-19|||1971-12-02|||1966-04-12||1964-05-26
TRIAL STUDY 134XCP|EX|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|100|||||||||||UL/ML|AEROSOL, FOAM|Q5H||INTRAPLEURAL||SUPRACLAVICULAR LYMPH NODE|UNILATERAL|PERIPHERAL|NA|||OPEN LABEL TREATMENT|1966-06-14|1969-04-18|||1970-11-26|||1973-04-09||1965-01-27
TRIAL STUDY 134XCP|EX|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|101|||||||||||HZ/S|CAPSULE, DELAYED RELEASE|Q11H||INTRAVESICAL||ANTERIOR TIBIAL ARTERY|CONTRALATERAL|CAUDAL|U|||BASELINE|1961-12-18|1968-11-06|||1967-04-07|||1968-07-18||1964-11-17
TRIAL STUDY 134XCP|EX|1F75D53C-E8AA-45DA-8410-F00266080E80|102|||||||||||%/S|RING|TID||EXTRA-AMNIOTIC||METATARSAL BONE|IPSILATERAL|INFERIOR|N|||CONTINUATION TREATMENT|1965-11-05|1962-11-17|||1968-12-12|||1970-09-06||1961-05-17
TRIAL STUDY 134XCP|EX|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|103|||||||||||GENEQ/ML|TABLET, FOR SUSPENSION|QD||TRANSMUCOSAL||MEDIASTINUM, POSTERIOR|UNILATERAL|PROXIMAL VOLAR|Y|||BASELINE|1969-07-04|1961-03-21|||1969-08-16|||1971-10-25||1965-03-15
TRIAL STUDY 134XCP|EX|EE14E53E-19A8-4441-BF82-31444CBC8B49|104|||||||||||CM2|PASTE, DENTIFRICE|2 TIMES PER WEEK||INTRACORPORUS CAVERNOSUM||MITRAL VALVE, ANTERIOR CUSP|UNILATERAL|PARIETO-OCCIPITAL|N|||OBSERVATION|1967-12-03|1966-05-20|||1967-04-17|||1971-06-14||1960-04-05
TRIAL STUDY 134XCP|EX|DAF741EF-DCCF-4E18-844B-05640A94C181|105|||||||||||MKAT|SOLUTION, FOR SLUSH|Q9H||INTRACORONARY||ANTRUM PYLORI|LATERAL|VOLAR|Y|||TREATMENT|1963-05-08|1963-03-04|||1964-10-22|||1965-03-24||1960-10-01
TRIAL STUDY 134XCP|EX|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|106|||||||||||CL|LIPSTICK|Q48H||IRRIGATION||T5 VERTEBRA|CONTRALATERAL|LOWER|NA|||BASELINE|1970-05-06|1969-10-26|||1964-05-09|||1970-11-02||1965-07-21
TRIAL STUDY 134XCP|EX|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|107|||||||||||MG/KG/MIN|FOR SUSPENSION, EXTENDED RELEASE|Q4H||INTRATHECAL||RETROCRURAL LYMPH NODE|LATERAL|LATERAL|Y|||WASHOUT|1972-10-11|1965-11-17|||1966-04-18|||1971-07-15||1968-08-27
TRIAL STUDY 134XCP|EX|CF3E1636-762F-4821-A44E-455F33F5E4CC|108|||||||||||MMOL/MOL|CREAM, AUGMENTED|EVERY AFTERNOON||ENTERAL||INGUINAL LYMPH NODE|RIGHT|ANTEROPOSTERIOR|N|||SCREENING|1971-08-31|1973-06-15|||1971-03-20|||1966-05-22||1971-12-27
TRIAL STUDY 134XCP|EX|3846A0A8-2D38-44C9-A579-84C66315C436|109|||||||||||SBE/ML|INJECTABLE, LIPOSOMAL|3 TIMES PER CYCLE||PERCUTANEOUS||OLFACTORY NERVE|RIGHT|OUTER|NA|||CONTINUATION TREATMENT|1971-07-12|1972-05-10|||1971-07-02|||1971-04-18||1962-03-25
TRIAL STUDY 134XCP|EX|75B429C2-E173-4F72-8D4A-76F62C97F006|110|||||||||||DNA COPIES/ML|SALVE|Q4M||TRANSDERMAL||COCCYGEAL VERTEBRA|UNILATERAL|SUPERIOR|N|||LONG-TERM FOLLOW-UP|1971-07-19|1966-08-03|||1960-07-17|||1968-09-01||1962-08-08
TRIAL STUDY 134XCP|EX|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|111|||||||||||MAC50|BEAD|Q14H||INTRALYMPHATIC||ASCENDING AORTA, AORTIC ROOT|UNILATERAL|LOWER|N|||BASELINE|1972-06-08|1965-08-26|||1968-07-17|||1966-11-26||1973-07-24
TRIAL STUDY 134XCP|EX|8065F0B9-9183-43E4-998A-D2F096D87998|112|||||||||||MG/KG/H|CLOTH|EVERY 2 WEEKS||INTRAHEPATIC||RETROPERITONEUM|IPSILATERAL|FORE|U|||RUN-IN|1960-08-25|1972-01-26|||1971-04-21|||1973-01-18||1969-06-22
TRIAL STUDY 134XCP|EX|697EB3B7-5AD1-4D1D-BB53-BB0556915957|113|||||||||||ML/DAY|GEL, METERED|Q3H||INTRACARTILAGINOUS||SACRAL VERTEBRA|BILATERAL|INFERIOR|N|||WASHOUT|1967-10-19|1966-07-10|||1961-03-09|||1963-01-26||1972-07-13
TRIAL STUDY 134XCP|EX|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|114|||||||||||KG/CM|TABLET, IMMEDIATE RELEASE|Q14H||INTRAPULMONARY||INTESTINE|BILATERAL|LOWER FLEXOR SURFACE|N|||SCREENING|1965-04-04|1971-07-18|||1971-11-18|||1965-07-19||1969-02-28
TRIAL STUDY 134XCP|EX|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|115|||||||||||LOG10 PFU|IMPLANT|EVERY 12 WEEKS||INTRAVITREAL||SCAPHOID-RADIUS JOINT|CONTRALATERAL|DORSOLATERAL|N|||RUN-IN|1965-01-03|1965-06-12|||1963-08-13|||1962-06-11||1971-07-16
TRIAL STUDY 134XCP|EX|52EC57AA-56E4-47A8-AADA-36F62653B423|116|||||||||||10^12/L|STRIP|2 TIMES PER WEEK||INTRABURSAL||GENITOURINARY SYSTEM|IPSILATERAL|PERIVENTRICULAR|U|||FOLLOW-UP|1964-07-21|1962-12-03|||1967-04-13|||1960-06-27||1968-02-29
TRIAL STUDY 134XCP|EX|F09C04A4-4F9E-4033-9115-81C6007DE8B4|117|||||||||||/MIN|SOAP|Q23H||INTRABILIARY||BRACHIAL PLEXUS|LEFT|LOWER FLEXOR SURFACE|N|||INDUCTION TREATMENT|1967-01-31|1960-04-28|||1968-01-01|||1969-02-11||1973-06-12
TRIAL STUDY 134XCP|EX|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|118|||||||||||V/V|CAPSULE|AD LIBITUM||INTRACARDIAC||ANTERIOR CINGULATE CORTEX|CONTRALATERAL|CAUDAL|U|||FOLLOW-UP|1971-04-25|1972-12-01|||1969-12-10|||1972-06-09||1967-08-11
TRIAL STUDY 134XCP|EX|4779A01C-1219-46AC-B0F7-71C9717A2B45|119|||||||||||NMOL/ML/MIN|SOLUTION, GEL FORMING, EXTENDED RELEASE|EVERY 3 YEARS||HEMODIALYSIS||ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LEFT|OCCIPITAL|NA|||SCREENING|1961-01-23|1962-03-27|||1960-08-08|||1963-03-05||1973-07-08
TRIAL STUDY 134XCP|EX|5F5C5DED-7547-40D2-9B34-77B37CCD7732|120|||||||||||10^7 TCID 50/DOSE|INTRAUTERINE DEVICE|9 TIMES PER DAY||UNASSIGNED||CAUDAL VERTEBRA|LEFT|CENTRAL|U|||CONTINUATION TREATMENT|1971-12-31|1962-08-28|||1971-07-19|||1967-05-09||1969-02-13
TRIAL STUDY 134XCP|EX|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|121|||||||||||10^3 ORGANISMS/ML|CAPSULE, LIQUID FILLED|PA||INTRASTOMAL||UPPER RESPIRATORY SYSTEM|LEFT|UPPER FLEXOR SURFACE|Y|||FOLLOW-UP|1965-04-23|1966-02-06|||1967-03-21|||1960-10-19||1960-01-22
TRIAL STUDY 134XCP|EX|48348DF0-33DA-457F-86C6-797FF7B32857|122|||||||||||CM2|CAPSULE, FILM COATED, EXTENDED RELEASE|Q4D||INTRAVENTRICULAR||BRAIN, PERIVENTRICULAR REGION|RIGHT|OUTER|Y|||OBSERVATION|1966-06-08|1967-08-23|||1972-05-13|||1962-06-26||1961-06-09
TRIAL STUDY 134XCP|EX|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|123|||||||||||NG/L|CLOTH|QD||INTRAOCULAR||AORTA|IPSILATERAL|PARIETO-OCCIPITAL|N|||CONTINUATION TREATMENT|1972-03-12|1963-03-22|||1968-09-13|||1971-08-29||1964-12-26
TRIAL STUDY 134XCP|EX|396CC122-5F23-418D-A75E-572ADF4FD6C1|124|||||||||||NG|IRRIGANT|3 TIMES PER MONTH||INTRACORPORUS CAVERNOSUM||ACCESSORY RENAL ARTERY|RIGHT|NASAL|U|||BASELINE|1961-02-21|1963-05-14|||1969-03-04|||1960-12-15||1967-12-09
TRIAL STUDY 134XCP|EX|9CF3CD51-5D5B-40E6-8F13-B314911BE461|125|||||||||||BAR|FOR SUSPENSION|5 TIMES PER WEEK||INTRACAVITARY||SUBMENTAL LYMPH NODE|LEFT|PROXIMAL|NA|||RUN-IN|1972-06-07|1963-08-05|||1970-10-27|||1972-02-14||1970-04-18
TRIAL STUDY 134XCP|EX|CB3B9054-5CDC-418D-8071-7429B1702587|126|||||||||||ML/S|GRANULE, EFFERVESCENT|4 TIMES PER WEEK||PERIODONTAL||C1 VERTEBRA|CONTRALATERAL|CAUDAL|N|||BLINDED TREATMENT|1963-11-27|1970-03-26|||1966-01-06|||1962-11-25||1972-03-02
TRIAL STUDY 134XCP|EX|1AC4DE34-3486-41FB-A979-8B368912F75A|127|||||||||||UMOL/MOL|GUM, CHEWING|EVERY 6 WEEKS||INTRACEREBRAL||GLOSSOPHARYNGEAL NERVE|LATERAL|TEMPORAL|U|||TREATMENT|1960-01-25|1962-06-07|||1965-04-21|||1965-08-14||1966-05-26
TRIAL STUDY 134XCP|EX|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|128|||||||||||S^-1(%O2)^-1|SWAB|Q6D||TRANSTYMPANIC||MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|MIDLINE|U|||CONTINUATION TREATMENT|1964-05-28|1963-10-07|||1964-09-29|||1972-10-14||1972-10-11
TRIAL STUDY 134XCP|EX|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|129|||||||||||MG/MIN|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|Q19H||INTRATHALAMIC||TIBIOTARSAL JOINT|RIGHT|LOWER|U|||TREATMENT|1973-02-16|1967-05-30|||1973-06-16|||1966-01-30||1966-09-28
TRIAL STUDY 134XCP|EX|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|130|||||||||||TITER|POWDER, FOR SUSPENSION|5 TIMES PER YEAR||INTRAMENINGEAL||MUSCULOSKELETAL SYSTEM|LATERAL|PERIVENTRICULAR|N|||OBSERVATION|1963-10-14|1970-08-16|||1970-01-25|||1966-12-08||1971-06-11
TRIAL STUDY 134XCP|EX|0194CD2F-7ABE-4BEE-A6FC-61298880173D|131|||||||||||USEC|GAS|3 TIMES PER YEAR||TRANSMUCOSAL||CORNEA|CONTRALATERAL|ANTEROLATERAL|U|||BLINDED TREATMENT|1972-07-28|1969-11-06|||1971-03-09|||1961-01-15||1963-03-25
TRIAL STUDY 134XCP|EX|A6E531C7-1BC1-402E-9B2E-03B44313487B|132|||||||||||ML/DAY|DRUG DELIVERY SYSTEM|EVERY WEEK||INTRAVITREAL||RETROCRURAL LYMPH NODE|RIGHT|UPPER|Y|||CONTINUATION TREATMENT|1971-10-01|1964-12-09|||1966-11-10|||1970-05-13||1968-11-01
TRIAL STUDY 134XCP|EX|47C0D833-BEAB-4BF2-B028-891808E729F1|133|||||||||||10^6 ORGANISMS|ELIXIR|QN||OPHTHALMIC||CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|CONTRALATERAL|HIND|U|||BASELINE|1972-08-04|1970-04-10|||1973-03-31|||1971-01-24||1972-11-20
TRIAL STUDY 134XCP|EX|BA1773BD-AA89-45FC-B7C6-C5267770B197|134|||||||||||MCI|CAPSULE, COATED PELLETS|EVERY AFTERNOON||INTRALUMINAL||CORPUS CALLOSUM, BODY|UNILATERAL|PARIETO-OCCIPITAL|U|||INDUCTION TREATMENT|1967-07-26|1962-03-15|||1968-02-12|||1963-02-07||1963-11-21
TRIAL STUDY 134XCP|EX|03D3DDC6-03FA-469A-B8A4-D504919B68F1|135|||||||||||KBQ/UL|SUSPENSION/DROPS|Q6H||INTRASURGICAL SITE||OPHTHALMIC ARTERY|BILATERAL|ANTEROMEDIAL|NA|||OPEN LABEL TREATMENT|1971-12-04|1965-10-18|||1969-03-14|||1962-05-07||1968-12-31
TRIAL STUDY 134XCP|EX|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|136|||||||||||SQU/ML|LOTION, AUGMENTED|Q3H||INTRACAUDAL||FACET JOINT|LEFT|NASAL|N|||INDUCTION TREATMENT|1960-07-05|1964-11-23|||1960-02-20|||1964-09-06||1973-07-10
TRIAL STUDY 134XCP|EX|1873D4CC-40B7-4303-9F07-8FE0E4595361|137|||||||||||KCAL|FOR SOLUTION|7 TIMES PER DAY||INTRATUMOR||HAND DIGIT 1|IPSILATERAL|FACIAL|U|||FOLLOW-UP|1967-02-28|1970-10-14|||1968-05-15|||1971-01-22||1966-08-24
TRIAL STUDY 134XCP|EX|23E5569E-B324-4399-AC8A-5EC7C343C1D3|138|||||||||||PATCH|POWDER, DENTIFRICE|3 TIMES PER WEEK||INTRAOVARIAN||THROAT|BILATERAL|VENTRAL|Y|||SCREENING|1969-07-03|1961-09-07|||1961-02-07|||1970-01-30||1968-02-25
TRIAL STUDY 134XCP|EX|B349DD89-C41F-470E-8B54-B3589F0982FE|139|||||||||||L/MIN/M2|AEROSOL, POWDER|1 TIME PER WEEK||DIETARY||LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|UNILATERAL|ROSTRAL|NA|||CONTINUATION TREATMENT|1972-03-18|1971-07-18|||1962-05-06|||1965-03-10||1971-03-20
TRIAL STUDY 134XCP|EX|415D178A-275A-440C-8617-154441A48F8D|140|||||||||||CMOL/L|TAPE|UNKNOWN||PERIDURAL||SALIVARY GLAND|LATERAL|PROXIMAL|NA|||BLINDED TREATMENT|1971-05-29|1973-03-12|||1962-09-18|||1962-05-03||1962-02-01
TRIAL STUDY 134XCP|EX|C23917E6-6CA5-4314-A59D-A0298483BF53|141|||||||||||U/M2/DAY|INJECTION, SOLUTION, CONCENTRATE|Q24H||HEMODIALYSIS||THIRD POSTEROLATERAL DESCENDING ARTERY|LATERAL|DISTAL VOLAR|NA|||OPEN LABEL TREATMENT|1962-10-01|1972-07-31|||1963-07-20|||1962-06-27||1965-04-17
TRIAL STUDY 134XCP|EX|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|142|||||||||||BLOCKS|CORE, EXTENDED RELEASE|EVERY 6 WEEKS||SUBMUCOSAL||INGUINAL REGION|IPSILATERAL|INNER|U|||RUN-IN|1964-03-11|1966-04-20|||1967-10-11|||1968-07-04||1968-12-10
TRIAL STUDY 134XCP|EX|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|143|||||||||||SCM|GRANULE, DELAYED RELEASE|8 TIMES PER DAY||INTRASURGICAL SITE||MEDIASTINAL LYMPH NODE|UNILATERAL|OUTER|U|||OPEN LABEL TREATMENT|1962-12-07|1967-05-31|||1961-09-06|||1972-05-16||1972-01-31
TRIAL STUDY 134XCP|EX|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|144|||||||||||10^10/L|CEMENT|EVERY EVENING||INTRAGASTRIC||XIPHOID PROCESS|RIGHT|TIP|NA|||CONTINUATION TREATMENT|1960-01-09|1968-03-08|||1970-03-26|||1973-03-24||1970-11-08
TRIAL STUDY 134XCP|EX|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|145|||||||||||DRUM|TABLET, MODIFIED RELEASE, LONG DURATION|BID||SUBLINGUAL||THYROID GLAND, RIGHT LOBE|LATERAL|SUPERFICIAL|U|||OPEN LABEL TREATMENT|1972-08-14|1964-09-11|||1963-04-12|||1969-09-27||1963-07-28
TRIAL STUDY 134XCP|EX|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|146|||||||||||UMOL/L/MIN|CAPLET|CONTINUOUS||PHARYNGEAL||HEAD|LEFT|LOWER EXTENSOR SURFACE|NA|||SCREENING|1961-12-18|1971-09-14|||1966-11-22|||1973-03-12||1973-02-03
TRIAL STUDY 134XCP|EX|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|147|||||||||||10^5/HPF|GLOBULE|QPM||ELECTRO-OSMOSIS||THORACIC CAVITY|UNILATERAL|DISTAL VOLAR|Y|||INDUCTION TREATMENT|1961-10-22|1961-01-12|||1967-07-24|||1968-04-12||1963-04-25
TRIAL STUDY 134XCP|EX|EDB6B55B-7903-4F89-805C-32F067C2A230|148|||||||||||LOG10 TCID 50/DOSE|PELLET|Q2H||INTRAVENOUS DRIP||SKIN OF THE HEAD|LATERAL|POSTERIOR|U|||CONTINUATION TREATMENT|1966-08-20|1966-03-25|||1965-10-14|||1972-11-13||1967-05-02
TRIAL STUDY 134XCP|EX|8F6772DE-E4CA-4706-8754-740D3859ABDF|149|||||||||||CAPFUL|INJECTION|AD LIBITUM||INTRAPERICARDIAL||ESOPHAGUS, THORACIC|LEFT|ANTEROMEDIAL|U|||FOLLOW-UP|1965-11-29|1968-06-12|||1960-04-20|||1969-01-18||1966-10-07
TRIAL STUDY 134XCP|EX|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|150|||||||||||KBQ/UL|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|EVERY WEEK||INTRAVITREAL||ISCHIUM|UNILATERAL|ANTEROPOSTERIOR|N|||RUN-IN|1968-08-24|1971-05-04|||1972-08-02|||1965-02-21||1962-12-22
TRIAL STUDY 134XCP|EX|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|151|||||||||||/100 HPFS|LOTION, AUGMENTED|7 TIMES PER DAY||INTRA-ARTERIAL||PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|SUBCORTICAL|NA|||WASHOUT|1970-08-21|1971-03-03|||1963-05-07|||1968-09-13||1962-09-14
TRIAL STUDY 134XCP|EX|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|152|||||||||||PLUG|SUTURE|2 TIMES PER YEAR||RECTAL||OVARIAN FOLLICLE|IPSILATERAL|INNER|Y|||WASHOUT|1965-08-06|1967-07-27|||1963-09-01|||1970-01-14||1968-09-24
TRIAL STUDY 134XCP|EX|B3987A78-0D92-419D-A289-039C87C6C202|153|||||||||||POINT|AEROSOL, FOAM|Q21H||PERCUTANEOUS||PARIETAL LOBE|BILATERAL|SURFACE|U|||OBSERVATION|1962-11-19|1964-01-04|||1966-05-12|||1962-12-01||1960-12-20
TRIAL STUDY 134XCP|EX|2A0D27D8-EC46-4B40-B1BB-078268E03355|154|||||||||||MMOL/DAY|INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE|Q7D||INTRAPERICARDIAL||GINGIVA|IPSILATERAL|CAUDAL|N|||BASELINE|1965-04-23|1970-09-06|||1971-11-08|||1971-07-08||1966-03-02
TRIAL STUDY 134XCP|EX|65EBB2AF-B97A-403A-9FB5-31C1559074C4|155|||||||||||UV2|TABLET, MULTILAYER, EXTENDED RELEASE|8 TIMES PER DAY||INTRATHORACIC||PROXIMAL PHALANX 4 OF THE HAND|IPSILATERAL|UPPER FLEXOR SURFACE|N|||INDUCTION TREATMENT|1970-03-05|1970-05-01|||1962-10-28|||1964-06-15||1961-04-06
TRIAL STUDY 134XCP|EX|90892428-99C3-4E7D-B3A8-3C526812EDD2|156|||||||||||MIN/DAY|FILM, EXTENDED RELEASE|4 TIMES PER WEEK||INTRAILEAL||LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LATERAL|INTERMEDIATE|N|||OBSERVATION|1969-01-04|1962-10-05|||1969-04-19|||1961-07-06||1963-11-02
TRIAL STUDY 134XCP|EX|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|157|||||||||||MU/G|LIQUID, EXTENDED RELEASE|3 TIMES PER MONTH||INTRAVENOUS||MID-RIGHT CORONARY ARTERY CONDUIT|LEFT|ANTEROPOSTERIOR|Y|||INDUCTION TREATMENT|1969-12-17|1965-05-12|||1968-03-10|||1963-01-31||1968-05-23
TRIAL STUDY 134XCP|EX|2B443EEA-B98B-47D9-8D27-801582804AB5|158|||||||||||10^6 COPIES/ML|INJECTABLE, LIPOSOMAL|8 TIMES PER DAY||INTRAMEDULLARY||ADDUCTOR MAGNUS MUSCLE|IPSILATERAL|DEEP|NA|||BASELINE|1968-10-05|1969-09-27|||1961-07-10|||1971-01-13||1961-10-13
TRIAL STUDY 134XCP|EX|0278D57A-30D6-4B7A-A45C-EB973F6686C6|159|||||||||||M|OINTMENT|Q36H||NOT APPLICABLE||CHOROID PLEXUS|IPSILATERAL|VENTRAL|Y|||TREATMENT|1964-06-12|1972-11-27|||1968-04-17|||1972-12-16||1967-07-24
TRIAL STUDY 134XCP|EX|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|160|||||||||||/100 WBC|GEL, DENTIFRICE|UNKNOWN||INTRABURSAL||FUNDUS OF THE EYE|RIGHT|DORSAL|Y|||INDUCTION TREATMENT|1963-12-17|1970-12-24|||1963-08-17|||1972-04-11||1964-08-20
TRIAL STUDY 134XCP|EX|67D6A191-10C7-4414-BA63-DB7701998DF0|161|||||||||||UMOL/L/H|LIPSTICK|4 TIMES PER YEAR||INTRA-ABDOMINAL||PAROTID GLAND|LEFT|PROXIMAL VOLAR|Y|||BASELINE|1971-12-19|1966-04-24|||1968-06-26|||1965-03-04||1963-01-11
TRIAL STUDY 134XCP|EX|499B5A47-893A-40DE-9B64-60967378C81A|162|||||||||||MG/KG/DAY|CEMENT|EVERY 16 WEEKS||INTRAEPIDERMAL||SPLENIC VEIN|IPSILATERAL|BASAL|Y|||BLINDED TREATMENT|1973-04-17|1960-09-23|||1964-02-15|||1963-12-16||1970-08-22
TRIAL STUDY 134XCP|EX|984103CA-F301-4510-A9DD-4916FA858EA2|163|||||||||||MOL/G|GLOBULE|Q4D||INTRAVITREAL||KNEE JOINT TENDONS|BILATERAL|PROXIMAL VOLAR|Y|||SCREENING|1973-06-29|1964-04-30|||1966-03-26|||1970-06-14||1960-04-29
TRIAL STUDY 134XCP|EX|50E626B3-9133-4A50-8907-2388DAC22AD1|164|||||||||||IMPLANT|LIQUID|Q3H||INTRABILIARY||TRIGEMINAL NERVE|IPSILATERAL|NASAL|NA|||SCREENING|1968-04-29|1965-11-19|||1965-03-08|||1969-11-11||1970-12-15
TRIAL STUDY 134XCP|EX|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|165|||||||||||WATT|INJECTION|Q2H||ENDOTRACHEAL||RIB 2|LEFT|PARIETO-OCCIPITAL|N|||CONTINUATION TREATMENT|1967-11-20|1972-02-08|||1961-02-16|||1972-07-19||1966-07-24
TRIAL STUDY 134XCP|EX|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|166|||||||||||KAT|CEMENT|Q2H||PHARYNGEAL||PLEURAL CAVITY|LATERAL|ANTEROLATERAL|Y|||SCREENING|1963-12-15|1964-06-06|||1964-12-26|||1964-07-20||1965-03-08
TRIAL STUDY 134XCP|EX|F8F17A43-A74B-4570-8A06-D7657A4636B4|167|||||||||||UKAT/10^12 RBC|GLOBULE|Q45MIN||TOPICAL||THYMUS GLAND|BILATERAL|TIP|NA|||INDUCTION TREATMENT|1960-12-30|1967-07-17|||1961-03-22|||1965-06-08||1967-03-13
TRIAL STUDY 134XCP|EX|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|168|||||||||||PACKET|NOT APPLICABLE|EVERY 4 WEEKS||ENTERAL||VESTIBULOCOCHLEAR NERVE|BILATERAL|VENTROLATERAL|U|||WASHOUT|1965-12-24|1960-05-23|||1967-05-14|||1971-10-08||1960-07-30
TRIAL STUDY 134XCP|EX|1177FD36-AAE8-4139-991A-A8C98B607565|169|||||||||||VP/DOSE|CAPSULE, COATED, EXTENDED RELEASE|Q10H||ENDOTRACHEAL||ABDUCTOR DIGITI QUINTI MUSCLE|UNILATERAL|ROSTRAL|N|||SCREENING|1961-07-22|1972-05-17|||1971-09-15|||1967-09-22||1963-12-30
TRIAL STUDY 134XCP|EX|8C57F469-7CDF-493A-9839-C179D912A8A5|170|||||||||||NMOL/L|EXTRACT|QAM||PERCUTANEOUS||ASCENDING AORTA, AORTIC ROOT|UNILATERAL|LOWER MEDIAL|NA|||RUN-IN|1972-08-13|1963-05-04|||1966-01-23|||1968-02-10||1962-06-02
TRIAL STUDY 134XCP|EX|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|171|||||||||||DNA COPIES/UG|INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE|6 TIMES PER YEAR||INTRABRONCHIAL||PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|DEEP|N|||FOLLOW-UP|1960-09-18|1964-04-27|||1964-06-17|||1967-05-15||1968-07-09
TRIAL STUDY 134XCP|EX|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|172|||||||||||/5X10^4 WBC|TABLET, MODIFIED RELEASE, LONG DURATION|7 TIMES PER WEEK||DENTAL||RIB 12|CONTRALATERAL|FORE|NA|||CONTINUATION TREATMENT|1962-03-30|1972-09-02|||1964-04-06|||1968-02-06||1970-06-23
TRIAL STUDY 134XCP|EX|0AE36450-F37E-4F97-A250-79166011FCD7|173|||||||||||VOXEL|GEL|3 TIMES PER MONTH||INTRAUTERINE||SPLEEN, HILUM|IPSILATERAL|CENTRAL|N|||FOLLOW-UP|1967-02-11|1968-07-28|||1971-03-20|||1964-08-17||1968-12-24
TRIAL STUDY 134XCP|EX|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|174|||||||||||AMP|CONE|3 TIMES PER YEAR||INTRADURAL||BLADDER, DOME|UNILATERAL|APICAL|N|||TREATMENT|1971-10-18|1969-08-14|||1964-08-17|||1973-05-03||1965-11-26
TRIAL STUDY 134XCP|EX|707FC46F-B8B1-456B-9E09-CABC86EA61D5|175|||||||||||NMOL/L/H|TABLET, MODIFIED RELEASE|3 TIMES PER WEEK||UNKNOWN||LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|RIGHT|TEMPORAL|U|||OPEN LABEL TREATMENT|1965-01-10|1972-08-31|||1963-06-03|||1973-08-09||1963-06-25
TRIAL STUDY 134XCP|EX|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|176|||||||||||FINGERTIP UNIT|GAS|QID||INTRALYMPHATIC||L5 VERTEBRA|RIGHT|DORSOLATERAL|Y|||TREATMENT|1965-08-20|1962-10-17|||1969-10-03|||1967-08-30||1968-09-15
TRIAL STUDY 134XCP|EX|70196099-5D40-4048-AABF-EB40CE345328|177|||||||||||10^6 ORGANISMS/G|CAPSULE, IMMEDIATE RELEASE|TID||NASOGASTRIC||METATARSOPHALANGEAL JOINT 5|LEFT|VENTROLATERAL|NA|||CONTINUATION TREATMENT|1965-06-06|1973-08-28|||1967-01-26|||1964-12-16||1966-03-14
TRIAL STUDY 134XCP|EX|F9D4C544-F217-4676-AC40-F71CC48045AF|178|||||||||||L/DAY|AEROSOL, METERED|EVERY 3 YEARS||INTRACAVERNOUS||METACARPOPHALANGEAL JOINT 4|UNILATERAL|PARIETO-OCCIPITAL|Y|||LONG-TERM FOLLOW-UP|1963-05-27|1968-05-25|||1972-11-12|||1963-01-05||1969-03-01
TRIAL STUDY 134XCP|EX|E6A42133-B082-4BD7-B840-A60E49E0562B|179|||||||||||CFU/ML|FILM, EXTENDED RELEASE|4 TIMES PER WEEK||OROPHARYNGEAL||SPINOUS PROCESS|CONTRALATERAL|PERIPHERAL|U|||LONG-TERM FOLLOW-UP|1972-08-14|1970-10-09|||1960-09-16|||1963-01-14||1965-09-18
TRIAL STUDY 134XCP|EX|72C9FDBC-AA86-4001-9820-90AAF5422074|180|||||||||||PATCH|TABLET, MODIFIED RELEASE|2 TIMES PER CYCLE||INTRAMANDIBULAR||LIMB|RIGHT|UPPER|Y|||WASHOUT|1965-06-05|1970-11-21|||1962-06-29|||1967-04-04||1965-11-14
TRIAL STUDY 134XCP|EX|186520B9-8AAD-4063-B48F-16040EF49944|181|||||||||||10^3 DNA COPIES/ML|TABLET, SOLUBLE|Q7D||INTRACARDIAC||CORPUS UTERI|UNILATERAL|CRANIAL|N|||CONTINUATION TREATMENT|1972-11-08|1972-03-13|||1961-12-13|||1971-07-01||1964-04-07
TRIAL STUDY 134XCP|EX|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|182|||||||||||V/V|SOLUTION, CONCENTRATE|5 TIMES PER MONTH||ORAL||ABDUCENS NERVE|LATERAL|UPPER FLEXOR SURFACE|N|||WASHOUT|1968-10-02|1971-09-04|||1971-04-02|||1972-12-16||1964-05-13
TRIAL STUDY 134XCP|EX|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|183|||||||||||BQ/L|CAPSULE, EXTENDED RELEASE|INTERMITTENT||OROPHARYNGEAL||COLON, SIGMOID|BILATERAL|ANTEROLATERAL|Y|||BASELINE|1965-10-29|1967-02-13|||1969-01-18|||1963-05-28||1973-06-18
TRIAL STUDY 134XCP|EX|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|184|||||||||||UU/DL|TABLET, MULTILAYER|TWICE||TRANSTYMPANIC||SUPERIOR PUBIC RAMUS|IPSILATERAL|CENTRAL|U|||BASELINE|1966-05-14|1967-12-20|||1964-05-04|||1967-07-04||1966-02-27
TRIAL STUDY 134XCP|EX|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|185|||||||||||VIAL|CORE, EXTENDED RELEASE|EVERY 3 YEARS||SUPRACHOROIDAL||URETERIC ORIFICE|RIGHT|SUBCORTICAL|Y|||CONTINUATION TREATMENT|1966-12-28|1967-02-06|||1966-08-29|||1973-08-14||1961-07-08
TRIAL STUDY 134XCP|EX|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|186|||||||||||DNA COPIES/UG|DOUCHE|QN||TOPICAL||ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|LOWER MEDIAL|NA|||TREATMENT|1963-10-24|1967-08-10|||1971-03-06|||1971-03-19||1969-01-23
TRIAL STUDY 134XCP|EX|460486B3-B7C8-4B54-848B-21BA899EAAD6|187|||||||||||ABSORBANCE U/ML|PASTE, DENTIFRICE|Q11H||BUCCAL||RECTUS FEMORIS MUSCLE|LEFT|LATERAL|Y|||OBSERVATION|1962-01-12|1961-11-05|||1964-05-15|||1971-05-09||1969-08-18
TRIAL STUDY 134XCP|EX|A068436F-E26E-44C5-8959-0BCBA28832D1|188|||||||||||10^12/L|DRUG DELIVERY SYSTEM|Q3M||INTRAVENOUS DRIP||LOWER RESPIRATORY SYSTEM|LATERAL|PROXIMAL VOLAR|N|||RUN-IN|1967-10-02|1960-09-08|||1960-10-04|||1973-07-09||1973-01-16
TRIAL STUDY 134XCP|EX|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|189|||||||||||IU|INJECTION, SUSPENSION, SONICATED|CONTINUOUS||BUCCAL||TESTIS|CONTRALATERAL|UPPER FLEXOR SURFACE|NA|||CONTINUATION TREATMENT|1963-03-13|1962-07-22|||1966-08-28|||1968-01-29||1972-09-30
TRIAL STUDY 134XCP|EX|E065D436-92D2-453F-86A7-27F70FE1FD03|190|||||||||||DAYS/WK|INJECTION, SUSPENSION, EXTENDED RELEASE|Q2M||INTRAPULMONARY||LIMB, LOWER|LEFT|ROSTRAL|Y|||WASHOUT|1971-02-10|1960-03-06|||1971-01-07|||1972-08-15||1971-03-16
TRIAL STUDY 134XCP|EX|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|191|||||||||||10^6 IU|TABLET|1 TIME PER WEEK||OPHTHALMIC||FRONTAL SINUS|UNILATERAL|LOWER MEDIAL|Y|||RUN-IN|1961-06-03|1963-02-22|||1968-03-16|||1971-03-08||1967-02-19
TRIAL STUDY 134XCP|EX|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|192|||||||||||CFU/G|AEROSOL, SPRAY|8 TIMES PER DAY||INTRATHALAMIC||TRACHEOBRONCHIAL TREE|UNILATERAL|UPPER FLEXOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1964-05-23|1960-12-15|||1960-01-26|||1964-06-14||1962-06-29
TRIAL STUDY 134XCP|EX|D108D040-7177-4A14-8CA7-748D59DC5F8B|193|||||||||||MAC50|SWAB|EVERY 6 WEEKS||INTRAMENINGEAL||PERIFACIAL LYMPH NODE|IPSILATERAL|UPPER EXTENSOR SURFACE|U|||OBSERVATION|1960-03-04|1969-11-03|||1968-06-03|||1967-07-31||1963-02-13
TRIAL STUDY 134XCP|EX|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|194|||||||||||CMOL/L|INJECTABLE, LIPOSOMAL|5 TIMES PER DAY||INTRASTOMAL||TIBIO-PERONEAL TRUNK|UNILATERAL|ANTEROPOSTERIOR|Y|||RUN-IN|1960-05-10|1960-01-02|||1968-09-07|||1972-06-13||1969-05-20
TRIAL STUDY 134XCP|EX|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|195|||||||||||PMOL/L/H|LIQUID|EVERY WEEK||PHARYNGEAL||EPIGLOTTIS|LEFT|PARIETO-OCCIPITAL|Y|||SCREENING|1962-06-02|1960-07-19|||1962-05-14|||1970-10-23||1963-07-26
TRIAL STUDY 134XCP|EX|580CCA66-3D51-4A5C-80E1-361A90369055|196|||||||||||PIPE|SYRUP|Q11H||SUPRACHOROIDAL||ARTERY|CONTRALATERAL|ANTERIOR|Y|||BLINDED TREATMENT|1966-01-18|1961-09-25|||1973-01-02|||1965-09-11||1965-08-12
TRIAL STUDY 134XCP|EX|DAB276EB-3581-4C20-88AC-5A3D267E54D8|197|||||||||||CI/G|FOR SOLUTION|UNKNOWN||INTRASTOMAL||ILIOPSOAS MUSCLE|LEFT|TIP|NA|||OPEN LABEL TREATMENT|1963-11-26|1961-09-27|||1970-07-16|||1969-06-26||1969-12-01
TRIAL STUDY 134XCP|EX|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|198|||||||||||USIEMENS|SUSPENSION|Q4H||TRANSTYMPANIC||TIBIALIS POSTERIOR MUSCLE|LEFT|POSTERIOR|N|||LONG-TERM FOLLOW-UP|1960-07-14|1973-07-31|||1965-07-12|||1969-02-26||1963-03-20
TRIAL STUDY 134XCP|EX|5B703A43-A280-4D6A-AC40-FF5187521DB2|199|||||||||||M|SOLUTION, GEL FORMING / DROPS|3 TIMES PER CYCLE||INTRAPULMONARY||VASTUS MEDIALIS MUSCLE|BILATERAL|FORE|U|||OPEN LABEL TREATMENT|1966-01-24|1965-11-10|||1965-01-21|||1967-03-01||1962-08-16
TRIAL STUDY 134XCP|EX|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|200|||||||||||LOG10 PFU/ML|BEAD, IMPLANT, EXTENDED RELEASE|10 DAYS PER MONTH||PERIARTICULAR||PYLORIC SPHINCTER|BILATERAL|APICAL|NA|||INDUCTION TREATMENT|1960-03-26|1961-01-05|||1973-07-03|||1970-06-03||1960-04-07
TRIAL STUDY 134XCP|EX|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|201|||||||||||V/SEC|PATCH|Q19H||INTRAVASCULAR||LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT|ROSTRAL|Y|||CONTINUATION TREATMENT|1972-06-24|1967-10-02|||1968-05-30|||1961-09-15||1966-06-11
TRIAL STUDY 134XCP|EX|51F3D3C1-3361-499F-B037-CCE8AB989989|202|||||||||||POINT|SHAMPOO|Q5H||INTRAVITREAL||MIDDLE PHALANX 5 OF THE HAND|LATERAL|BASAL|Y|||SCREENING|1965-05-22|1964-09-26|||1965-02-20|||1964-11-21||1965-07-21
TRIAL STUDY 134XCP|EX|231D401F-CA93-49E0-AC5C-C7F636343D2F|203|||||||||||SHOCK WAVE|OINTMENT, AUGMENTED|QID||INTRADERMAL||SKIN OF THE FOOT|RIGHT|DISTAL VOLAR|Y|||LONG-TERM FOLLOW-UP|1973-01-30|1965-11-30|||1972-01-29|||1964-11-25||1963-10-05
TRIAL STUDY 134XCP|EX|2704A3C0-3345-48E5-AC9B-C00EA51AB085|204|||||||||||CIGAR|TABLET, ORALLY DISINTEGRATING|QOD||INTRAVESICAL||SKIN OF THE ELBOW|UNILATERAL|LOWER EXTENSOR SURFACE|Y|||SCREENING|1972-01-13|1963-10-29|||1969-05-11|||1967-03-08||1970-11-08
TRIAL STUDY 134XCP|EX|2F636370-94FE-4BC0-9E16-DDD42D19A985|205|||||||||||OSM|CIGARETTE|9 TIMES PER DAY||INTRATYMPANIC||PECTORALIS MAJOR MUSCLE|LATERAL|PROXIMAL|Y|||OPEN LABEL TREATMENT|1966-04-10|1972-01-05|||1971-07-07|||1962-12-01||1969-09-04
TRIAL STUDY 134XCP|EX|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|206|||||||||||MOSM/L|FILM, SOLUBLE|3 TIMES PER YEAR||CUTANEOUS||PERIURETHRAL REGION|LATERAL|ANTEROTEMPORAL|U|||CONTINUATION TREATMENT|1970-02-26|1969-10-07|||1963-08-07|||1972-05-16||1967-11-10
TRIAL STUDY 134XCP|EX|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|207|||||||||||DIP|GLOBULE|EVERY 4 WEEKS||INTRAILEAL||NAVICULAR BONE|IPSILATERAL|INTERMEDIATE|N|||FOLLOW-UP|1969-11-10|1968-08-12|||1964-06-13|||1968-10-02||1969-05-29
TRIAL STUDY 134XCP|EX|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|208|||||||||||G/MOL|CREAM, AUGMENTED|8 TIMES PER DAY||INTRAILEAL||LARYNX|RIGHT|SURFACE|N|||TREATMENT|1969-01-14|1964-04-19|||1966-04-23|||1971-12-03||1963-02-08
TRIAL STUDY 134XCP|EX|A1FAB383-1757-4832-B888-90C133842EF8|209|||||||||||UMOL/DAY|GLOBULE|EVERY 7 WEEKS||INTRACAVITARY||FOREHEAD|CONTRALATERAL|OUTER|NA|||CONTINUATION TREATMENT|1963-08-26|1962-07-02|||1965-05-19|||1964-12-04||1972-08-27
TRIAL STUDY 134XCP|EX|72AA1945-E676-4485-BD7F-6B969E314D83|210|||||||||||U/10^12 RBC|DISC|5 TIMES PER DAY||INTRAGASTRIC||URETHRA, POSTERIOR|IPSILATERAL|PROXIMAL VOLAR|N|||INDUCTION TREATMENT|1962-05-14|1960-09-23|||1969-05-20|||1970-04-16||1963-11-04
TRIAL STUDY 134XCP|EX|B297C689-0D99-4E36-9F27-F93D4F43E2DD|211|||||||||||STEPS/MIN|AEROSOL|EVERY 16 WEEKS||INFILTRATION||AORTIC VALVE, NON-CORONARY CUSP|LEFT|CENTRAL|NA|||WASHOUT|1965-03-20|1963-08-30|||1972-12-09|||1971-09-11||1973-03-28
TRIAL STUDY 134XCP|EX|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|212|||||||||||MET|SHAMPOO|QAM||TRANSDERMAL||FLEXOR HALLUCIS LONGUS MUSCLE|UNILATERAL|DORSAL|NA|||WASHOUT|1972-01-19|1970-09-26|||1972-12-02|||1969-11-07||1964-05-23
TRIAL STUDY 134XCP|EX|3F18534E-367D-45C8-BB08-C82151A0CF00|213|||||||||||DDU|NOT APPLICABLE|BID||AURICULAR (OTIC)||LEFT VENTRICULAR APEX SEGMENT|LEFT|SUPERFICIAL|N|||BASELINE|1972-02-27|1967-06-21|||1966-08-30|||1970-07-19||1967-02-10
TRIAL STUDY 134XCP|EX|81C10FB0-3B47-46D8-B8B7-9C772246CA55|214|||||||||||MV*MIN|CAPSULE, GELATIN COATED|Q15H||OCCLUSIVE DRESSING TECHNIQUE||FRONTAL LOBE|RIGHT|ANTERIOR|Y|||TREATMENT|1966-11-25|1967-04-28|||1964-11-08|||1962-05-23||1963-09-24
TRIAL STUDY 134XCP|EX|67C99F41-D839-4B8E-9220-6EC161FCD457|215|||||||||||RATIO|DRUG DELIVERY SYSTEM|7 TIMES PER WEEK||INTERSTITIAL||RIB 1|BILATERAL|APICAL|U|||FOLLOW-UP|1965-05-10|1967-11-22|||1973-05-07|||1969-05-28||1967-05-09
TRIAL STUDY 134XCP|EX|76B9C25F-B418-4979-9E18-4372C8AA700C|216|||||||||||DROP|GRANULE, FOR SOLUTION|CONTINUOUS||INTRATUBULAR||SKIN OF THE PALM|IPSILATERAL|ANTEROLATERAL|NA|||CONTINUATION TREATMENT|1969-08-16|1960-01-23|||1967-10-04|||1969-05-16||1967-04-20
TRIAL STUDY 134XCP|EX|9F622B53-71F8-4362-99A5-251993E3A946|217|||||||||||10^3 ORGANISMS/G|CAPSULE, COATED, EXTENDED RELEASE|Q14H||TRANSTRACHEAL||SUBSTANTIA NIGRA|LATERAL|INFERIOR|NA|||FOLLOW-UP|1961-08-22|1969-09-01|||1963-08-03|||1972-10-23||1960-03-30
TRIAL STUDY 134XCP|EX|8F2DC6EB-0264-4112-B379-17896F4266E4|218|||||||||||LB|RINSE|4 TIMES PER YEAR||INTRALESIONAL||TEMPORAL ARTERY|RIGHT|LOWER|N|||TREATMENT|1967-12-08|1973-03-10|||1965-06-27|||1963-07-03||1962-05-01
TRIAL STUDY 134XCP|EX|448246D1-5625-4F69-B214-3A8848E86C28|219|||||||||||GMFI|PASTE, DENTIFRICE|Q23H||DIETARY||PERIRECTAL LYMPH NODE|LATERAL|SUPERFICIAL|NA|||LONG-TERM FOLLOW-UP|1964-08-22|1963-04-22|||1969-11-20|||1971-08-03||1969-08-16
TRIAL STUDY 134XCP|EX|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|220|||||||||||COPIES/UL|STICK|THRICE||SUBRETINAL||OCCIPITAL LYMPH NODE|UNILATERAL|VENTRAL|Y|||OPEN LABEL TREATMENT|1970-12-10|1971-12-09|||1963-04-17|||1963-02-06||1965-05-19
TRIAL STUDY 134XCP|EX|27DDBB16-ED11-45B6-987D-FB0D8223B993|221|||||||||||MOL/MG|TABLET, MODIFIED RELEASE|10 DAYS PER MONTH||CONJUNCTIVAL||CHEST WALL|LEFT|DORSAL|Y|||BASELINE|1961-10-27|1963-10-31|||1963-09-27|||1965-12-25||1961-11-22
TRIAL STUDY 134XCP|EX|5545846C-F90F-4346-A075-05999641B872|222|||||||||||RPM|CAPLET|EVERY 8 WEEKS||BUCCAL||HAIR ROOT|UNILATERAL|INNER|NA|||TREATMENT|1963-10-01|1964-05-25|||1970-01-01|||1966-04-26||1973-03-19
TRIAL STUDY 134XCP|EX|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|223|||||||||||DAYS/MONTH|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|Q11H||INTRAVENTRICULAR||HAIR FOLLICLE|RIGHT|ANTEROLATERAL|Y|||INDUCTION TREATMENT|1972-04-10|1965-12-29|||1961-09-09|||1964-11-25||1968-12-07
TRIAL STUDY 134XCP|EX|111541DB-D863-4C68-9E62-B8741A62401C|224|||||||||||/100 HPFS|SUSPENSION/DROPS|Q7H||INTRASTOMAL||DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|BASAL|Y|||CONTINUATION TREATMENT|1971-10-03|1970-11-12|||1960-11-15|||1963-12-27||1960-01-28
TRIAL STUDY 134XCP|EX|5095C113-7278-4D41-B860-0DF6B9B98738|225|||||||||||U/M2|CAPSULE, COATED, EXTENDED RELEASE|3 TIMES PER MONTH||VAGINAL||CEREBRUM|CONTRALATERAL|MEDIAL|N|||BASELINE|1973-03-23|1967-06-07|||1962-05-26|||1965-12-07||1965-11-12
TRIAL STUDY 134XCP|EX|61319D2E-A512-425F-9301-BAD27B5F5C9B|226|||||||||||MEQ/MMOL|STICK|BID||INTRAPERITONEAL||LATERAL SECOND DIAGONAL BRANCH ARTERY|LEFT|FRONTAL|NA|||OPEN LABEL TREATMENT|1962-11-18|1960-07-16|||1961-02-17|||1960-05-26||1968-07-27
TRIAL STUDY 134XCP|EX|3B865A8F-949B-4B64-A818-85472EABB8FB|227|||||||||||10^9/G|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|EVERY 5 YEARS||INTRAOVARIAN||WAIST|LEFT|TIP|NA|||INDUCTION TREATMENT|1973-03-30|1962-12-19|||1960-12-18|||1967-11-30||1969-09-23
TRIAL STUDY 134XCP|EX|A6909912-22B9-4EE7-AEDF-F791F243A6B7|228|||||||||||BLOCKS|GRANULE, DELAYED RELEASE|Q9H||INTRAVITREAL||CAROTID ARTERY|IPSILATERAL|ANTEROPOSTERIOR|NA|||LONG-TERM FOLLOW-UP|1963-09-23|1963-04-23|||1965-12-14|||1972-04-06||1962-06-01
TRIAL STUDY 134XCP|EX|83C8AAD3-B22D-42C6-870A-D069FAC601F3|229|||||||||||/10^3|MOUTHWASH|2 TIMES PER CYCLE||IONTOPHORESIS||AXILLARY LYMPH NODE LEVEL I|UNILATERAL|FACIAL|Y|||OBSERVATION|1973-03-11|1964-08-24|||1965-02-16|||1961-12-07||1972-06-22
TRIAL STUDY 134XCP|EX|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|230|||||||||||G/G|CAPSULE, COATED|UNKNOWN||CUTANEOUS||THYROID GLAND, LEFT LOBE|UNILATERAL|TEMPORAL|U|||OPEN LABEL TREATMENT|1967-11-27|1964-03-28|||1961-07-16|||1960-05-03||1964-01-06
TRIAL STUDY 134XCP|EX|937BF41A-157D-45F6-9797-2C5D19D100E6|231|||||||||||LX|CONCENTRATE|PRN||INTRAPARENCHYMAL||POSTERIOR CERVICAL LYMPH NODE|CONTRALATERAL|UPPER EXTENSOR SURFACE|NA|||SCREENING|1961-07-17|1964-01-04|||1967-12-07|||1963-10-31||1970-12-18
TRIAL STUDY 134XCP|EX|1BA56D89-E536-491E-AD6A-190A07331BEA|232|||||||||||TUBERCULIN UNIT|SOLUTION, FOR SLUSH|Q48H||URETERAL||PULMONARY ARTERY BRANCH|RIGHT|POSTERIOR|U|||BLINDED TREATMENT|1961-07-10|1964-03-21|||1969-04-04|||1962-03-02||1970-09-30
TRIAL STUDY 134XCP|EX|BE208D93-7322-427F-A8E5-1DBE5040BE8F|233|||||||||||NFIU|PATCH, EXTENDED RELEASE|Q20H||HEMODIALYSIS||PRELARYNGEAL LYMPH NODE|RIGHT|TIP|NA|||WASHOUT|1967-08-23|1970-03-12|||1972-05-12|||1970-06-26||1961-09-21
TRIAL STUDY 134XCP|EX|A58C5E7B-21EC-4F59-BB74-3264AC945F61|234|||||||||||DNA COPIES/UG|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|Q4H||INTRAVESICAL||HEART, BASE|UNILATERAL|DEEP|NA|||BASELINE|1960-11-16|1960-10-06|||1972-01-15|||1963-02-14||1972-01-24
TRIAL STUDY 134XCP|EX|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|235|||||||||||U/M2/MIN|SPRAY, SUSPENSION|Q21H||INTRABILIARY||BLADDER, NECK|LATERAL|DISTAL|Y|||LONG-TERM FOLLOW-UP|1966-10-17|1971-10-28|||1963-03-26|||1968-03-18||1964-01-12
TRIAL STUDY 134XCP|EX|434B4F6A-C436-4F92-8FA5-9C2F1964098A|236|||||||||||PL|GRAFT|3 TIMES PER CYCLE||INTRALUMINAL||GASTROINTESTINAL SYSTEM|UNILATERAL|SUPERIOR|NA|||TREATMENT|1963-08-09|1973-04-06|||1964-06-23|||1963-08-26||1966-03-22
TRIAL STUDY 134XCP|EX|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|237|||||||||||MAMP|DRESSING|CONTINUOUS||RECTAL||LYMPH NODE HILUM|IPSILATERAL|ANTEROPOSTERIOR|N|||INDUCTION TREATMENT|1972-10-24|1973-02-13|||1960-04-20|||1960-04-06||1970-09-16
TRIAL STUDY 134XCP|EX|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|238|||||||||||APPLICATION|CIGARETTE|4 TIMES PER WEEK||SUBTENON||NAIL BED|LATERAL|DORSOLATERAL|NA|||OPEN LABEL TREATMENT|1963-02-08|1960-09-07|||1961-01-09|||1969-07-22||1970-12-22
TRIAL STUDY 134XCP|EX|73C4A4D7-2177-47F3-818A-C0774F5E4A08|239|||||||||||U/ML|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|6 TIMES PER YEAR||INTRAGINGIVAL||PARASPINAL REGION|LEFT|LOWER EXTENSOR SURFACE|U|||OBSERVATION|1969-05-04|1961-12-25|||1969-04-23|||1973-06-09||1971-11-19
TRIAL STUDY 134XCP|EX|4E3929B3-63F2-4E89-8EB4-60991E7284E1|240|||||||||||ML*CMH2O|TABLET, MULTILAYER, EXTENDED RELEASE|Q4D||PHARYNGEAL||INFERIOR VENA CAVA|CONTRALATERAL|DISTAL VOLAR|U|||FOLLOW-UP|1965-10-18|1972-08-09|||1971-07-17|||1963-08-11||1971-06-17
TRIAL STUDY 134XCP|EX|F26E2F67-3F90-448C-92BB-AD60E71D5664|241|||||||||||LINEAR FT*LB|INJECTION, SUSPENSION, LIPOSOMAL|Q10H||IONTOPHORESIS||WRIST JOINT EXTENSOR MUSCLES|IPSILATERAL|ANTEROTEMPORAL|NA|||LONG-TERM FOLLOW-UP|1963-05-23|1967-09-05|||1968-08-05|||1971-01-18||1971-05-21
TRIAL STUDY 134XCP|EX|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|242|||||||||||ATM|CIGARETTE|QN||UNKNOWN||CORONARY ARTERY|CONTRALATERAL|INTERMEDIATE|U|||SCREENING|1963-08-06|1961-06-11|||1962-01-08|||1964-11-01||1965-04-08
TRIAL STUDY 134XCP|EX|F2F1151C-F987-49CE-BC16-719DD339DBE7|243|||||||||||ABSORBANCE U/ML|PATCH, EXTENDED RELEASE|Q2M||OPHTHALMIC||FINGER EXTENSOR MUSCLES|LEFT|LOWER EXTENSOR SURFACE|N|||BASELINE|1970-07-09|1963-01-21|||1960-03-22|||1960-01-02||1965-05-18
TRIAL STUDY 134XCP|EX|F88FCFA6-90D7-4033-86DF-223A63A6152D|244|||||||||||DAGU|CAPSULE, COATED PELLETS|Q3D||SUBCUTANEOUS||FEMORAL CONDYLE|LEFT|DISTAL|NA|||INDUCTION TREATMENT|1969-06-02|1961-11-21|||1960-11-12|||1970-05-13||1966-08-17
TRIAL STUDY 134XCP|EX|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|245|||||||||||/10^4|BEAD, IMPLANT, EXTENDED RELEASE|Q3M||NASAL||RETINAL PIGMENTED EPITHELIAL LAYER|RIGHT|FORE|N|||RUN-IN|1961-07-02|1961-08-21|||1972-02-08|||1963-01-11||1964-06-28
TRIAL STUDY 134XCP|EX|7D35B2F5-7334-448B-B4E1-14671B850B6A|246|||||||||||ML/CM|CONE|QN||TRANSPLACENTAL||CALCANEAL TUBEROSITY|LATERAL|APICAL|N|||OPEN LABEL TREATMENT|1972-04-28|1970-06-18|||1971-05-23|||1968-11-23||1968-07-08
TRIAL STUDY 134XCP|EX|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|247|||||||||||MASK|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|EVERY EVENING||INTRAUTERINE||WRIST JOINT FLEXOR MUSCLES|RIGHT|LOWER|Y|||SCREENING|1971-10-26|1968-11-02|||1960-08-10|||1972-09-03||1967-03-21
TRIAL STUDY 134XCP|EX|B09D371C-2E5C-4F84-986E-5A603C0C4A28|248|||||||||||PG/DL|CLOTH|3 TIMES PER MONTH||TRANSTRACHEAL||CERVICAL VERTEBRA|LATERAL|VENTROLATERAL|U|||CONTINUATION TREATMENT|1967-05-02|1968-06-20|||1969-06-23|||1969-12-14||1972-12-02
TRIAL STUDY 134XCP|EX|11CB653E-F113-4639-B15C-B236A2F65F47|249|||||||||||10^7 TCID 50/DOSE|CONCENTRATE|3 TIMES PER CYCLE||INTRAMUSCULAR||BODY OF STOMACH|IPSILATERAL|FACIAL|NA|||OBSERVATION|1970-11-29|1961-10-21|||1962-12-18|||1965-08-07||1967-06-13
TRIAL STUDY 134XCP|EX|2AB992E7-55B7-4327-987C-47FD605B7D78|250|||||||||||U.CARR|SUSPENSION|Q17H||TRANSTYMPANIC||RETINAL NERVE FIBER LAYER|RIGHT|SUBCORTICAL|Y|||LONG-TERM FOLLOW-UP|1966-09-21|1971-08-31|||1969-10-01|||1967-07-02||1965-03-27
TRIAL STUDY 134XCP|EX|6AF1B0B0-9923-459A-8629-5E628400AD00|251|||||||||||DIP|GRANULE|Q2M||PERIVENOUS||SUPRATENTORIAL BRAIN|LEFT|SUPERIOR|NA|||SCREENING|1966-10-28|1969-04-03|||1973-05-06|||1971-12-13||1963-10-29
TRIAL STUDY 134XCP|EX|E1305E4E-DF64-4FD1-B0B2-131459AB629D|252|||||||||||/SEC|GENERATOR|EVERY 2 WEEKS||OROPHARYNGEAL||RENAL ARTERY|BILATERAL|CENTRAL|N|||SCREENING|1962-10-14|1963-06-21|||1964-07-26|||1962-06-01||1967-10-05
TRIAL STUDY 134XCP|EX|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|253|||||||||||NMOL/DAY|LIQUID|Q48H||OROPHARYNGEAL||SKIN OF THE AXILLA|CONTRALATERAL|PROXIMAL VOLAR|N|||TREATMENT|1973-04-13|1972-11-04|||1966-04-12|||1966-09-13||1964-02-13
TRIAL STUDY 134XCP|EX|0FD7F837-3D76-4A1C-B414-373B55A39506|254|||||||||||MOL/DAY|DIAPHRAGM|Q4H||INTRADERMAL||GENITALIA|LEFT|POSTERIOR|U|||OBSERVATION|1960-10-03|1972-11-13|||1963-09-25|||1964-09-08||1970-05-29
TRIAL STUDY 134XCP|EX|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|255|||||||||||MOL/MOL|CORE, EXTENDED RELEASE|UNKNOWN||TRANSDERMAL||PRONATOR QUADRATUS MUSCLE|IPSILATERAL|ANTEROPOSTERIOR|Y|||WASHOUT|1967-09-16|1963-05-24|||1963-10-21|||1969-09-20||1961-08-14
TRIAL STUDY 134XCP|EX|92FB0125-67D2-41CC-9116-8C949F15614A|256|||||||||||MIN|JELLY|QAM||INTRASPINAL||PORTAL LYMPH NODE|CONTRALATERAL|UPPER|N|||WASHOUT|1970-06-22|1967-12-05|||1969-10-09|||1973-05-15||1971-05-27
TRIAL STUDY 134XCP|EX|7042617F-0C29-4928-B3ED-9549A53BC195|257|||||||||||UMOL/L/H|SOLUTION, GEL FORMING / DROPS|5 TIMES PER MONTH||INTRACAUDAL||POPLITEAL ARTERY ABOVE KNEE|LATERAL|FORE|N|||CONTINUATION TREATMENT|1960-06-06|1971-01-14|||1971-11-26|||1960-08-01||1967-07-27
TRIAL STUDY 134XCP|EX|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|258|||||||||||PELLET|PILL|EVERY 16 WEEKS||INTRACAVERNOUS||BRAIN STEM|BILATERAL|ANTEROMEDIAL|N|||WASHOUT|1961-05-14|1966-01-24|||1972-01-10|||1972-09-01||1973-01-18
TRIAL STUDY 134XCP|EX|6633CC54-D711-4780-A833-A71756D8B234|259|||||||||||PA|PELLET|8 TIMES PER DAY||INTRASINAL||PERIURETHRAL REGION|RIGHT|ANTEROTEMPORAL|N|||INDUCTION TREATMENT|1968-07-05|1963-09-21|||1970-11-24|||1965-02-23||1965-06-09
TRIAL STUDY 134XCP|EX|84C642FE-6D84-4525-AB1C-15FAF740D63B|260|||||||||||10^3/HPF|GRANULE, FOR SOLUTION|1 TIME PER WEEK||INTRALYMPHATIC||AXILLARY LYMPH NODE LEVEL III|LEFT|OUTER|Y|||BASELINE|1968-01-31|1971-08-14|||1960-04-01|||1973-08-06||1969-11-11
TRIAL STUDY 134XCP|EX|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|261|||||||||||K|INJECTION, SUSPENSION, LIPOSOMAL|Q12H||INTRAMENINGEAL||WALDEYER'S TONSILLAR RING|BILATERAL|DISTAL|U|||RUN-IN|1968-11-09|1966-08-09|||1966-08-19|||1970-02-09||1966-01-09
TRIAL STUDY 134XCP|EX|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|262|||||||||||UG/KG/H|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|Q22H||PARENTERAL||GALLBLADDER|UNILATERAL|ANTERIOR|U|||TREATMENT|1967-08-22|1960-03-01|||1969-02-13|||1962-09-30||1961-07-12
TRIAL STUDY 134XCP|EX|A0757669-2DF6-4E78-A021-9C777BEF5697|263|||||||||||U/MG|CAPSULE, LIQUID FILLED|7 TIMES PER DAY||NASOGASTRIC||DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|BILATERAL|INNER|N|||INDUCTION TREATMENT|1972-10-28|1962-12-18|||1963-07-03|||1962-11-17||1971-10-15
TRIAL STUDY 134XCP|EX|DAF7255A-888D-43D3-97B8-5E432938747F|264|||||||||||MPA|JELLY|THRICE||PERIODONTAL||SMALL INTESTINE|IPSILATERAL|BASAL|NA|||OPEN LABEL TREATMENT|1966-03-26|1960-05-19|||1962-06-14|||1964-05-30||1969-07-18
TRIAL STUDY 134XCP|EX|51989FEC-B63E-4F58-B748-2FF5E73E5D14|265|||||||||||WAFER|GUM, RESIN|Q45MIN||PERIVENOUS||GASTROCNEMIUS MUSCLE|CONTRALATERAL|SUBCORTICAL|N|||SCREENING|1966-08-13|1971-10-27|||1960-06-25|||1972-02-13||1966-05-17
TRIAL STUDY 134XCP|EX|776299DC-1CD5-448F-82C2-C1659CEE689D|266|||||||||||MM2|TINCTURE|EVERY 2 WEEKS||INTRAVAGINAL||PENIS|BILATERAL|LOWER|N|||OBSERVATION|1962-06-20|1960-01-30|||1962-10-29|||1961-08-24||1962-04-09
TRIAL STUDY 134XCP|EX|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|267|||||||||||GAUSS|STICK|EVERY 6 WEEKS||INTRASYNOVIAL||LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LATERAL|DISTAL VOLAR|Y|||SCREENING|1962-04-17|1961-07-29|||1962-08-23|||1967-10-20||1963-05-03
TRIAL STUDY 134XCP|EX|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|268|||||||||||DRUM|SUPPOSITORY|4 TIMES PER YEAR||INTRACORONAL, DENTAL||INTERPHALANGEAL JOINT 1 OF THE FOOT|UNILATERAL|LATERAL|NA|||WASHOUT|1971-03-28|1968-01-02|||1970-05-02|||1962-07-18||1968-07-28
TRIAL STUDY 134XCP|EX|054D4740-C675-4904-B912-B00A0B089F12|269|||||||||||UEQ|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|Q48H||ELECTRO-OSMOSIS||NAIL BED|LATERAL|UPPER|NA|||OPEN LABEL TREATMENT|1971-02-25|1962-07-27|||1961-01-20|||1964-12-19||1961-12-01
TRIAL STUDY 134XCP|EX|9548556E-EECF-4460-A7DD-D93F853E9EA8|270|||||||||||L/MIN/M2|TABLET, MODIFIED RELEASE, SHORT DURATION|QHS||INTRAMANDIBULAR||KIDNEY, UPPER LOBE|IPSILATERAL|DISTAL VOLAR|U|||BASELINE|1960-09-04|1971-09-24|||1969-01-19|||1970-12-21||1971-09-06
TRIAL STUDY 134XCP|EX|0BCF6152-3718-402C-9333-A3EFBB3086FF|271|||||||||||MG/L FEU|CAPLET|Q7H||INTRAVAGINAL||INTERPHALANGEAL JOINT 1 OF THE FOOT|BILATERAL|PROXIMAL|NA|||OBSERVATION|1966-01-27|1964-09-15|||1967-08-09|||1962-07-05||1964-05-19
TRIAL STUDY 134XCP|EX|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|272|||||||||||LOG10 IU/ML|TABLET, MULTILAYER|Q36H||INTRADUCTAL||CORRUGATOR SUPERCILII MUSCLE|IPSILATERAL|LOWER EXTENSOR SURFACE|Y|||BASELINE|1966-09-13|1969-03-14|||1968-06-11|||1961-11-09||1969-03-19
TRIAL STUDY 134XCP|EX|EED12AC0-1CBD-4D42-8786-91834AB33A46|273|||||||||||SEC|CAPSULE|TID||INTRA-ABDOMINAL||ACCESSORY RENAL ARTERY|CONTRALATERAL|POSTERIOR|N|||CONTINUATION TREATMENT|1970-10-17|1971-02-10|||1965-04-06|||1961-12-31||1962-03-22
TRIAL STUDY 134XCP|EX|F30DC3E9-E919-4920-87FE-103CD85D89FA|274|||||||||||KV|SUPPOSITORY, EXTENDED RELEASE|Q6H||ENTERAL||INTERPHALANGEAL THUMB JOINT|UNILATERAL|VOLAR|NA|||BLINDED TREATMENT|1966-07-18|1961-04-30|||1970-04-04|||1969-05-19||1969-11-04
TRIAL STUDY 134XCP|EX|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|275|||||||||||G/ANIMAL|PASTE|2 TIMES PER YEAR||IONTOPHORESIS||COSTOCHONDRAL JOINT 7|UNILATERAL|HIND|Y|||OBSERVATION|1963-02-01|1960-02-16|||1960-09-15|||1963-03-13||1964-11-10
TRIAL STUDY 134XCP|EX|729D254F-628C-4D35-8906-A1344833A610|276|||||||||||GENEQ|GRANULE, FOR SOLUTION|QOD||INTRASURGICAL SITE||PORTACAVAL LYMPH NODE|LEFT|VENTROLATERAL|NA|||RUN-IN|1969-01-30|1969-02-22|||1973-06-29|||1967-08-08||1966-10-09
TRIAL STUDY 134XCP|EX|A78936A2-B8B1-4D07-8679-E324F6447EFF|277|||||||||||DAYS/WK|SOLID|Q21H||INTRACAMERAL||LEFT POSTEROLATERAL DESCENDING ARTERY|BILATERAL|DORSAL|NA|||FOLLOW-UP|1962-09-02|1971-10-15|||1964-07-06|||1971-02-01||1968-08-17
TRIAL STUDY 134XCP|EX|239B331A-08CD-41D9-BBB8-CE229480FC12|278|||||||||||KDA|GAS|3 TIMES PER YEAR||BUCCAL||L5-S1 INTERVERTEBRAL SPACE|UNILATERAL|ANTERIOR|Y|||INDUCTION TREATMENT|1960-12-04|1970-11-05|||1964-03-01|||1964-08-12||1960-01-21
TRIAL STUDY 134XCP|EX|958D39CD-D511-40C8-A0A6-8A138225470B|279|||||||||||MMOL/S|PATCH, EXTENDED RELEASE|Q18H||INTRAVENOUS BOLUS||SUPRATENTORIAL BRAIN|BILATERAL|PERIVENTRICULAR|NA|||OBSERVATION|1963-05-02|1962-06-29|||1973-04-25|||1967-03-14||1964-09-30
TRIAL STUDY 134XCP|EX|5DA21FE5-E5B9-4461-9509-94AA264B59A8|280|||||||||||TORR|CIGARETTE|OCCASIONAL||INTRAOCULAR||ADDUCTOR LONGUS MUSCLE|RIGHT|ANTEROMEDIAL|NA|||WASHOUT|1965-03-22|1962-07-30|||1964-10-22|||1966-05-24||1960-06-07
TRIAL STUDY 134XCP|EX|B125DCB9-1705-430B-9982-A20E7C4CA6A8|281|||||||||||DAGU/ML|GEL, CHEWABLE|Q9H||BUCCAL||TOOTH|UNILATERAL|VENTROLATERAL|U|||RUN-IN|1964-04-02|1968-06-15|||1968-08-26|||1970-02-18||1972-10-15
TRIAL STUDY 134XCP|EX|95C72325-301E-40D4-AA2D-49B80067FE23|282|||||||||||PFU/ML|TABLET, DELAYED RELEASE|9 TIMES PER DAY||INTRAEPIDERMAL||GASTROINTESTINAL SYSTEM|UNILATERAL|APICAL|NA|||OBSERVATION|1961-12-12|1968-09-18|||1966-12-18|||1970-06-18||1965-08-17
TRIAL STUDY 134XCP|EX|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|283|||||||||||10^9 CFU|INJECTION, POWDER, FOR SOLUTION|BIM||INTRAOCULAR||METACARPOPHALANGEAL JOINT 3|UNILATERAL|SUPERIOR|NA|||CONTINUATION TREATMENT|1970-02-14|1963-06-22|||1965-07-23|||1963-02-20||1965-02-15
TRIAL STUDY 134XCP|EX|7DF25CA4-0846-4180-9356-F53C704F0233|284|||||||||||HZ|SPRAY|4 TIMES PER MONTH||INTRAVENOUS||ELBOW EXTENSOR MUSCLES|IPSILATERAL|DISTAL VOLAR|U|||OBSERVATION|1965-08-05|1965-04-26|||1968-09-25|||1972-01-06||1962-07-23
TRIAL STUDY 134XCP|EX|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|285|||||||||||LENS|TABLET, DELAYED RELEASE PARTICLES|Q2H||ORAL GAVAGE||CEREBRAL HEMISPHERE, LEFT|LATERAL|FORE|NA|||BASELINE|1971-02-20|1972-05-03|||1966-10-24|||1962-11-24||1961-12-07
TRIAL STUDY 134XCP|EX|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|286|||||||||||NEEDLE GAUGE|CREAM, AUGMENTED|EVERY AFTERNOON||LARYNGEAL||SUPRARENAL AORTA|CONTRALATERAL|PROXIMAL VOLAR|N|||TREATMENT|1969-01-07|1972-09-28|||1972-06-27|||1972-06-29||1967-09-03
TRIAL STUDY 134XCP|EX|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|287|||||||||||M/SEC|PELLETS, COATED, EXTENDED RELEASE|Q13H||INTRA-AMNIOTIC||PROXIMAL URETHRA|BILATERAL|DISTAL|Y|||WASHOUT|1972-07-09|1965-09-24|||1967-07-23|||1961-02-27||1971-02-05
TRIAL STUDY 134XCP|EX|2C15756E-1096-403B-989D-D2C3D31396A9|288|||||||||||NMOL/MOL|AEROSOL, METERED|5 TIMES PER MONTH||NOT APPLICABLE||CALF MUSCULAR VEIN|IPSILATERAL|UPPER EXTENSOR SURFACE|NA|||WASHOUT|1969-04-23|1963-02-13|||1969-03-28|||1969-04-30||1966-12-12
TRIAL STUDY 134XCP|EX|CD103276-37FC-4E40-A0C8-8D1300D21AE1|289|||||||||||MMOL2/L2|LIQUID|1 TIME PER WEEK||INTRATESTICULAR||BRACHIAL ARTERY|UNILATERAL|PROXIMAL|U|||OBSERVATION|1961-01-30|1961-05-30|||1967-04-01|||1960-01-01||1965-07-05
TRIAL STUDY 134XCP|EX|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|290|||||||||||TRANSDUCING UNIT|AEROSOL, POWDER|Q6M||PERIODONTAL||LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|BILATERAL|FORE|NA|||RUN-IN|1961-05-16|1961-11-15|||1961-04-07|||1966-03-27||1969-05-13
TRIAL STUDY 134XCP|EX|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|291|||||||||||FARAD|SUSPENSION/DROPS|INTERMITTENT||TRANSPLACENTAL||TALUS|LATERAL|PARIETO-OCCIPITAL|NA|||SCREENING|1962-08-11|1968-06-01|||1965-05-07|||1962-08-17||1962-07-03
TRIAL STUDY 134XCP|EX|7B583F10-E460-4B25-8A6B-530A154442CD|292|||||||||||CIGARETTE|JELLY|Q2M||INTRACAVERNOUS||GASTROINTESTINAL SYSTEM|BILATERAL|INFERIOR|NA|||WASHOUT|1970-06-03|1966-10-26|||1961-01-24|||1971-08-19||1970-02-07
TRIAL STUDY 134XCP|EX|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|293|||||||||||MET*MIN|DRUG DELIVERY SYSTEM|Q4H||INTRAILEAL||HEPATIC LYMPH NODE|LEFT|ANTEROLATERAL|NA|||LONG-TERM FOLLOW-UP|1970-02-28|1968-05-10|||1966-12-01|||1961-04-19||1970-01-15
TRIAL STUDY 134XCP|EX|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|294|||||||||||HOURS|TABLET, MULTILAYER|EVERY WEEK||ENDOSINUSIAL||DISTAL INTERPHALANGEAL JOINT 3|LEFT|PROXIMAL|Y|||BASELINE|1963-11-10|1963-06-16|||1963-11-12|||1963-11-05||1965-07-19
TRIAL STUDY 134XCP|EX|51FE575E-2161-414B-B772-9F1888E7C5CC|295|||||||||||OSM|GRANULE, FOR SOLUTION|EVERY 6 WEEKS||INTRADURAL||LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|IPSILATERAL|UPPER EXTENSOR SURFACE|U|||OBSERVATION|1969-04-24|1965-11-15|||1966-07-20|||1973-08-26||1973-02-08
TRIAL STUDY 134XCP|EX|991C72FC-777F-4CED-824B-A4DECA57BE99|296|||||||||||L|FOR SOLUTION|Q9H||LARYNGEAL||FINGERNAIL|CONTRALATERAL|LOWER MEDIAL|NA|||OBSERVATION|1965-08-18|1964-06-30|||1967-06-20|||1960-02-10||1965-08-16
TRIAL STUDY 134XCP|EX|FFECA538-8D16-421C-ACA2-4A769BC15D7D|297|||||||||||PIXELS/CM|INJECTION, EMULSION|EVERY WEEK||SOFT TISSUE||LATISSIMUS DORSI MUSCLE|RIGHT|DISTAL|N|||OPEN LABEL TREATMENT|1972-10-13|1964-10-19|||1965-07-05|||1966-03-30||1969-07-14
TRIAL STUDY 134XCP|EX|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|298|||||||||||SUPPOSITORY|INJECTION, SOLUTION, CONCENTRATE|1 TIME PER WEEK||VAGINAL||SUPERFICIAL FEMORAL ARTERY|LEFT|UPPER FLEXOR SURFACE|U|||RUN-IN|1970-10-23|1963-08-22|||1971-10-14|||1971-10-18||1967-07-21
TRIAL STUDY 134XCP|EX|54507F00-0C16-4F35-A762-104B47390283|299|||||||||||CYCLE/MIN|LINIMENT|CONTINUOUS||ENDOSINUSIAL||HUMERUS|IPSILATERAL|DEEP|U|||CONTINUATION TREATMENT|1972-12-19|1972-08-02|||1964-02-15|||1967-10-12||1970-09-13
TRIAL STUDY 134XCP|EX|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|300|||||||||||U/L|SUSPENSION|QAM||OROMUCOSAL||VERTEBRA|RIGHT|BASAL|Y|||OPEN LABEL TREATMENT|1960-10-23|1966-09-23|||1969-04-09|||1971-04-02||1963-06-21
TRIAL STUDY 134XCP|EX|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|301|||||||||||MG/ML/MIN|AEROSOL, SPRAY|QPM||DIETARY||DISTAL PHALANX 3 OF THE HAND|CONTRALATERAL|PROXIMAL|NA|||SCREENING|1973-03-26|1962-06-26|||1966-01-24|||1973-08-29||1962-01-20
TRIAL STUDY 134XCP|EX|CF8F9036-3380-4A0B-B17A-7EF814B02700|302|||||||||||10^9 ORGANISMS/ML|LINER, DENTAL|Q11H||INTRATYMPANIC||HYPOGLOSSAL NERVE|LEFT|TIP|NA|||WASHOUT|1967-09-25|1962-10-14|||1970-06-18|||1969-02-16||1960-05-23
TRIAL STUDY 134XCP|EX|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|303|||||||||||MMHG|FOR SUSPENSION, EXTENDED RELEASE|Q12H||INTRACORPORUS CAVERNOSUM||CELIAC LYMPH NODE|LEFT|DISTAL VOLAR|U|||TREATMENT|1969-09-04|1970-10-17|||1963-04-08|||1962-08-27||1972-11-28
TRIAL STUDY 134XCP|EX|58360390-F6AB-41D7-9A0D-1039E795403E|304|||||||||||/DAY|IRRIGANT|QN||INTRACAVERNOUS||HEEL OF THE HAND|LATERAL|VENTRAL|N|||RUN-IN|1960-09-07|1973-03-30|||1965-10-05|||1968-12-18||1963-04-05
TRIAL STUDY 134XCP|EX|61B02780-0C99-47F8-93B2-CA839876604E|305|||||||||||CM2|KIT|Q6M||INTRADUCTAL||GASTROCNEMIUS MUSCLE, LATERAL HEAD|LATERAL|FORE|N|||WASHOUT|1961-02-22|1972-02-12|||1971-06-07|||1964-06-17||1968-01-05
TRIAL STUDY 134XCP|EX|1381458A-D702-467D-ADCA-984EE7BD894D|306|||||||||||MAC50|SPONGE|3 TIMES PER MONTH||SUBCUTANEOUS||EAR, OUTER|IPSILATERAL|LOWER EXTENSOR SURFACE|Y|||RUN-IN|1969-12-08|1967-08-07|||1960-07-23|||1963-03-13||1965-05-16
TRIAL STUDY 134XCP|EX|04211DA3-CFD5-4750-9D61-C91FF7BC338A|307|||||||||||L|TABLET, EFFERVESCENT|10 DAYS PER MONTH||INTRALESIONAL||SPLEEN|CONTRALATERAL|DEEP|U|||BLINDED TREATMENT|1972-02-12|1971-11-18|||1963-03-20|||1971-06-21||1966-06-28
TRIAL STUDY 134XCP|EX|EF707A48-6FAD-47C0-913A-5CBCACA539E0|308|||||||||||DL|PASTE, DENTIFRICE|3 TIMES PER CYCLE||INTRABILIARY||MASTOID PROCESS|UNILATERAL|INTERMEDIATE|N|||WASHOUT|1973-06-28|1960-09-12|||1970-08-23|||1962-04-16||1966-08-24
TRIAL STUDY 134XCP|EX|C896767E-2418-4226-A8AE-D875DA40F9FB|309|||||||||||FRACTION OF 1|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|EVERY 6 WEEKS||RECTAL||HUMERUS|LATERAL|INFERIOR|NA|||OBSERVATION|1972-04-06|1966-05-08|||1969-02-17|||1965-01-24||1967-06-14
TRIAL STUDY 134XCP|EX|666BC019-B828-4DB4-BD2F-973BA689C9E7|310|||||||||||ML/CAGE/DAY|TABLET, MULTILAYER, EXTENDED RELEASE|PA||LARYNGEAL||MAXILLARY SINUS|BILATERAL|TIP|U|||LONG-TERM FOLLOW-UP|1962-09-25|1970-10-29|||1965-06-17|||1963-08-17||1962-08-15
TRIAL STUDY 134XCP|EX|91282D87-4943-4527-8F33-27A5C153951C|311|||||||||||FOZ_US|RING|Q8H||CONJUNCTIVAL||OCCIPITAL LYMPH NODE|RIGHT|LOWER|Y|||INDUCTION TREATMENT|1965-05-22|1971-07-10|||1964-12-28|||1966-04-02||1960-09-07
TRIAL STUDY 134XCP|EX|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|312|||||||||||10^6 ORGANISMS|SUSPENSION/DROPS|Q21H||DENTAL||BICEPS BRACHII MUSCLE|UNILATERAL|HIND|U|||FOLLOW-UP|1973-07-08|1973-07-03|||1966-11-28|||1968-05-18||1972-03-26
TRIAL STUDY 134XCP|EX|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|313|||||||||||DAGU/ML|OIL|5 TIMES PER DAY||OCCLUSIVE DRESSING TECHNIQUE||TESTIS|RIGHT|MEDIAL|U|||FOLLOW-UP|1967-12-14|1963-12-09|||1961-05-15|||1969-01-04||1963-09-25
TRIAL STUDY 134XCP|EX|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|314|||||||||||USIEMENS|SPRAY, SUSPENSION|INTERMITTENT||SUBTENON||AXILLARY LYMPH NODE LEVEL I|CONTRALATERAL|DISTAL|U|||OBSERVATION|1965-10-01|1965-05-06|||1960-10-21|||1972-09-20||1973-01-03
TRIAL STUDY 134XCP|EX|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|315|||||||||||BQ/L|POWDER, FOR SOLUTION|Q6M||INTRACAVITARY||HAIR ROOT|LATERAL|VOLAR|U|||OPEN LABEL TREATMENT|1967-09-13|1963-03-30|||1967-05-15|||1972-10-14||1960-07-05
TRIAL STUDY 134XCP|EX|0320460C-3770-486A-85EB-ECD133AE6EFA|316|||||||||||DAYS/MONTH|POWDER, FOR SUSPENSION|Q48H||OROPHARYNGEAL||INTERPHALANGEAL JOINT 1 OF THE FOOT|RIGHT|ANTEROMEDIAL|U|||SCREENING|1964-06-09|1969-08-03|||1966-11-08|||1965-07-01||1962-12-09
TRIAL STUDY 134XCP|EX|810B0B08-9236-41EC-8879-924661FA224E|317|||||||||||L/KG|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|TID||IONTOPHORESIS||HEART|IPSILATERAL|INTERMEDIATE|NA|||OBSERVATION|1969-11-10|1960-12-09|||1962-10-12|||1960-02-10||1968-01-10
TRIAL STUDY 134XCP|EX|BA3B0D91-DC95-4916-8ACA-71451447BE81|318|||||||||||MG/ML/DAY|POULTICE|EVERY AFTERNOON||TRANSMUCOSAL||DISTAL PHALANX 4 OF THE HAND|LEFT|VENTRAL|NA|||INDUCTION TREATMENT|1960-06-18|1962-11-20|||1968-11-28|||1964-07-23||1966-06-06
TRIAL STUDY 134XCP|EX|DE385129-5FB9-43C3-9FB1-005886674C9B|319|||||||||||G/DAY|INJECTION, POWDER, FOR SOLUTION|5 TIMES PER MONTH||INFILTRATION||RIB 9|IPSILATERAL|FRONTAL|Y|||TREATMENT|1970-10-18|1972-12-07|||1970-07-04|||1971-02-27||1968-11-23
TRIAL STUDY 134XCP|EX|8AE8077F-A13C-4593-B012-213A5EBE0A1D|320|||||||||||PPB|SOLUTION, GEL FORMING / DROPS|4 TIMES PER WEEK||INTRACEREBRAL||ILEUM, TERMINAL|LATERAL|DORSOLATERAL|NA|||OPEN LABEL TREATMENT|1960-07-06|1966-12-01|||1963-07-06|||1972-12-18||1973-05-11
TRIAL STUDY 134XCP|EX|72FCE18B-B3D6-45AC-993F-9883E4D11313|321|||||||||||FEU|LIQUID|Q6D||CONJUNCTIVAL||PALATINE BONE|RIGHT|NASAL|NA|||FOLLOW-UP|1962-04-26|1971-09-26|||1960-08-21|||1965-07-14||1965-04-01
TRIAL STUDY 134XCP|EX|1123F894-0821-41DF-9C28-ED6BC4A7098C|322|||||||||||U/10^12 RBC|LOTION|Q72H||INTRALYMPHATIC||SOFT PALATE|LEFT|INFERIOR|N|||FOLLOW-UP|1960-11-01|1964-02-29|||1965-02-20|||1962-06-19||1968-06-04
TRIAL STUDY 134XCP|EX|42DD827A-E788-4E61-8E9F-421136A16166|323|||||||||||KA_U/DL|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|Q10H||INTRAJEJUNAL||RIB 12|BILATERAL|OCCIPITAL|U|||LONG-TERM FOLLOW-UP|1964-11-23|1960-01-19|||1960-02-25|||1963-06-18||1973-06-28
TRIAL STUDY 134XCP|EX|CC1E2338-4454-4CBA-8848-0B994C459F05|324|||||||||||L/H/M2|TABLET, ORALLY DISINTEGRATING|BID||PERCUTANEOUS||EPIGLOTTIS|LATERAL|SUPERFICIAL|NA|||CONTINUATION TREATMENT|1969-11-29|1969-01-23|||1964-07-09|||1972-07-19||1960-08-26
TRIAL STUDY 134XCP|EX|ED04E60D-256A-4DB9-9290-4EFD0602A130|325|||||||||||SACHET|SOLUTION/ DROPS|Q72H||INTRACISTERNAL||CARPOMETACARPAL JOINT 4|BILATERAL|NASAL|N|||INDUCTION TREATMENT|1962-05-07|1962-04-08|||1968-02-21|||1970-04-19||1969-11-14
TRIAL STUDY 134XCP|EX|C70F82F6-3280-429D-9657-CDFBA6B7F626|326|||||||||||LINEAR FT*LB|PATCH, EXTENDED RELEASE|Q18H||INTRATESTICULAR||FOOT DIGIT 2|BILATERAL|DORSOLATERAL|U|||BLINDED TREATMENT|1964-08-20|1960-05-23|||1960-11-12|||1973-02-18||1961-10-21
TRIAL STUDY 134XCP|EX|D735D137-2C27-4F27-BA18-9A0F7FF0B145|327|||||||||||/WK|SOLUTION, CONCENTRATE|Q11H||PERIVENOUS||MIDBRAIN|RIGHT|ANTEROLATERAL|Y|||CONTINUATION TREATMENT|1967-08-29|1964-03-02|||1966-09-19|||1966-12-01||1966-11-15
TRIAL STUDY 134XCP|EX|B00194E0-0E85-46DD-86C3-CD9048535986|328|||||||||||UG/DAY|CAPLET|Q3M||INTRAMEDULLARY||TRICUSPID VALVE, POSTERIOR CUSP|RIGHT|LOWER|NA|||TREATMENT|1960-07-08|1967-06-05|||1967-04-10|||1960-05-07||1967-12-25
TRIAL STUDY 134XCP|EX|B4F372E9-C461-414A-95B4-93CA0221D396|329|||||||||||APPLICATION|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|AD LIBITUM||DENTAL||PANCREAS, HEAD|UNILATERAL|FRONTAL|Y|||LONG-TERM FOLLOW-UP|1963-06-19|1964-08-06|||1973-05-23|||1961-01-24||1968-03-14
TRIAL STUDY 134XCP|EX|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|330|||||||||||U/MG|DOUCHE|Q11H||ENDOSINUSIAL||MEDIASTINUM, SUPERIOR|RIGHT|LOWER FLEXOR SURFACE|NA|||WASHOUT|1960-07-02|1963-05-05|||1972-09-07|||1972-03-02||1969-11-20
TRIAL STUDY 134XCP|EX|E43169E4-8B57-47D7-9C91-D42E40DD579B|331|||||||||||IU/MG|LOTION|Q7H||INTRABILIARY||NAVICULAR BONE|IPSILATERAL|UPPER|N|||FOLLOW-UP|1966-04-06|1970-03-18|||1973-06-26|||1967-04-10||1968-08-24
TRIAL STUDY 134XCP|EX|066393EE-D112-41DD-AF8F-65EF57A4415B|332|||||||||||10^4/L|INSERT, EXTENDED RELEASE|Q72H||INTRAVENOUS||TRACHEA|IPSILATERAL|VENTRAL|N|||WASHOUT|1970-09-30|1965-11-16|||1971-12-24|||1969-06-26||1972-05-07
TRIAL STUDY 134XCP|EX|573C9228-D341-491C-9D66-0D0435E2C631|333|||||||||||INHALATION|FILM|4 TIMES PER WEEK||INTRASTOMAL||C6 VERTEBRA|BILATERAL|OUTER|NA|||OPEN LABEL TREATMENT|1973-05-25|1970-02-20|||1972-03-16|||1965-05-17||1963-11-17
TRIAL STUDY 134XCP|EX|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|334|||||||||||PKAT/L|FILM, SOLUBLE|EVERY AFTERNOON||NASAL||PARASYMPATHETIC GANGLIA|IPSILATERAL|DEEP|N|||WASHOUT|1968-12-10|1972-03-19|||1960-06-16|||1972-02-02||1968-11-24
TRIAL STUDY 134XCP|EX|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|335|||||||||||U/L|LINIMENT|5 TIMES PER YEAR||TRANSTRACHEAL||MEDIAN OR LOWER CERVICAL LYMPH NODE|LATERAL|APICAL|NA|||TREATMENT|1963-02-07|1967-05-02|||1966-01-04|||1962-01-25||1969-05-23
TRIAL STUDY 134XCP|EX|61C75130-5C1A-4B8D-804C-92D3288B55D2|336|||||||||||10^3 CFU|TABLET, COATED|Q24H||INTRAPLEURAL||SCAPHOID-TRAPEZIUM JOINT|IPSILATERAL|APICAL|Y|||CONTINUATION TREATMENT|1973-02-05|1970-09-07|||1971-09-10|||1973-07-06||1972-01-09
TRIAL STUDY 134XCP|EX|90AFB57A-125C-4C08-AE92-061F66FC2DAC|337|||||||||||/2500 WBC|SUPPOSITORY|1 TIME PER WEEK||LARYNGEAL||FEMORAL LYMPH NODE|IPSILATERAL|APICAL|U|||RUN-IN|1964-08-13|1970-06-14|||1962-06-17|||1971-06-26||1960-07-12
TRIAL STUDY 134XCP|EX|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|338|||||||||||ML/CM3/MIN|CAPSULE, HARD, EXTENDED RELEASE|3 TIMES PER MONTH||INTRASTOMAL||HAND DIGIT 4|BILATERAL|APICAL|NA|||FOLLOW-UP|1962-05-07|1963-09-07|||1969-07-22|||1962-12-28||1960-12-20
TRIAL STUDY 134XCP|EX|01A42FAE-1EE2-4203-A62E-E368F31434F7|339|||||||||||BQ/L|TABLET, SUGAR COATED|TWICE||INTRADISCAL||HAIR SHAFT|LEFT|ANTEROTEMPORAL|U|||LONG-TERM FOLLOW-UP|1961-11-18|1969-05-20|||1963-02-25|||1960-01-03||1963-01-21
TRIAL STUDY 134XCP|EX|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|340|||||||||||KN/CM2|SALVE|Q18H||INTRAPULMONARY||RETINAL PIGMENTED EPITHELIAL LAYER|LEFT|INNER|NA|||OPEN LABEL TREATMENT|1966-07-18|1964-06-22|||1960-12-21|||1972-07-24||1972-08-25
TRIAL STUDY 134XCP|EX|92232C8B-0D28-4E2A-AA56-BA938429CCBF|341|||||||||||NFIU|CREAM|EVERY 5 YEARS||ORAL||METACARPAL BONE|BILATERAL|SUPERIOR|U|||INDUCTION TREATMENT|1969-07-23|1964-12-30|||1967-02-01|||1969-04-03||1968-08-08
TRIAL STUDY 134XCP|EX|F4F12AAA-E825-45D7-B414-A06F2D20381A|342|||||||||||GLOBULE|GRANULE, EFFERVESCENT|PRN||PARENTERAL||LIVER FISSURE|LATERAL|ANTERIOR|U|||BASELINE|1965-04-14|1960-03-31|||1960-06-21|||1970-05-22||1966-02-05
TRIAL STUDY 134XCP|EX|6CF611F2-686E-4AE9-B491-32157710F46D|343|||||||||||UMOL/L/MIN|STRIP|1 TIME PER WEEK||NASOGASTRIC||CARPOMETACARPAL JOINT 1|LEFT|ANTEROMEDIAL|U|||RUN-IN|1965-11-03|1973-03-14|||1961-01-19|||1968-07-10||1971-03-30
TRIAL STUDY 134XCP|EX|417DBC64-7BF9-4EB8-A14B-C5F63541F826|344|||||||||||TROCHE|LOZENGE|EVERY WEEK||OROMUCOSAL||RENAL PELVIS|LATERAL|PROXIMAL VOLAR|N|||OPEN LABEL TREATMENT|1969-10-02|1968-10-29|||1966-07-12|||1972-09-10||1969-02-09
TRIAL STUDY 134XCP|EX|C3EF644E-25DC-4E0D-9073-735AED77EFAF|345|||||||||||S*KPA|INJECTION, SUSPENSION, LIPOSOMAL|QH||INTRACORPORUS CAVERNOSUM||AORTIC VALVE|CONTRALATERAL|DORSOLATERAL|NA|||SCREENING|1965-09-23|1967-01-26|||1967-02-15|||1960-09-10||1963-06-13
TRIAL STUDY 134XCP|EX|CAE5F41C-0560-4782-BA27-E314BF7E66B6|346|||||||||||ML/CAGE|CAPSULE|QM||DENTAL||LOWER RESPIRATORY SYSTEM|CONTRALATERAL|ANTEROLATERAL|Y|||BLINDED TREATMENT|1973-06-05|1971-08-23|||1971-03-06|||1969-06-29||1970-05-12
TRIAL STUDY 134XCP|EX|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|347|||||||||||TCID 50/DOSE|INTRAUTERINE DEVICE|Q19H||LARYNGEAL||XIPHOID PROCESS|LEFT|FORE|Y|||OPEN LABEL TREATMENT|1970-07-12|1971-10-28|||1965-10-17|||1968-11-15||1967-12-07
TRIAL STUDY 134XCP|EX|F34E7DCC-8637-463D-88E6-28AEBF495E9B|348|||||||||||MPH|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|ONCE||INTRATENDINOUS||AXILLARY LYMPH NODE|RIGHT|UPPER|Y|||RUN-IN|1967-03-15|1969-11-28|||1971-10-09|||1966-01-01||1962-12-30
TRIAL STUDY 134XCP|EX|69530FE0-6896-4585-8B20-29AE90DB91F5|349|||||||||||LINEAR FT*LB|PATCH|Q24H||INTRAPLEURAL||TRICUSPID VALVE, SEPTAL CUSP|BILATERAL|LOWER|Y|||SCREENING|1973-07-29|1967-01-03|||1967-10-26|||1960-11-13||1966-01-26
TRIAL STUDY 134XCP|EX|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|350|||||||||||MG/CM2|CAPSULE, SOFTGEL, EXTENDED RELEASE|QH||INTRACORONAL, DENTAL||SKIN OF THE KNEE|LATERAL|LOWER EXTENSOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1960-09-17|1972-11-09|||1962-02-08|||1971-07-26||1960-01-31
TRIAL STUDY 134XCP|EX|F1EF928C-B819-4620-8991-ABDC4E182217|351|||||||||||/40 HPFS|TABLET, SOLUBLE|QAM||INTRATESTICULAR||TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL|POSTERIOR|N|||CONTINUATION TREATMENT|1966-04-01|1966-07-13|||1963-03-11|||1971-06-29||1960-10-06
TRIAL STUDY 134XCP|EX|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|352|||||||||||HOUNSFIELD UNIT|DRUG DELIVERY SYSTEM|Q11H||INTRAOVARIAN||OVARY|BILATERAL|SUPERFICIAL|N|||CONTINUATION TREATMENT|1967-10-02|1964-06-30|||1964-01-17|||1968-10-25||1960-03-26
TRIAL STUDY 134XCP|EX|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|353|||||||||||SBE/ML|TABLET, FILM COATED, EXTENDED RELEASE|2 TIMES PER WEEK||INTRABRONCHIAL||VAGINAL WALL|UNILATERAL|UPPER FLEXOR SURFACE|NA|||BASELINE|1973-06-29|1966-01-02|||1967-09-24|||1963-07-21||1973-04-26
TRIAL STUDY 134XCP|EX|27D5690D-BCB3-4FEC-988C-666C29D5239A|354|||||||||||U/CL|FOR SOLUTION|CONTINUOUS||INTRADUODENAL||BICEPS FEMORIS MUSCLE|UNILATERAL|ANTEROMEDIAL|NA|||OPEN LABEL TREATMENT|1972-08-04|1962-05-05|||1965-03-28|||1970-10-27||1967-10-01
TRIAL STUDY 134XCP|EX|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|355|||||||||||/CMH2O|LIQUID, EXTENDED RELEASE|Q72H||IRRIGATION||DORSALIS PEDIS ARTERY|LATERAL|PERIVENTRICULAR|N|||WASHOUT|1964-02-13|1973-03-28|||1971-05-14|||1961-06-12||1963-04-18
TRIAL STUDY 134XCP|EX|8E25F21F-A565-40CB-B0D7-6CC496171293|356|||||||||||CM/MIN|TABLET, ORALLY DISINTEGRATING|EVERY 3 WEEKS||INTRABRONCHIAL||SKIN OF THE LOWER LIMB|LEFT|SURFACE|U|||OPEN LABEL TREATMENT|1968-04-22|1960-10-23|||1971-09-16|||1970-05-29||1969-11-26
TRIAL STUDY 134XCP|EX|8CDD2247-485D-495C-9186-FF4CA3FFC32E|357|||||||||||G/CAGE|FOR SUSPENSION|INTERMITTENT||AURICULAR (OTIC)||LUNG|LEFT|LOWER MEDIAL|N|||TREATMENT|1962-11-15|1972-10-15|||1961-12-26|||1963-10-06||1963-05-10
TRIAL STUDY 134XCP|EX|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|358|||||||||||CAPSULE|CLOTH|3 TIMES PER CYCLE||SUBTENON||ANTERIOR CINGULATE CORTEX|UNILATERAL|UPPER FLEXOR SURFACE|NA|||INDUCTION TREATMENT|1964-10-13|1960-11-23|||1965-10-02|||1967-05-11||1960-07-14
TRIAL STUDY 134XCP|EX|C004A8EB-220F-4FC5-A150-B5159DCA84D9|359|||||||||||FT2|BEAD, IMPLANT, EXTENDED RELEASE|Q20H||INTRA-ARTICULAR||GINGIVA|LEFT|MEDIAL|Y|||BLINDED TREATMENT|1965-01-17|1970-01-03|||1970-09-12|||1969-03-05||1968-02-28
TRIAL STUDY 134XCP|EX|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|360|||||||||||UMOL/DL|INJECTION|2 TIMES PER CYCLE||SUBMUCOSAL||FLOOR OF MOUTH|LEFT|TEMPORAL|N|||OPEN LABEL TREATMENT|1963-10-27|1964-06-07|||1964-08-05|||1970-03-20||1960-02-19
TRIAL STUDY 134XCP|EX|AE127EDD-D708-4B1A-95F7-176A541A9584|361|||||||||||SQU/ML|GAS|QPM||INTRAVENOUS||HEART|RIGHT|INTERMEDIATE|N|||INDUCTION TREATMENT|1961-04-26|1966-01-05|||1969-12-11|||1965-04-11||1961-12-26
TRIAL STUDY 134XCP|EX|F642D4A0-A67F-4A10-BB21-E4644E963D45|362|||||||||||MS/MMHG|LOTION/SHAMPOO|QN||MICRODIALYSIS||MITRAL VALVE, POSTERIOR CUSP|UNILATERAL|UPPER EXTENSOR SURFACE|Y|||WASHOUT|1962-06-17|1961-07-28|||1966-02-10|||1967-03-05||1967-04-25
TRIAL STUDY 134XCP|EX|933A6DFF-D519-46F4-AB52-78E6A898E4A1|363|||||||||||/100 HPFS|ENEMA|4 TIMES PER YEAR||SOFT TISSUE||ENDOCERVIX|UNILATERAL|SUPERFICIAL|U|||RUN-IN|1968-06-07|1961-08-19|||1962-05-09|||1962-10-17||1967-01-25
TRIAL STUDY 134XCP|EX|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|364|||||||||||ML/KG|AEROSOL, SPRAY|7 TIMES PER WEEK||INTRAEPIDERMAL||INFERIOR PUBIC RAMUS|RIGHT|VENTRAL|U|||TREATMENT|1967-08-04|1962-07-15|||1964-10-14|||1972-09-27||1969-01-17
TRIAL STUDY 134XCP|EX|38E177D4-1A58-4E78-90B7-85F76BF66826|365|||||||||||AU/ML|GUM, RESIN|ONCE||INTRANODAL||RETROPHARYNGEAL LYMPH NODE|IPSILATERAL|UPPER|U|||BASELINE|1960-07-12|1961-09-08|||1964-02-12|||1973-03-18||1964-05-12
TRIAL STUDY 134XCP|EX|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|366|||||||||||UKAT/L|TABLET, DELAYED RELEASE PARTICLES|2 TIMES PER YEAR||SOFT TISSUE||PERIPANCREATIC LYMPH NODE|LEFT|CAUDAL|Y|||LONG-TERM FOLLOW-UP|1971-04-30|1969-10-01|||1963-07-27|||1967-04-23||1963-09-07
TRIAL STUDY 134XCP|EX|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|367|||||||||||BOTTLE|EMULSION|Q13H||INTRATYMPANIC||EARLOBE|IPSILATERAL|LATERAL|U|||BASELINE|1967-05-05|1963-04-27|||1960-08-28|||1960-04-15||1966-11-03
TRIAL STUDY 134XCP|EX|50CFC814-7135-4356-BAC2-3F975B9F6AE3|368|||||||||||BQ/UG|INJECTION, SUSPENSION, EXTENDED RELEASE|AD LIBITUM||INTRACAVERNOUS||PROXIMAL INTERPHALANGEAL JOINT 2|RIGHT|MIDLINE|NA|||INDUCTION TREATMENT|1970-01-10|1973-08-01|||1960-10-05|||1967-02-06||1973-08-23
TRIAL STUDY 134XCP|EX|8A639816-D878-4FD7-AF28-CF9EA2236462|369|||||||||||100 IU/ML|SWAB|CONTINUOUS||PERCUTANEOUS||LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT|BASAL|U|||CONTINUATION TREATMENT|1968-07-29|1966-06-20|||1961-01-31|||1966-04-09||1971-08-14
TRIAL STUDY 134XCP|EX|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|370|||||||||||EQ|PELLET|UNKNOWN||INTRAPLEURAL||PECTORALIS MAJOR MUSCLE|BILATERAL|INFERIOR|Y|||FOLLOW-UP|1972-05-30|1965-08-16|||1972-06-04|||1970-06-03||1967-08-05
TRIAL STUDY 134XCP|EX|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|371|||||||||||PRESSOR UNITS|TABLET, MODIFIED RELEASE|Q6D||ELECTRO-OSMOSIS||MUSCULOSKELETAL SYSTEM|BILATERAL|DORSOLATERAL|U|||BASELINE|1970-08-01|1971-11-24|||1963-11-14|||1970-01-21||1969-04-01
TRIAL STUDY 134XCP|EX|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|372|||||||||||CFU/ML|LOZENGE|Q5D||INTRADUODENAL||VERTEBRAL ARTERY|CONTRALATERAL|TEMPORAL|U|||BASELINE|1969-10-25|1963-08-22|||1967-10-24|||1967-08-02||1960-06-24
TRIAL STUDY 134XCP|EX|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|373|||||||||||TCID 50/DOSE|CONE|5 TIMES PER DAY||INTRAVENTRICULAR||VESTIBULOCOCHLEAR NERVE|CONTRALATERAL|ANTEROTEMPORAL|U|||INDUCTION TREATMENT|1973-07-12|1972-01-17|||1966-09-08|||1960-02-08||1964-03-19
TRIAL STUDY 134XCP|EX|30419F44-B519-488C-A505-F23D88A46024|374|||||||||||S^-1(%O2)^-1|TAMPON|3 TIMES PER CYCLE||INTRAOCULAR||URACHAL TRACT|UNILATERAL|ANTEROLATERAL|U|||FOLLOW-UP|1969-12-03|1963-07-09|||1965-03-05|||1967-03-15||1960-07-03
TRIAL STUDY 134XCP|EX|2AF06F66-5E51-4AC9-AF62-A34329724F7D|375|||||||||||EIA UNIT|UNASSIGNED|1 TIME PER WEEK||SUBARACHNOID||ILIOTIBIAL BAND|LEFT|ROSTRAL|U|||BASELINE|1971-07-23|1967-01-09|||1969-04-17|||1971-10-12||1969-12-29
TRIAL STUDY 134XCP|EX|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|376|||||||||||GY/MIN|STICK|Q3D||RECTAL||ESOPHAGUS, ABDOMINAL|CONTRALATERAL|PROXIMAL|NA|||SCREENING|1966-10-01|1960-07-24|||1963-04-22|||1960-02-25||1968-07-25
TRIAL STUDY 134XCP|EX|94F4C997-3114-4444-BF89-E762226AAC89|377|||||||||||IU/L|TAPE|INTERMITTENT||SUBCUTANEOUS||RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LEFT|POSTERIOR|NA|||LONG-TERM FOLLOW-UP|1962-08-09|1970-08-21|||1962-10-02|||1966-11-03||1970-01-23
TRIAL STUDY 134XCP|EX|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|378|||||||||||/7.5 ML|FOR SOLUTION|EVERY 4 WEEKS||ORAL||SUPERIOR SAGITTAL SINUS|CONTRALATERAL|ANTEROLATERAL|NA|||BASELINE|1963-09-02|1962-11-19|||1968-06-11|||1972-01-26||1971-10-14
TRIAL STUDY 134XCP|EX|D20DE6F0-DA30-4453-8F80-61093BF046A6|379|||||||||||STRIP|CEMENT|Q4H||SUBMUCOSAL||HEART, RIGHT VENTRICULAR FREE WALL|LEFT|PERIVENTRICULAR|Y|||WASHOUT|1965-10-05|1969-07-10|||1967-08-06|||1967-09-17||1972-10-14
TRIAL STUDY 134XCP|EX|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|380|||||||||||DPM/100MG|TABLET, SOLUBLE|7 TIMES PER DAY||INTRAHEPATIC||SKIN|RIGHT|INTERMEDIATE|N|||OBSERVATION|1972-05-08|1972-10-09|||1973-08-10|||1962-08-25||1969-05-10
TRIAL STUDY 134XCP|EX|F20939CF-C668-4514-A2CF-63723560FA46|381|||||||||||/HPF|FOR SUSPENSION|TID||INTRACORPORUS CAVERNOSUM||WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|FRONTAL|U|||FOLLOW-UP|1964-06-29|1971-11-23|||1965-10-15|||1973-01-11||1968-02-12
TRIAL STUDY 134XCP|EX|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|382|||||||||||UEQ|SOLUTION, CONCENTRATE|Q15H||URETERAL||SEMINAL VESICLE|IPSILATERAL|PERIPHERAL|Y|||SCREENING|1970-11-09|1972-01-13|||1972-06-11|||1967-05-26||1972-01-16
TRIAL STUDY 134XCP|EX|9A60A414-54A0-4A7F-84EE-FCB8246D2477|383|||||||||||10^3 CFU/G|PELLET, IMPLANTABLE|Q23H||INTRATENDINOUS||INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|FRONTAL|Y|||CONTINUATION TREATMENT|1963-10-15|1968-09-20|||1962-05-12|||1973-03-12||1969-01-02
TRIAL STUDY 134XCP|EX|8D546F1C-E719-4C03-A66A-9916EFF2A144|384|||||||||||PT_BR|CIGARETTE|Q3M||INTRATHECAL||MITRAL VALVE, ANTERIOR ANNULUS|UNILATERAL|POSTERIOR|U|||TREATMENT|1972-03-24|1964-08-15|||1965-04-09|||1963-09-20||1967-06-09
TRIAL STUDY 134XCP|EX|B998085D-F227-46C8-B2D8-37E97BA799D2|385|||||||||||IN|OINTMENT, AUGMENTED|Q7H||INTRAVENOUS||BUCCAL MUCOSA|LATERAL|DORSOLATERAL|NA|||WASHOUT|1970-11-20|1971-11-16|||1960-09-22|||1968-07-24||1969-06-08
TRIAL STUDY 134XCP|EX|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|386|||||||||||/5X10^4 WBC|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|BID||RECTAL||PAW|IPSILATERAL|UPPER EXTENSOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1963-06-30|1969-02-07|||1964-04-21|||1964-01-30||1960-11-27
TRIAL STUDY 134XCP|EX|537CE647-EA58-430C-B37B-F56BF20B5AF0|387|||||||||||CAL|INJECTION, POWDER, FOR SUSPENSION|Q36H||INTERSTITIAL||RENAL PELVIS|UNILATERAL|HIND|N|||RUN-IN|1971-12-14|1972-08-21|||1961-06-02|||1960-01-23||1965-12-09
TRIAL STUDY 134XCP|EX|3464201C-9704-40B6-B3B3-2BADE02BD58F|388|||||||||||DPM/MG|CAPSULE, COATED, EXTENDED RELEASE|QHS||TRANSPLACENTAL||GASTROINTESTINAL TRACT, LOWER, WALL|IPSILATERAL|INNER|Y|||OPEN LABEL TREATMENT|1965-04-19|1965-02-08|||1966-05-17|||1969-05-08||1961-02-03
TRIAL STUDY 134XCP|EX|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|389|||||||||||10^6/EJACULATE U|LIQUID|QID||INTRAVENTRICULAR||ANTERIOR HORN OF THE LATERAL VENTRICLE|RIGHT|TEMPORAL|U|||SCREENING|1966-04-29|1968-11-28|||1960-05-03|||1965-04-03||1967-03-01
TRIAL STUDY 134XCP|EX|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|390|||||||||||HOMEOPATHIC DILUTION|TABLET, COATED PARTICLES|EVERY 5 WEEKS||URETERAL||LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|ANTEROTEMPORAL|Y|||FOLLOW-UP|1971-01-06|1971-06-25|||1973-06-14|||1970-06-22||1967-12-21
TRIAL STUDY 134XCP|EX|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|391|||||||||||PPTH|TABLET, MODIFIED RELEASE, SHORT DURATION|QD||ORAL||RETROCRURAL LYMPH NODE|UNILATERAL|PERIPHERAL|U|||FOLLOW-UP|1966-06-01|1973-03-04|||1969-02-26|||1973-06-29||1970-01-11
TRIAL STUDY 134XCP|EX|11A6144A-895B-4143-85D2-69952C6D452C|392|||||||||||BISCUIT|CAPSULE, COATED, EXTENDED RELEASE|Q12H||INTRAVENOUS||HIPPOCAMPUS|CONTRALATERAL|LOWER FLEXOR SURFACE|NA|||WASHOUT|1973-02-26|1962-08-16|||1971-10-18|||1973-01-12||1963-07-05
TRIAL STUDY 134XCP|EX|8958D35E-F685-4542-AE01-625133F1EF7D|393|||||||||||NCI|GEL, METERED|Q17H||RESPIRATORY (INHALATION)||OLFACTORY NERVE|CONTRALATERAL|DISTAL VOLAR|NA|||TREATMENT|1968-06-30|1961-12-30|||1967-11-15|||1972-09-12||1970-12-24
TRIAL STUDY 134XCP|EX|00982640-C826-4CD4-B927-A311227E63CC|394|||||||||||G/M2/DAY|INJECTION, POWDER, FOR SUSPENSION|PRN||OROMUCOSAL||OPTIC DISC|UNILATERAL|LOWER FLEXOR SURFACE|Y|||WASHOUT|1966-03-21|1965-04-26|||1966-04-14|||1970-05-09||1970-09-28
TRIAL STUDY 134XCP|EX|C213CAA8-2FAC-402C-A19E-11A60708A71A|395|||||||||||PKAT/L|STICK|EVERY EVENING||INTRATUMOR||VERTEBRAL COLUMN|BILATERAL|OCCIPITAL|N|||INDUCTION TREATMENT|1971-10-11|1967-07-08|||1968-06-01|||1962-08-23||1968-05-16
TRIAL STUDY 134XCP|EX|F0559682-CD36-4ED0-8082-A54D40305512|396|||||||||||UMOL/MOL|CAPSULE, COATED|Q4H||INTRACEREBRAL||T11 VERTEBRA|RIGHT|DORSAL|U|||SCREENING|1967-10-15|1961-04-01|||1970-07-27|||1971-06-05||1968-10-02
TRIAL STUDY 134XCP|EX|C004A4D5-DBD0-4967-9597-8C1653AB8298|397|||||||||||MCI/KG|DOUCHE|QOD||RECTAL||IRIS|BILATERAL|PERIPHERAL|Y|||INDUCTION TREATMENT|1972-01-20|1960-09-12|||1960-03-17|||1969-04-08||1967-09-25
TRIAL STUDY 134XCP|EX|ABB838A1-2387-471E-8F50-1F48205BC8EE|398|||||||||||10^9/L|CRYSTAL|6 TIMES PER DAY||INTRALYMPHATIC||EPIDURAL SPACE|LATERAL|CRANIAL|U|||OBSERVATION|1969-11-14|1964-05-24|||1972-02-25|||1965-03-28||1960-10-02
TRIAL STUDY 134XCP|EX|88126417-8564-4659-AA60-63642067113D|399|||||||||||MG/M2|SWAB|Q23H||INTRASTOMAL||MEDIASTINUM, ANTERIOR|BILATERAL|CRANIAL|N|||LONG-TERM FOLLOW-UP|1971-03-09|1972-07-11|||1965-01-10|||1964-04-30||1972-09-13
TRIAL STUDY 134XCP|EX|6ADA444E-F1B4-4E59-9F2D-26DC78845397|400|||||||||||UMOL/L/H|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|Q19H||INTRA-ARTICULAR||PROXIMAL PHALANX 2 OF THE HAND|IPSILATERAL|LOWER EXTENSOR SURFACE|Y|||OBSERVATION|1972-09-04|1965-04-14|||1966-11-10|||1969-04-08||1964-09-27
TRIAL STUDY 134XCP|EX|85060A90-92F7-4440-AD1C-62A70C2FD5CB|401|||||||||||NMOL/DAY|JELLY|QM||INTRACAUDAL||POSTERIOR TIBIAL VEIN|CONTRALATERAL|LATERAL|NA|||OBSERVATION|1968-12-23|1965-08-30|||1968-01-13|||1968-02-03||1972-05-16
TRIAL STUDY 134XCP|EX|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|402|||||||||||MPL U/ML|INJECTION, SUSPENSION, LIPOSOMAL|Q12H||BUCCAL||MID-CIRCUMFLEX ARTERY|LATERAL|ANTEROTEMPORAL|NA|||RUN-IN|1964-03-08|1969-03-17|||1964-11-03|||1962-04-24||1964-06-22
TRIAL STUDY 134XCP|EX|170052E6-031C-48EF-9CE4-CA84ED6B77FF|403|||||||||||10^6 RNA COPIES/ML|GUM, RESIN|CONTINUOUS||AURICULAR (OTIC)||COLON|LATERAL|NASAL|Y|||FOLLOW-UP|1972-06-06|1961-04-28|||1964-06-25|||1964-09-20||1961-11-13
TRIAL STUDY 134XCP|EX|D3F628DE-8358-4C2C-B474-763E48719E5E|404|||||||||||PACKAGE|CONCENTRATE|QPM||INTRAPERITONEAL||URETHRA, POSTERIOR|IPSILATERAL|FACIAL|N|||OBSERVATION|1973-03-13|1965-04-21|||1961-09-06|||1964-11-02||1967-08-13
TRIAL STUDY 134XCP|EX|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|405|||||||||||MMHG/SEC|FOR SOLUTION|2 TIMES PER YEAR||INTRAESOPHAGEAL||OCCIPITAL SCALP|IPSILATERAL|FACIAL|N|||LONG-TERM FOLLOW-UP|1964-10-20|1961-07-15|||1960-12-21|||1970-03-15||1961-08-28
TRIAL STUDY 134XCP|EX|4395486D-C521-4478-9442-68CF0344C6FB|406|||||||||||MEQ|CORE, EXTENDED RELEASE|EVERY 8 WEEKS||SUBCUTANEOUS||CANINE TOOTH|LEFT|CENTRAL|Y|||FOLLOW-UP|1966-03-30|1966-02-26|||1965-10-17|||1965-02-21||1972-06-10
TRIAL STUDY 134XCP|EX|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|407|||||||||||MMHG|CAPSULE, GELATIN COATED|QH||RETROBULBAR||DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|OCCIPITAL|NA|||RUN-IN|1971-04-08|1963-08-11|||1960-06-02|||1967-05-23||1969-03-24
TRIAL STUDY 134XCP|EX|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|408|||||||||||10^6 ORGANISMS/MG|CAPSULE, HARD, EXTENDED RELEASE|EVERY 7 WEEKS||INTRADUCTAL||SACRAL TUBEROSITY|RIGHT|INTERMEDIATE|U|||FOLLOW-UP|1973-03-28|1962-05-09|||1963-03-07|||1964-08-27||1962-04-22
TRIAL STUDY 134XCP|EX|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|409|||||||||||AFU|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|Q4H||UNASSIGNED||HIPPOCAMPUS|RIGHT|SUPERFICIAL|Y|||BASELINE|1971-02-23|1971-07-04|||1969-06-19|||1967-03-23||1965-01-01
TRIAL STUDY 134XCP|EX|19394300-46A6-484F-AE02-50BDD39096E3|410|||||||||||10^6 CFU/ML|TABLET, MODIFIED RELEASE, LONG DURATION|EVERY 16 WEEKS||OPHTHALMIC||LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|LATERAL|U|||SCREENING|1964-12-29|1972-05-03|||1971-07-04|||1969-08-29||1973-07-15
TRIAL STUDY 134XCP|EX|8C89BD60-3504-4F8B-8F33-7F0C949DB407|411|||||||||||MG/L FEU|TABLET|5 TIMES PER YEAR||URETERAL||COLON, LEFT|CONTRALATERAL|ROSTRAL|N|||BASELINE|1971-03-05|1973-04-11|||1972-05-15|||1972-09-27||1964-12-04
TRIAL STUDY 134XCP|EX|4746A481-011E-4376-9D2F-5E57F560A6DE|412|||||||||||L/MIN|IMPLANT|6 TIMES PER DAY||INTRASTOMAL||PORTACAVAL LYMPH NODE|CONTRALATERAL|ROSTRAL|U|||CONTINUATION TREATMENT|1972-09-11|1962-06-13|||1966-08-11|||1970-06-12||1962-05-08
TRIAL STUDY 134XCP|EX|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|413|||||||||||U/KG/DAY|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|QN||INTERSTITIAL||TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|APICAL|N|||CONTINUATION TREATMENT|1964-11-30|1969-05-03|||1961-01-13|||1961-01-01||1961-04-12
TRIAL STUDY 134XCP|EX|04F5220E-7A8C-4982-9379-496306612E33|414|||||||||||CFU/ML|TROCHE|Q7D||CUTANEOUS||FINGER FLEXOR MUSCLES|RIGHT|ANTEROLATERAL|U|||BLINDED TREATMENT|1972-09-07|1964-10-19|||1967-06-30|||1964-12-31||1970-02-08
TRIAL STUDY 134XCP|EX|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|415|||||||||||NMOL/KG/DAY|SWAB|Q4M||TOPICAL||T2 VERTEBRA|CONTRALATERAL|MIDLINE|U|||OPEN LABEL TREATMENT|1961-10-23|1963-04-07|||1963-01-07|||1961-05-27||1963-06-18
TRIAL STUDY 134XCP|EX|73BDFAA2-6260-4E1D-8039-7523F0C52873|416|||||||||||10^12/L|GEL, CHEWABLE|EVERY 2 WEEKS||TOPICAL||LIVER, RIGHT LOBE|RIGHT|DORSOLATERAL|Y|||LONG-TERM FOLLOW-UP|1964-05-18|1963-10-13|||1965-03-10|||1969-09-12||1970-06-10
TRIAL STUDY 134XCP|EX|147C2E77-A2C5-4219-9BB5-D209813E563B|417|||||||||||BQ/UL|DIAPHRAGM|CONTINUOUS||RESPIRATORY (INHALATION)||DISTAL PHALANX 5 OF THE HAND|UNILATERAL|ANTEROMEDIAL|Y|||OPEN LABEL TREATMENT|1961-05-29|1964-06-01|||1969-02-03|||1960-01-17||1972-12-28
TRIAL STUDY 134XCP|EX|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|418|||||||||||CI/UG|TABLET, MULTILAYER, EXTENDED RELEASE|7 TIMES PER WEEK||LARYNGEAL||NOSTRIL|RIGHT|MIDLINE|Y|||BLINDED TREATMENT|1962-09-04|1966-05-16|||1970-06-29|||1973-04-01||1961-06-15
TRIAL STUDY 134XCP|EX|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|419|||||||||||10^6 CFU/G|SOLID|10 DAYS PER MONTH||ENDOTRACHEAL||TRICUSPID VALVE, POSTERIOR ANNULUS|UNILATERAL|BASAL|NA|||OBSERVATION|1972-10-22|1963-05-13|||1963-06-15|||1961-09-02||1971-10-20
TRIAL STUDY 134XCP|EX|25E17A89-8A2F-4870-B076-1D32634F5620|420|||||||||||CI/UG|SOLUTION/ DROPS|6 TIMES PER YEAR||TRANSTRACHEAL||SMALL INTESTINE|RIGHT|BASAL|Y|||SCREENING|1969-02-06|1969-05-16|||1968-06-16|||1961-06-08||1964-07-21
TRIAL STUDY 134XCP|EX|B7B67C06-0802-4E69-A5A1-469213BE7E48|421|||||||||||F|KIT|Q7D||SUBLINGUAL||XIPHOID PROCESS|LEFT|ANTEROMEDIAL|Y|||WASHOUT|1960-05-17|1966-04-01|||1960-02-18|||1962-06-07||1963-08-23
TRIAL STUDY 134XCP|EX|626E3EA7-423B-434F-89E4-CA076A39B8DB|422|||||||||||NMOL BCE/L|GRANULE, FOR SOLUTION|EVERY 5 WEEKS||INTRASPINAL||EPITROCHLEAR LYMPH NODE|RIGHT|DEEP|Y|||CONTINUATION TREATMENT|1972-07-09|1963-11-02|||1972-06-04|||1972-03-18||1966-01-09
TRIAL STUDY 134XCP|EX|98ED3A38-1E74-470E-BF45-0D1E905BEF36|423|||||||||||PMOL|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|Q14H||URETHRAL||SOLEUS MUSCLE|CONTRALATERAL|OCCIPITAL|Y|||RUN-IN|1963-01-29|1969-02-28|||1968-10-22|||1961-12-27||1966-01-12
TRIAL STUDY 134XCP|EX|99DF7819-987E-4E55-89FD-FF49E7C02A5A|424|||||||||||CS|SOLUTION/ DROPS|Q9H||INTRATHORACIC||LINGULA OF THE LUNG|BILATERAL|NASAL|U|||CONTINUATION TREATMENT|1963-12-11|1966-07-11|||1961-04-26|||1965-07-24||1960-07-26
TRIAL STUDY 134XCP|EX|05481BE7-9309-4356-B46E-9C2525D2C54E|425|||||||||||ML/MIN/1.73M2|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|Q24H||INTRALYMPHATIC||LEG|CONTRALATERAL|ROSTRAL|NA|||BASELINE|1972-02-01|1964-03-22|||1968-09-30|||1965-03-21||1970-10-09
TRIAL STUDY 134XCP|EX|2F49D512-0A23-4D2D-959B-A1756991E817|426|||||||||||PMOL/G|ENEMA|PA||SUBLINGUAL||ANTERIOR TIBIAL VEIN|CONTRALATERAL|UPPER FLEXOR SURFACE|Y|||OBSERVATION|1969-06-16|1970-02-28|||1963-03-11|||1962-05-18||1961-06-23
TRIAL STUDY 134XCP|EX|E884C56C-1612-49CC-A594-B65E7B354842|427|||||||||||SQU/ML|GRANULE, DELAYED RELEASE|Q6M||EPIDURAL||CALF|CONTRALATERAL|VOLAR|Y|||FOLLOW-UP|1968-02-28|1971-07-19|||1968-11-03|||1966-07-11||1964-12-02
TRIAL STUDY 134XCP|EX|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|428|||||||||||APL U|TABLET, COATED|Q72H||UNKNOWN||FLEXOR CARPI RADIALIS MUSCLE|IPSILATERAL|UPPER FLEXOR SURFACE|NA|||FOLLOW-UP|1968-04-12|1973-04-14|||1960-08-01|||1969-07-22||1962-02-14
TRIAL STUDY 134XCP|EX|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|429|||||||||||KPA|INJECTION, SUSPENSION, LIPOSOMAL|Q11H||BUCCAL||SKIN AROUND THE EYE|RIGHT|ANTEROLATERAL|NA|||RUN-IN|1963-12-24|1963-12-24|||1962-11-16|||1969-09-15||1969-06-28
TRIAL STUDY 134XCP|EX|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|430|||||||||||CCID 50/DOSE|FILM, SOLUBLE|Q18H||INTRAPULMONARY||RENAL PELVIS|RIGHT|ANTEROMEDIAL|N|||INDUCTION TREATMENT|1960-01-08|1960-01-10|||1964-11-20|||1964-09-05||1966-08-24
TRIAL STUDY 134XCP|EX|0B140787-9458-4F66-B7E9-1FAFF239085E|431|||||||||||MOL/L|TABLET, SUGAR COATED|Q4D||INTRACAVITARY||SKIN OF THE NECK|LATERAL|FRONTAL|NA|||RUN-IN|1969-04-29|1967-03-31|||1964-06-23|||1973-08-31||1970-10-02
TRIAL STUDY 134XCP|EX|FB91BADF-308B-4F6A-90D0-032E93E20C4A|432|||||||||||PATCH|AEROSOL, FOAM|BIM||OROPHARYNGEAL||PECTORALIS MAJOR MUSCLE|CONTRALATERAL|OUTER|Y|||LONG-TERM FOLLOW-UP|1964-07-23|1966-12-06|||1972-06-07|||1964-08-21||1962-02-06
TRIAL STUDY 134XCP|EX|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|433|||||||||||FL|TABLET, CHEWABLE|Q9H||IRRIGATION||SKIN OF THE HAND|CONTRALATERAL|LOWER MEDIAL|N|||RUN-IN|1967-12-11|1960-12-07|||1968-07-27|||1961-12-21||1962-05-30
TRIAL STUDY 134XCP|EX|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|434|||||||||||/MM2|INJECTION, SOLUTION|EVERY 7 WEEKS||INTRATHALAMIC||MESENTERIC ARTERY|BILATERAL|INFERIOR|U|||OPEN LABEL TREATMENT|1960-06-06|1962-06-04|||1964-04-20|||1970-12-26||1969-10-01
TRIAL STUDY 134XCP|EX|3B583022-3A2C-4387-80A5-035E3FD111BD|435|||||||||||AMPULE|CRYSTAL|QH||OROPHARYNGEAL||THYROID GLAND ISTHMUS|CONTRALATERAL|PROXIMAL|NA|||OBSERVATION|1971-07-15|1967-01-19|||1961-04-01|||1969-04-06||1968-09-27
TRIAL STUDY 134XCP|EX|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|436|||||||||||DB|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|Q5D||VAGINAL||POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|RIGHT|INNER|U|||OPEN LABEL TREATMENT|1968-08-14|1970-02-02|||1966-12-25|||1972-03-22||1960-12-18
TRIAL STUDY 134XCP|EX|B5370AC4-3185-48DC-B1BC-A00AE8496783|437|||||||||||ML/DL|PATCH|4 TIMES PER YEAR||INTRASYNOVIAL||PERIFACIAL LYMPH NODE|LEFT|SURFACE|U|||LONG-TERM FOLLOW-UP|1965-09-19|1971-07-21|||1970-07-27|||1968-04-26||1968-06-21
TRIAL STUDY 134XCP|EX|1112A903-1F2A-4583-BB9A-41DD206D5B4A|438|||||||||||TORR|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|Q4H||INFILTRATION||FLEXOR DIGITORUM LONGUS MUSCLE|CONTRALATERAL|LOWER MEDIAL|U|||TREATMENT|1970-06-29|1963-05-19|||1971-04-16|||1961-02-08||1964-05-31
TRIAL STUDY 134XCP|EX|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|439|||||||||||KG/M2|INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE|QAM||IRRIGATION||SARTORIUS MUSCLE|IPSILATERAL|LOWER EXTENSOR SURFACE|NA|||TREATMENT|1961-11-22|1970-06-11|||1971-07-02|||1964-03-11||1962-06-16
TRIAL STUDY 134XCP|EX|D09F047E-E380-453B-875D-FF3C8C5EA839|440|||||||||||UIU/L|SUSPENSION, EXTENDED RELEASE|CONTINUOUS||INTRAPERITONEAL||CEREBRAL VEIN|CONTRALATERAL|SURFACE|U|||INDUCTION TREATMENT|1962-07-24|1967-03-29|||1965-12-06|||1968-05-15||1973-01-11
TRIAL STUDY 134XCP|EX|E1B16559-B9CA-4B14-A77A-4AD546EF5262|441|||||||||||MEQ/L|PELLET, IMPLANTABLE|Q3D||INTRALUMINAL||APPENDICEAL TIP|LATERAL|INNER|Y|||OPEN LABEL TREATMENT|1962-03-20|1966-08-01|||1962-07-17|||1964-06-15||1973-07-01
TRIAL STUDY 134XCP|EX|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|442|||||||||||SHOCK WAVE|DIAPHRAGM|Q2M||INTRATUMOR||ADDUCTOR LONGUS MUSCLE|UNILATERAL|UPPER FLEXOR SURFACE|Y|||LONG-TERM FOLLOW-UP|1972-02-18|1961-01-28|||1963-02-15|||1969-10-19||1965-02-08
TRIAL STUDY 134XCP|EX|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|443|||||||||||ML/BEAT|POWDER, FOR SUSPENSION|10 DAYS PER MONTH||TRANSTRACHEAL||FOREBRAIN|LATERAL|VENTROLATERAL|U|||LONG-TERM FOLLOW-UP|1961-05-28|1960-12-27|||1970-09-12|||1969-05-19||1962-07-09
TRIAL STUDY 134XCP|EX|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|444|||||||||||BOTTLE|BEAD|7 TIMES PER DAY||INTRAVASCULAR||ANTERIOR CINGULATE CORTEX|RIGHT|MEDIAL|N|||TREATMENT|1961-12-25|1972-10-11|||1972-07-05|||1963-07-05||1966-12-19
TRIAL STUDY 134XCP|EX|44199000-F1B7-4187-9E5A-AA5F69E831C3|445|||||||||||KAT|LOTION|Q19H||TRANSTRACHEAL||UTERINE ARTERY|UNILATERAL|LATERAL|U|||LONG-TERM FOLLOW-UP|1973-08-20|1964-01-09|||1972-01-12|||1971-09-02||1967-07-13
TRIAL STUDY 134XCP|EX|1D487F49-92DB-4132-BD95-1B8797594DE7|446|||||||||||PRESSOR UNITS|GENERATOR|4 TIMES PER MONTH||ENTERAL||CEREBRUM|IPSILATERAL|LOWER FLEXOR SURFACE|Y|||INDUCTION TREATMENT|1970-08-07|1969-06-09|||1960-11-03|||1970-12-20||1965-03-09
TRIAL STUDY 134XCP|EX|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|447|||||||||||IU/DL|KIT|Q6M||INTRAGINGIVAL||TARSUS BONE|UNILATERAL|FORE|U|||WASHOUT|1972-03-08|1964-07-12|||1972-01-17|||1965-08-20||1964-05-28
TRIAL STUDY 134XCP|EX|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|448|||||||||||/CMH2O|CONE|4 TIMES PER YEAR||HEMODIALYSIS||RETROPERITONEUM|LEFT|CRANIAL|Y|||CONTINUATION TREATMENT|1969-08-26|1973-07-14|||1961-01-06|||1964-06-21||1968-05-22
TRIAL STUDY 134XCP|EX|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|449|||||||||||V|GRANULE, DELAYED RELEASE|QOD||TRANSPLACENTAL||ANTERIOR CINGULATE CORTEX|LEFT|LATERAL|U|||FOLLOW-UP|1969-03-13|1970-05-06|||1967-05-09|||1969-05-10||1966-04-22
TRIAL STUDY 134XCP|EX|33233744-4E16-437D-852B-B5F2CCC94B1A|450|||||||||||IU/DAY|JELLY|BIM||INTRASURGICAL SITE||TRICUSPID VALVE, POSTERIOR CUSP|CONTRALATERAL|ANTEROPOSTERIOR|NA|||BASELINE|1967-08-22|1962-06-20|||1964-09-15|||1973-04-04||1965-08-30
TRIAL STUDY 134XCP|EX|B27DC754-F6E2-41E3-9804-0F92AE0006B4|451|||||||||||GBQ/G|SUPPOSITORY, EXTENDED RELEASE|EVERY 4 WEEKS||INTRADUCTAL||CORNEAL EPITHELIUM|RIGHT|DORSOLATERAL|Y|||BLINDED TREATMENT|1968-04-20|1972-10-29|||1972-04-21|||1968-02-21||1966-06-13
TRIAL STUDY 134XCP|EX|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|452|||||||||||S/H|IMPLANT|EVERY 5 YEARS||INTRAVAGINAL||TEMPLE|RIGHT|MIDLINE|NA|||TREATMENT|1968-12-05|1964-11-17|||1968-09-28|||1963-08-17||1969-12-06
TRIAL STUDY 134XCP|EX|BDE843D8-2F69-4542-BC47-D52302FD4898|453|||||||||||SCOOPFUL|GLOBULE|Q36H||TRANSTRACHEAL||PECTORALIS MAJOR MUSCLE|CONTRALATERAL|FACIAL|U|||WASHOUT|1969-04-26|1970-01-23|||1968-12-07|||1970-07-10||1968-01-12
TRIAL STUDY 134XCP|EX|A8C8CB0C-C575-414C-BF1C-846361DB03BC|454|||||||||||G/MOL|CAPSULE, SOFTGEL, EXTENDED RELEASE|Q21H||INTRAOSSEOUS||FOOT DIGIT 4|IPSILATERAL|TIP|NA|||OPEN LABEL TREATMENT|1963-11-23|1962-09-06|||1973-06-24|||1964-02-26||1962-12-03
TRIAL STUDY 134XCP|EX|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|455|||||||||||ANTI-XA IU|PILL|3 TIMES PER YEAR||INTRAEPIDERMAL||AXIAL SKELETON|UNILATERAL|OUTER|Y|||BLINDED TREATMENT|1968-01-31|1964-07-28|||1965-09-21|||1960-05-16||1972-09-14
TRIAL STUDY 134XCP|EX|86198851-0F45-45E0-A0CE-C50FEC078456|456|||||||||||ML/M2/H|STRIP|Q21H||INTRATHALAMIC||INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|ANTEROTEMPORAL|N|||SCREENING|1971-09-13|1965-08-21|||1968-05-27|||1973-06-15||1961-05-04
TRIAL STUDY 134XCP|EX|9CD28016-BED9-4159-9C1B-60821D74615B|457|||||||||||CM H2O|INJECTABLE, LIPOSOMAL|EVERY 3 WEEKS||PERIODONTAL||CRANIAL CAVITY|UNILATERAL|UPPER|NA|||WASHOUT|1962-08-04|1962-12-01|||1970-05-01|||1967-08-27||1963-06-28
TRIAL STUDY 134XCP|EX|BE578D25-C23E-416F-8A57-C901F7B58596|458|||||||||||TSP|SPRAY|QAM||INTRATUBULAR||COLON, RECTOSIGMOID|LEFT|LOWER|U|||OBSERVATION|1961-02-14|1972-03-09|||1960-09-20|||1961-06-17||1967-06-14
TRIAL STUDY 134XCP|EX|A60D5FE6-26BA-487D-98E0-5F464305924C|459|||||||||||L|AEROSOL, SPRAY|EVERY EVENING||INTRALYMPHATIC||COLON LYMPH NODE|LATERAL|DORSOLATERAL|N|||BASELINE|1969-02-15|1961-07-11|||1962-04-15|||1973-08-25||1968-09-03
TRIAL STUDY 134XCP|EX|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|460|||||||||||BQ|PATCH, EXTENDED RELEASE|QPM||INTRACARDIAC||INFRACLAVICULAR LYMPH NODE|UNILATERAL|PERIVENTRICULAR|Y|||TREATMENT|1962-01-23|1963-05-12|||1960-11-16|||1960-07-29||1960-05-01
TRIAL STUDY 134XCP|EX|89739AE0-A8B9-44DE-970E-9D679ED58C4F|461|||||||||||ABSORBANCE U/MIN|PLASTER|QD||INTRALUMINAL||FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|IPSILATERAL|SUPERFICIAL|N|||BASELINE|1963-04-05|1960-08-15|||1966-10-13|||1969-08-26||1967-07-08
TRIAL STUDY 134XCP|EX|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|462|||||||||||MMOL/KG|AEROSOL|Q6M||INTRAJEJUNAL||LUMBRICAL MUSCLES OF THE HAND|CONTRALATERAL|SURFACE|N|||BASELINE|1968-02-06|1963-08-07|||1963-08-27|||1967-09-19||1970-12-12
TRIAL STUDY 134XCP|EX|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|463|||||||||||PMOL/L/H|CEMENT|Q18H||DIETARY||RIB 3|LATERAL|VENTRAL|U|||SCREENING|1967-09-03|1972-02-18|||1960-06-10|||1968-04-09||1970-05-23
TRIAL STUDY 134XCP|EX|CED88848-769E-41C1-9ACD-99E45766D27B|464|||||||||||GPS U|WAFER|QM||PARENTERAL||ANTERIOR SUPERIOR ILIAC SPINE|IPSILATERAL|ROSTRAL|Y|||FOLLOW-UP|1972-01-18|1960-07-02|||1961-10-08|||1966-02-28||1970-08-26
TRIAL STUDY 134XCP|EX|E7958F8B-D987-4929-993A-8960EB30A309|465|||||||||||TRACE|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|Q14H||INTRAILEAL||HAIR FOLLICLE|LATERAL|SUPERIOR|NA|||OPEN LABEL TREATMENT|1965-04-13|1961-03-18|||1968-01-21|||1960-12-25||1966-09-06
TRIAL STUDY 134XCP|EX|A633D973-B611-4014-A43E-C8C2D21DBFC2|466|||||||||||MV/SEC|TABLET, EFFERVESCENT|QH||INTRAMEDULLARY||PERIHILAR LYMPH NODE|LATERAL|ANTEROPOSTERIOR|NA|||LONG-TERM FOLLOW-UP|1967-06-08|1968-08-12|||1966-07-24|||1963-01-03||1972-11-13
TRIAL STUDY 134XCP|EX|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|467|||||||||||10^6 ORGANISMS/ML|GENERATOR|Q3H||TRANSTRACHEAL||OPTIC NERVE|LEFT|VENTRAL|N|||FOLLOW-UP|1969-04-04|1964-09-15|||1962-05-06|||1962-03-31||1960-09-14
TRIAL STUDY 134XCP|EX|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|468|||||||||||UG/MIN|DRUG DELIVERY SYSTEM|Q2M||INTRADURAL||MUCOSA|RIGHT|SUPERIOR|N|||WASHOUT|1962-09-24|1969-07-20|||1964-12-25|||1964-03-02||1967-05-20
TRIAL STUDY 134XCP|EX|264AA652-A25E-43CE-A54F-6FEB54AB62F3|469|||||||||||LOG10 TCID 50/UL|OINTMENT|3 TIMES PER MONTH||INTRATESTICULAR||CORONARY ARTERY, LEFT|IPSILATERAL|LATERAL|Y|||WASHOUT|1962-03-23|1973-08-22|||1962-11-27|||1969-10-23||1973-02-03
TRIAL STUDY 134XCP|EX|4DE042DC-2F1E-425C-BA36-F64A3493CE76|470|||||||||||GLOBULE|INSERT, EXTENDED RELEASE|Q10H||INTRAVENOUS||MEDIASTINUM, MIDDLE|UNILATERAL|OCCIPITAL|N|||TREATMENT|1970-01-14|1961-11-04|||1965-04-15|||1970-10-29||1961-05-04
TRIAL STUDY 134XCP|EX|872942E9-A575-4929-9B21-D30DE51B367B|471|||||||||||10^9 CFU/ML|GRANULE, EFFERVESCENT|Q6D||DENTAL||TRICUSPID VALVE, POSTERIOR CUSP|RIGHT|LOWER|U|||OPEN LABEL TREATMENT|1972-04-19|1962-12-15|||1960-07-01|||1973-08-22||1970-03-17
TRIAL STUDY 134XCP|EX|628822F3-4983-44F8-B98D-7A35AAFF2962|472|||||||||||GY/H|SOAP|Q8H||INTRAVENOUS BOLUS||EYE BULGE|LEFT|NASAL|Y|||OPEN LABEL TREATMENT|1961-09-07|1969-06-26|||1968-09-08|||1960-11-08||1961-05-23
TRIAL STUDY 134XCP|EX|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|473|||||||||||SQU/ML|TABLET, SUGAR COATED|QAM||NASOGASTRIC||HAIR|UNILATERAL|CENTRAL|N|||SCREENING|1971-10-10|1968-04-01|||1963-05-13|||1973-06-04||1960-08-06
TRIAL STUDY 134XCP|EX|6045DFAB-0734-4E6D-A492-34BD613EC783|474|||||||||||NMOL/L/MIN|TABLET, EXTENDED RELEASE|5 TIMES PER WEEK||INTRAMANDIBULAR||PREPUTIAL GLAND|BILATERAL|CAUDAL|Y|||OBSERVATION|1962-08-03|1962-10-26|||1962-10-21|||1966-02-03||1961-04-26
TRIAL STUDY 134XCP|EX|482F0519-E738-46DE-A5C4-4AC76B6E7011|475|||||||||||NMOL BCE/NMOL|CAPSULE, COATED PELLETS|Q2H||INTRACARTILAGINOUS||NOSE|CONTRALATERAL|PARIETO-OCCIPITAL|U|||INDUCTION TREATMENT|1968-01-23|1961-01-11|||1969-08-25|||1964-08-03||1963-02-15
TRIAL STUDY 134XCP|EX|DFDD42F5-749C-4AF0-8351-780DB9614F61|476|||||||||||/4.0 ML|PELLETS, COATED, EXTENDED RELEASE|Q7D||INTRAMANDIBULAR||STERNUM|RIGHT|OCCIPITAL|NA|||INDUCTION TREATMENT|1962-06-14|1970-03-31|||1966-03-01|||1965-11-09||1964-12-11
TRIAL STUDY 134XCP|EX|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|477|||||||||||ML/SEC/1.73M2|GEL, CHEWABLE|Q7H||INTRACAMERAL||LARYNX|LEFT|MEDIAL|Y|||OBSERVATION|1966-04-20|1960-09-16|||1968-08-08|||1964-01-18||1968-09-06
TRIAL STUDY 134XCP|EX|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|478|||||||||||ML/BEAT|WAFER|Q45MIN||INFILTRATION||EYELASH|BILATERAL|LOWER EXTENSOR SURFACE|N|||CONTINUATION TREATMENT|1963-07-13|1961-12-23|||1969-03-07|||1972-05-20||1968-10-21
TRIAL STUDY 134XCP|EX|E0434C66-0F59-476F-9913-55766C4AED1B|479|||||||||||WATT|FOR SUSPENSION|PA||UNASSIGNED||LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LEFT|PROXIMAL VOLAR|Y|||BLINDED TREATMENT|1963-09-13|1964-07-14|||1960-02-02|||1964-08-21||1967-06-24
TRIAL STUDY 134XCP|EX|60B57F98-61FF-4322-8084-7A536964F60A|480|||||||||||EIA UNIT|CAPSULE, COATED|6 TIMES PER DAY||INTRAPERICARDIAL||PRELARYNGEAL LYMPH NODE|UNILATERAL|FRONTAL|N|||FOLLOW-UP|1964-01-22|1964-10-27|||1961-09-12|||1972-02-12||1967-09-08
TRIAL STUDY 134XCP|EX|C79CA198-24E2-4A76-8C32-F3AA973EA41E|481|||||||||||USIEMENS|SOAP|OCCASIONAL||INTRAMANDIBULAR||PERIURETERAL REGION|BILATERAL|BASAL|Y|||BLINDED TREATMENT|1970-08-14|1969-07-20|||1968-02-24|||1962-12-24||1963-07-23
TRIAL STUDY 134XCP|EX|D250194D-9BBD-40D3-A13B-BBCEB53DB450|482|||||||||||CI/UL|CAPSULE, SOFTGEL, EXTENDED RELEASE|EVERY 16 WEEKS||INTRAPERITONEAL||ULNAR ARTERY|LATERAL|LOWER EXTENSOR SURFACE|NA|||RUN-IN|1963-03-03|1973-07-12|||1965-11-24|||1969-09-27||1970-05-13
TRIAL STUDY 134XCP|EX|369AE0AF-8693-4363-9A6E-CD30567BD614|483|||||||||||UGEQ|TABLET, IMMEDIATE RELEASE|Q5H||INTRACEREBRAL||ANKLE JOINT ANTERIOR EXTENSOR TENDONS|IPSILATERAL|DEEP|NA|||OPEN LABEL TREATMENT|1962-10-19|1971-12-03|||1964-07-12|||1971-01-25||1969-01-21
TRIAL STUDY 134XCP|EX|4497DB94-5B91-4169-9D73-73EE5C1D9B76|484|||||||||||GTT|FOR SUSPENSION|QH||PERINEURAL||PRELARYNGEAL LYMPH NODE|RIGHT|UPPER FLEXOR SURFACE|U|||FOLLOW-UP|1962-03-23|1961-09-23|||1965-06-29|||1960-08-22||1965-09-14
TRIAL STUDY 134XCP|EX|487D7E2D-6E7E-4A5E-ADC7-72B888746263|485|||||||||||IU/DL|INJECTION, SUSPENSION|QH||CUTANEOUS||METACARPOPHALANGEAL JOINT 1|UNILATERAL|VOLAR|U|||RUN-IN|1962-11-04|1971-02-06|||1971-02-24|||1966-04-21||1972-05-14
TRIAL STUDY 134XCP|EX|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|486|||||||||||UL|UNASSIGNED|PA||RESPIRATORY (INHALATION)||RADIUS-LUNATE JOINT|LEFT|ROSTRAL|NA|||BLINDED TREATMENT|1962-08-25|1968-08-30|||1961-06-25|||1962-08-20||1961-04-12
TRIAL STUDY 134XCP|EX|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|487|||||||||||%(W/V)|SOLUTION, GEL FORMING, EXTENDED RELEASE|EVERY 8 WEEKS||TRANSDERMAL||LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LATERAL|INFERIOR|Y|||TREATMENT|1969-11-02|1973-06-17|||1961-10-21|||1968-12-01||1966-07-10
TRIAL STUDY 134XCP|EX|8BF6E538-2F39-48E4-B115-AE1693843BBC|488|||||||||||SEC|GRANULE, FOR SOLUTION|10 DAYS PER MONTH||INTRAVASCULAR||LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|RIGHT|PARIETO-OCCIPITAL|N|||SCREENING|1961-12-09|1969-04-30|||1960-03-06|||1971-08-23||1969-10-11
TRIAL STUDY 134XCP|EX|57F001BC-36EB-44AF-9487-373FA31B7311|489|||||||||||L/H/M2|TABLET, FILM COATED|BIM||INTRAMUSCULAR||RIB 7|RIGHT|NASAL|NA|||FOLLOW-UP|1972-04-23|1970-03-07|||1972-11-24|||1964-04-15||1965-12-23
TRIAL STUDY 134XCP|EX|3FBDC961-EB02-4B28-8672-2A0A0A33529E|490|||||||||||NCI|TINCTURE|6 TIMES PER YEAR||INTRACORPORUS CAVERNOSUM||TRICUSPID VALVE, ANTERIOR CUSP|LEFT|FRONTAL|Y|||BASELINE|1965-09-15|1965-11-04|||1972-03-28|||1962-12-22||1967-12-31
TRIAL STUDY 134XCP|EX|1B524FC4-365B-4A16-A4D7-ED818C6E6086|491|||||||||||MCI/L|CONCENTRATE|Q4M||INTRALYMPHATIC||MESENTERIC ARTERY|LATERAL|LATERAL|U|||INDUCTION TREATMENT|1968-03-30|1971-04-16|||1965-01-17|||1961-03-29||1973-06-12
TRIAL STUDY 134XCP|EX|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|492|||||||||||/MM2|GUM, RESIN|Q22H||INTRABRONCHIAL||CAROTID ARTERY|CONTRALATERAL|ANTEROTEMPORAL|N|||SCREENING|1968-01-01|1969-08-25|||1972-05-13|||1961-09-29||1967-05-27
TRIAL STUDY 134XCP|EX|27671577-2C6D-429F-BED9-0EDAB15CCB33|493|||||||||||WEBER|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|QPM||TRANSTYMPANIC||SKIN OF THE FOREARM|BILATERAL|POSTERIOR|NA|||BLINDED TREATMENT|1973-07-04|1965-05-28|||1973-05-12|||1964-09-28||1971-05-23
TRIAL STUDY 134XCP|EX|CD69750D-957B-405C-A397-AFA331D30535|494|||||||||||10^5/HPF|SHAMPOO|EVERY EVENING||UNASSIGNED||PROSTATE GLAND|UNILATERAL|LOWER FLEXOR SURFACE|NA|||OBSERVATION|1969-04-16|1969-01-06|||1965-03-11|||1972-03-11||1966-12-19
TRIAL STUDY 134XCP|EX|5BFDDFC2-7D15-4B01-8140-62376D160EF0|495|||||||||||ML/ANIMAL|INHALANT|Q36H||IRRIGATION||PRESACRAL SPACE|RIGHT|INFERIOR|N|||SCREENING|1967-10-15|1964-05-17|||1962-06-29|||1973-07-31||1972-11-05
TRIAL STUDY 134XCP|EX|DEA8E573-2709-41F9-AB0D-8C39F5169B48|496|||||||||||CMH2O/ML|FILM, EXTENDED RELEASE|Q22H||BUCCAL||DELTOID MUSCLE|BILATERAL|TIP|U|||CONTINUATION TREATMENT|1962-02-14|1962-11-14|||1971-08-06|||1972-05-15||1968-08-24
TRIAL STUDY 134XCP|EX|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|497|||||||||||CMOL/L|SPRAY|3 TIMES PER WEEK||INTRATHORACIC||PARANASAL SINUS|LATERAL|SURFACE|Y|||CONTINUATION TREATMENT|1966-12-01|1960-01-22|||1964-03-22|||1969-08-06||1972-04-13
TRIAL STUDY 134XCP|EX|77CF8795-CFF5-40C6-A811-624972806A38|498|||||||||||FFU|IMPLANT|Q17H||INTRAOVARIAN||METACARPAL BONE 4|IPSILATERAL|LOWER EXTENSOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1964-12-05|1970-06-24|||1971-04-24|||1973-05-31||1973-08-24
TRIAL STUDY 134XCP|EX|D43B827C-D393-41D4-81C5-AACB1A7673A1|499|||||||||||POINT|TABLET, MODIFIED RELEASE, LONG DURATION|QH||INTRAVESICAL||LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LATERAL|DEEP|N|||RUN-IN|1964-01-21|1970-10-24|||1972-01-14|||1970-07-27||1972-05-13
TRIAL STUDY 134XCP|EX|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|500|||||||||||/LPF|PATCH|EVERY 16 WEEKS||INTRAPROSTATIC||UPPER URINARY SYSTEM|UNILATERAL|UPPER|Y|||RUN-IN|1963-10-19|1962-05-07|||1973-05-06|||1968-04-18||1972-12-05
TRIAL STUDY 134XCP|EX|0671FB62-42B8-4882-93ED-0E11CFE07DE9|501|||||||||||ATM|STICK|Q4M||EXTRACORPOREAL||CHIN|UNILATERAL|INNER|NA|||OBSERVATION|1962-12-25|1962-06-02|||1965-07-24|||1968-08-25||1963-07-29
TRIAL STUDY 134XCP|EX|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|502|||||||||||SV|INJECTION, SOLUTION, CONCENTRATE|Q3H||ORAL||FACIAL BONE|IPSILATERAL|UPPER FLEXOR SURFACE|Y|||TREATMENT|1971-01-15|1969-09-06|||1966-09-21|||1970-11-06||1971-08-20
TRIAL STUDY 134XCP|EX|E9161164-3B91-4855-AFBA-12C6BD93F95F|503|||||||||||UG/DL|ELIXIR|2 TIMES PER YEAR||BUCCAL||PONS VAROLII|LATERAL|CENTRAL|U|||BLINDED TREATMENT|1965-03-25|1968-02-12|||1966-05-20|||1969-10-12||1973-05-22
TRIAL STUDY 134XCP|EX|FBB66C13-05F5-4337-B34A-9900EB5F50F3|504|||||||||||PG/L|RING|6 TIMES PER MONTH||INTRA-ABDOMINAL||PERIPANCREATIC LYMPH NODE|IPSILATERAL|POSTERIOR|NA|||INDUCTION TREATMENT|1971-07-08|1961-04-11|||1965-01-30|||1961-10-15||1967-03-23
TRIAL STUDY 134XCP|EX|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|505|||||||||||SUPPOSITORY|PELLETS, COATED, EXTENDED RELEASE|Q19H||BUCCAL||EYE|UNILATERAL|PROXIMAL VOLAR|U|||LONG-TERM FOLLOW-UP|1962-10-21|1971-01-21|||1961-12-31|||1968-08-30||1964-08-02
TRIAL STUDY 134XCP|EX|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|506|||||||||||PHERESIS UNIT|CAPSULE, COATED, EXTENDED RELEASE|EVERY EVENING||OROPHARYNGEAL||PROSTATE GLAND, MIDDLE LOBE|LATERAL|TEMPORAL|NA|||INDUCTION TREATMENT|1969-04-18|1969-06-07|||1960-11-26|||1965-04-28||1961-09-17
TRIAL STUDY 134XCP|EX|21223189-5527-4B3F-AFD5-21F77AC0DEBE|507|||||||||||VG/ML|TABLET|QAM||INTRACAMERAL||SKIN OF THE SOLE|UNILATERAL|HIND|Y|||TREATMENT|1960-12-22|1972-02-11|||1967-07-07|||1966-08-27||1962-09-18
TRIAL STUDY 134XCP|EX|CA6ECC17-3E3B-435C-A485-8612C267E52B|508|||||||||||UG/KG|FOR SUSPENSION, EXTENDED RELEASE|AD LIBITUM||INTRAMENINGEAL||TARSAL JOINT|UNILATERAL|MIDLINE|NA|||BLINDED TREATMENT|1967-03-17|1962-07-23|||1967-04-12|||1970-01-02||1963-09-06
TRIAL STUDY 134XCP|EX|BCB41507-87B3-4773-B1E5-AE039853DED0|509|||||||||||ML/S/M2|SOLUTION, FOR SLUSH|Q8H||INTRACISTERNAL||EPIGLOTTIS|LEFT|CAUDAL|Y|||INDUCTION TREATMENT|1964-11-11|1965-12-29|||1960-02-20|||1963-06-22||1963-11-26
TRIAL STUDY 134XCP|EX|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|510|||||||||||10^6 RNA COPIES/ML|GUM, CHEWING|Q14H||PERIODONTAL||EPICONDYLE|LATERAL|ANTEROPOSTERIOR|NA|||BLINDED TREATMENT|1972-04-29|1971-02-10|||1962-08-23|||1962-12-06||1964-10-15
TRIAL STUDY 134XCP|EX|EC726B09-0B0F-4933-94F4-8941DF68EDE6|511|||||||||||PACK|LINIMENT|TWICE||INTRAPERICARDIAL||EPICONDYLE|LEFT|VENTROLATERAL|U|||LONG-TERM FOLLOW-UP|1965-06-27|1971-02-26|||1970-01-28|||1960-07-14||1960-02-13
TRIAL STUDY 134XCP|EX|9F703096-9152-422E-AEAB-AD22F00863ED|512|||||||||||UGEQ/L|PELLETS, COATED, EXTENDED RELEASE|7 TIMES PER DAY||DIETARY||PALPEBRAL FISSURE|IPSILATERAL|SUPERIOR|N|||TREATMENT|1973-01-05|1966-01-22|||1962-04-11|||1965-12-28||1966-01-16
TRIAL STUDY 134XCP|EX|57455593-8872-4B17-8B3F-8A02FE855290|513|||||||||||10^9 CFU|INJECTABLE, LIPOSOMAL|EVERY 5 YEARS||ENTERAL||PULMONARY VALVE|LATERAL|APICAL|Y|||WASHOUT|1969-04-26|1966-05-30|||1964-08-27|||1972-04-25||1971-03-18
TRIAL STUDY 134XCP|EX|97F58005-7367-49DC-967B-FAD681B55DF8|514|||||||||||DEG/S|FIBER, EXTENDED RELEASE|EVERY 2 WEEKS||INTRALUMINAL||EXTRAHEPATIC PERIHILAR BILE DUCT REGION|LEFT|OCCIPITAL|N|||SCREENING|1962-03-20|1967-10-28|||1963-05-09|||1971-03-07||1968-07-02
TRIAL STUDY 134XCP|EX|83AC0828-3C22-4F7C-9D22-F044BB5B630D|515|||||||||||BAU/ML|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|Q6D||RECTAL||COMMON FEMORAL ARTERY|RIGHT|TIP|Y|||BASELINE|1963-07-01|1962-11-07|||1960-11-11|||1964-02-17||1965-07-12
TRIAL STUDY 134XCP|EX|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|516|||||||||||UG/KG/DAY|INJECTION, POWDER, FOR SOLUTION|Q12H||INTRAUTERINE||CORPUS CALLOSUM, SPLENIUM|CONTRALATERAL|VENTRAL|N|||TREATMENT|1968-09-06|1968-01-23|||1969-03-31|||1971-01-27||1971-04-28
TRIAL STUDY 134XCP|EX|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|517|||||||||||TABLET|FIBER, EXTENDED RELEASE|Q13H||INTRASINAL||SUBLINGUAL REGION|IPSILATERAL|UPPER|N|||BASELINE|1966-07-18|1965-09-04|||1960-10-10|||1968-03-29||1969-07-11
TRIAL STUDY 134XCP|EX|B386B813-1175-4421-9C86-F9AB597877FA|518|||||||||||ML/DAY|TABLET, ORALLY DISINTEGRATING|Q3D||INTRAPERITONEAL||METATARSOPHALANGEAL JOINT|LATERAL|TEMPORAL|U|||FOLLOW-UP|1962-09-15|1969-05-12|||1969-06-07|||1960-03-26||1972-12-20
TRIAL STUDY 134XCP|EX|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|519|||||||||||UG/M2/H|SUTURE|5 TIMES PER YEAR||INTRAVESICAL||FUNDUS OF THE STOMACH|RIGHT|LOWER EXTENSOR SURFACE|NA|||OBSERVATION|1972-01-23|1970-10-20|||1963-04-02|||1967-11-20||1966-04-20
TRIAL STUDY 134XCP|EX|7B33775D-1DFF-49A6-820E-7981F5C16AFF|520|||||||||||U/M2/MIN|CAPSULE, HARD, EXTENDED RELEASE|Q6M||INTRASURGICAL SITE||SKIN OF THE UPPER LIMB|LATERAL|PROXIMAL|NA|||BASELINE|1971-06-23|1972-01-04|||1966-07-08|||1964-05-26||1967-03-10
TRIAL STUDY 134XCP|EX|DC48DD03-B87E-422D-A2EE-D87342260E19|521|||||||||||SHOCK WAVE|KIT|Q24H||INTRAPROSTATIC||TEMPORAL LOBE|CONTRALATERAL|ANTEROPOSTERIOR|N|||SCREENING|1972-06-29|1961-10-30|||1967-09-05|||1964-12-19||1964-01-04
TRIAL STUDY 134XCP|EX|2E084441-61A3-4B8B-9050-A5D7B38CA978|522|||||||||||MV/SEC|FOR SUSPENSION, EXTENDED RELEASE|Q15H||INTRALYMPHATIC||CEREBRAL VEIN|UNILATERAL|ANTERIOR|Y|||FOLLOW-UP|1966-10-30|1972-07-28|||1971-06-01|||1971-12-28||1971-10-05
TRIAL STUDY 134XCP|EX|601D563B-AA21-4859-A87E-B2068C1E3F53|523|||||||||||CD*S/M2|SPRAY|Q4H||PERCUTANEOUS||CORPUS CALLOSUM, SPLENIUM|RIGHT|VOLAR|NA|||BASELINE|1967-05-26|1973-06-12|||1968-12-08|||1970-12-13||1964-04-23
TRIAL STUDY 134XCP|EX|D8FE5979-24C7-478F-8612-0102F28F5ADE|524|||||||||||ML/S/M2|GRANULE, EFFERVESCENT|3 TIMES PER MONTH||INTRADUODENAL||RECTO-UTERINE POUCH|LATERAL|TIP|N|||CONTINUATION TREATMENT|1967-04-19|1968-12-04|||1967-02-16|||1967-10-07||1968-12-28
TRIAL STUDY 134XCP|EX|D275315F-D3C5-4260-8BD6-37DDB67262B0|525|||||||||||POINT|GLOBULE|TWICE||NASAL||THYMUS GLAND|LEFT|MIDLINE|U|||LONG-TERM FOLLOW-UP|1970-11-28|1971-06-23|||1960-12-22|||1962-08-16||1966-11-27
TRIAL STUDY 134XCP|EX|34127CD2-378B-4335-AD4B-F305D0A21AF4|526|||||||||||AU/ML|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|Q4M||SUPRACHOROIDAL||ELBOW JOINT|CONTRALATERAL|UPPER EXTENSOR SURFACE|NA|||WASHOUT|1971-08-23|1971-08-26|||1964-10-02|||1964-11-02||1969-02-08
TRIAL STUDY 134XCP|EX|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|527|||||||||||IN|BEAD, IMPLANT, EXTENDED RELEASE|3 TIMES PER YEAR||INTRASPINAL||TIBIO-PERONEAL TRUNK|LATERAL|POSTERIOR|U|||RUN-IN|1966-07-25|1969-09-16|||1965-07-13|||1972-05-19||1962-01-11
TRIAL STUDY 134XCP|EX|6EE04A90-681B-439E-9783-04B40A4AF240|528|||||||||||GPL U|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|3 TIMES PER YEAR||INTRACISTERNAL||EPIGASTRIC REGION|RIGHT|SUPERFICIAL|U|||OBSERVATION|1972-12-21|1968-11-05|||1965-01-02|||1965-09-17||1965-05-30
TRIAL STUDY 134XCP|EX|A5C0B034-1226-40EE-87E3-D46A7342B550|529|||||||||||U/ML|SHAMPOO, SUSPENSION|Q6H||INTRA-AMNIOTIC||EYE, ANTERIOR SEGMENT|BILATERAL|OCCIPITAL|N|||CONTINUATION TREATMENT|1969-05-24|1967-10-21|||1960-11-04|||1968-07-01||1972-05-22
TRIAL STUDY 134XCP|EX|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|530|||||||||||MMOL/G|GRANULE|9 TIMES PER DAY||INTRAVENTRICULAR||TRIGEMINAL NERVE|LATERAL|LOWER EXTENSOR SURFACE|N|||OBSERVATION|1971-03-04|1962-06-27|||1961-11-19|||1965-04-26||1971-01-25
TRIAL STUDY 134XCP|EX|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|531|||||||||||PACK|CRYSTAL|2 TIMES PER CYCLE||INTRAVENTRICULAR||MEDIASTINUM, POSTERIOR|UNILATERAL|PROXIMAL VOLAR|NA|||OPEN LABEL TREATMENT|1968-04-13|1968-04-01|||1972-10-01|||1963-03-05||1968-02-14
TRIAL STUDY 134XCP|EX|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|532|||||||||||MG/L FEU|CAPSULE, EXTENDED RELEASE|Q19H||INTRATHALAMIC||SMALL INTESTINE|LEFT|DORSAL|U|||LONG-TERM FOLLOW-UP|1960-01-04|1965-02-23|||1965-07-19|||1968-07-11||1962-07-14
TRIAL STUDY 134XCP|EX|D58A8C37-6659-4B00-8BED-256E8754F93C|533|||||||||||SEC|SALVE|3 TIMES PER MONTH||INTRAPERITONEAL||LEG|UNILATERAL|MEDIAL|U|||SCREENING|1969-08-28|1964-10-16|||1961-04-22|||1965-02-26||1964-05-20
TRIAL STUDY 134XCP|EX|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|534|||||||||||10^6 ORGANISMS/MG|MOUTHWASH|6 TIMES PER WEEK||MICRODIALYSIS||FEMORAL VEIN|CONTRALATERAL|ANTEROPOSTERIOR|Y|||INDUCTION TREATMENT|1964-09-14|1967-02-17|||1971-02-21|||1966-10-24||1960-06-17
TRIAL STUDY 134XCP|EX|5440F45F-C220-46E7-8354-6AF34A003E5E|535|||||||||||G/DAY|GAS|EVERY 5 WEEKS||INTRAMEDULLARY||SKIN OF THE UPPER LIMB|IPSILATERAL|MEDIAL|Y|||TREATMENT|1962-09-23|1962-06-07|||1965-10-19|||1970-07-02||1970-01-29
TRIAL STUDY 134XCP|EX|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|536|||||||||||PMOL/DL|PASTE, DENTIFRICE|4 TIMES PER MONTH||INTRAEPIDERMAL||COCCYGEAL VERTEBRA|LEFT|SUPERIOR|N|||OBSERVATION|1964-04-09|1973-03-13|||1972-07-05|||1965-11-29||1962-09-24
TRIAL STUDY 134XCP|EX|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|537|||||||||||/10^5|NOT APPLICABLE|Q2H||TRANSPLACENTAL||INTERNAL ILIAC LYMPH NODE|CONTRALATERAL|MEDIAL|U|||CONTINUATION TREATMENT|1970-12-20|1965-07-12|||1962-02-26|||1970-02-14||1962-03-03
TRIAL STUDY 134XCP|EX|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|538|||||||||||CIGARETTE|INJECTION, LIPID COMPLEX|INTERMITTENT||TRANSPLACENTAL||BACK|UNILATERAL|MEDIAL|U|||OPEN LABEL TREATMENT|1969-04-01|1964-08-22|||1966-01-23|||1965-02-13||1973-07-26
TRIAL STUDY 134XCP|EX|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|539|||||||||||UGEQ/L|RING|Q17H||CONJUNCTIVAL||SEMITENDINOSUS MUSCLE|UNILATERAL|DORSAL|NA|||INDUCTION TREATMENT|1966-11-01|1973-04-16|||1968-09-01|||1962-05-05||1964-03-04
TRIAL STUDY 134XCP|EX|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|540|||||||||||FMOL/L|POWDER, METERED|EVERY 8 WEEKS||INTRAESOPHAGEAL||PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|OCCIPITAL|NA|||WASHOUT|1961-04-03|1962-07-24|||1970-12-27|||1969-03-25||1965-11-06
TRIAL STUDY 134XCP|EX|1E9C7E41-8565-4C60-9EEB-814914081596|541|||||||||||WAFER|ENEMA|Q2H||TRANSMUCOSAL||AORTIC VALVE|CONTRALATERAL|POSTERIOR|Y|||BLINDED TREATMENT|1969-04-04|1968-04-03|||1969-02-21|||1966-11-24||1972-10-16
TRIAL STUDY 134XCP|EX|D7A008CF-5990-4D74-934A-A4DD3180EBD4|542|||||||||||CARTRIDGE|TABLET, FOR SOLUTION|Q3M||SOFT TISSUE||HIP ADDUCTORS|UNILATERAL|MIDLINE|U|||LONG-TERM FOLLOW-UP|1961-01-29|1960-05-01|||1963-04-06|||1973-08-01||1970-11-06
TRIAL STUDY 134XCP|EX|C168FA23-40EE-46D8-9A56-8B80490A0EFB|543|||||||||||MU|INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE|CONTINUOUS||TRANSMAMMARY||DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|FACIAL|U|||TREATMENT|1961-01-08|1970-11-10|||1963-10-13|||1962-07-06||1968-06-18
TRIAL STUDY 134XCP|EX|215E4E69-70C3-493C-9D67-F717363E8138|544|||||||||||LX|TABLET, CHEWABLE|THRICE||ENDOTRACHEAL||CARPOMETACARPAL JOINT 5|IPSILATERAL|OUTER|N|||OBSERVATION|1969-10-12|1969-08-10|||1970-07-11|||1969-02-27||1971-11-01
TRIAL STUDY 134XCP|EX|962CD4CA-AF22-42FB-ADB5-85F76850CA81|545|||||||||||KG/MOL|CREAM|Q19H||INTRAMENINGEAL||PARA-AORTIC LYMPH NODE|LATERAL|OUTER|N|||LONG-TERM FOLLOW-UP|1969-03-10|1962-08-17|||1967-04-08|||1963-03-01||1966-08-25
TRIAL STUDY 134XCP|EX|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|546|||||||||||LB|TAMPON|6 TIMES PER WEEK||INTRAGINGIVAL||MESENTERIC VEIN|BILATERAL|DORSOLATERAL|U|||INDUCTION TREATMENT|1973-05-31|1962-12-24|||1963-11-02|||1962-01-07||1967-04-20
TRIAL STUDY 134XCP|EX|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|547|||||||||||%/MIN|INJECTION, SOLUTION, CONCENTRATE|EVERY 12 WEEKS||INTRAVENOUS DRIP||FACIAL BONE|LATERAL|TIP|U|||RUN-IN|1967-05-06|1970-10-16|||1965-05-22|||1964-05-17||1961-01-24
TRIAL STUDY 134XCP|EX|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|548|||||||||||U/L|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|Q7H||INTRACAUDAL||LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|ANTEROPOSTERIOR|N|||SCREENING|1970-12-04|1972-04-07|||1962-10-28|||1966-07-26||1967-07-18
TRIAL STUDY 134XCP|EX|4A5A02C2-F875-4146-B58D-9E0E4F00527D|549|||||||||||TSP|SUPPOSITORY, EXTENDED RELEASE|2 TIMES PER YEAR||DENTAL||LINGULA OF THE LUNG|RIGHT|UPPER FLEXOR SURFACE|NA|||SCREENING|1964-10-04|1973-06-22|||1971-08-24|||1966-12-03||1967-11-13
TRIAL STUDY 134XCP|EX|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|550|||||||||||MU/G|CAPSULE, SOFTGEL, EXTENDED RELEASE|Q72H||INTRACISTERNAL||TRAPEZOID-CAPITATE JOINT|RIGHT|DISTAL|N|||WASHOUT|1968-06-30|1966-03-18|||1969-07-23|||1968-10-28||1965-01-17
TRIAL STUDY 134XCP|EX|859D9297-58D0-4740-899D-E7BEC931D419|551|||||||||||NL|CAPLET|AD LIBITUM||INTRADISCAL||ANKLE MORTISE|LATERAL|ROSTRAL|NA|||RUN-IN|1963-06-19|1971-08-08|||1967-07-16|||1970-05-27||1967-09-19
TRIAL STUDY 134XCP|EX|A1E34C29-91C2-4C2B-942E-84CD6A10A056|552|||||||||||MET*H|CREAM|PRN||INTRASTOMAL||RESPIRATORY SYSTEM|BILATERAL|PROXIMAL VOLAR|N|||LONG-TERM FOLLOW-UP|1966-02-23|1962-07-06|||1968-05-10|||1964-08-24||1960-07-19
TRIAL STUDY 134XCP|EX|4E5FF284-E15A-421D-BC13-94655EEFE540|553|||||||||||10^6 IU|GEL, DENTIFRICE|PA||INTRALESIONAL||VAGINAL WALL|CONTRALATERAL|PERIPHERAL|Y|||WASHOUT|1965-08-15|1970-04-16|||1968-03-22|||1967-02-19||1967-09-01
TRIAL STUDY 134XCP|EX|30BAB760-662A-41DF-9599-CBE0BC3A57D9|554|||||||||||IN2|LIQUID, EXTENDED RELEASE|Q3D||PERIODONTAL||DISTAL PHALANX 5 OF THE HAND|LATERAL|TIP|N|||TREATMENT|1968-03-15|1972-04-04|||1963-09-27|||1966-09-01||1969-08-11
TRIAL STUDY 134XCP|EX|8747C2AB-18EB-430B-8E89-CF9183DBF322|555|||||||||||/40 HPFS|GEL|QN||PERINEURAL||TIBIOTARSAL JOINT|LEFT|OCCIPITAL|N|||TREATMENT|1973-09-07|1961-02-12|||1965-08-21|||1965-01-18||1969-04-14
TRIAL STUDY 134XCP|EX|5A0FF15D-E779-47BA-8D3C-247A0FA57854|556|||||||||||NMOL/L|GRANULE|BID||DIETARY||SKIN OF THE HEAD|IPSILATERAL|LOWER MEDIAL|Y|||INDUCTION TREATMENT|1964-10-31|1960-09-10|||1971-03-09|||1964-05-22||1964-05-04
TRIAL STUDY 134XCP|EX|73260E60-6ADB-44DA-9A45-776B91F8B453|557|||||||||||MIN|CONCENTRATE|5 TIMES PER WEEK||SUBRETINAL||SMALL INTESTINE|IPSILATERAL|INFERIOR|N|||BASELINE|1972-12-09|1973-06-01|||1968-06-08|||1962-08-08||1972-07-14
TRIAL STUDY 134XCP|EX|7B64252E-9A08-4177-BFA9-45B0C0E53097|558|||||||||||UMOL/DL|PATCH|1 TIME PER WEEK||INTRAUTERINE||ANTERIOR TIBIAL ARTERY|LEFT|INTERMEDIATE|Y|||OBSERVATION|1966-09-04|1969-08-21|||1969-11-15|||1966-09-28||1972-05-29
TRIAL STUDY 134XCP|EX|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|559|||||||||||VIRTUAL PIXEL|SUSPENSION|10 DAYS PER MONTH||AURICULAR (OTIC)||THYMUS GLAND|LEFT|INTERMEDIATE|Y|||OPEN LABEL TREATMENT|1971-01-06|1961-04-16|||1960-10-08|||1970-07-16||1964-10-22
TRIAL STUDY 134XCP|EX|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|560|||||||||||VOXEL|PELLETS, COATED, EXTENDED RELEASE|Q22H||INTRASURGICAL SITE||PARA-AORTIC LYMPH NODE|CONTRALATERAL|SUBCORTICAL|Y|||FOLLOW-UP|1972-05-08|1971-01-31|||1973-02-19|||1963-01-29||1963-10-20
TRIAL STUDY 134XCP|EX|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|561|||||||||||ANSON U|INJECTABLE, LIPOSOMAL|6 TIMES PER DAY||INTRATHALAMIC||JOINT|UNILATERAL|CENTRAL|NA|||TREATMENT|1972-09-09|1964-11-08|||1970-12-27|||1968-05-30||1962-02-25
TRIAL STUDY 134XCP|EX|1B0EE182-6729-4333-BB9B-5561CAB31D26|562|||||||||||/H|PASTILLE|EVERY 12 WEEKS||TOPICAL||MENINGES|LATERAL|MIDLINE|U|||TREATMENT|1962-09-16|1960-01-14|||1963-06-12|||1969-05-19||1961-03-08
TRIAL STUDY 134XCP|EX|1F3AD620-4B16-4EFF-8F5A-45105841BE02|563|||||||||||JOULE|TABLET, MULTILAYER, EXTENDED RELEASE|QH||TRANSMAMMARY||AORTIC VALVE, RIGHT CORONARY CUSP|LEFT|SUPERIOR|U|||INDUCTION TREATMENT|1971-07-20|1968-12-01|||1970-09-14|||1972-08-07||1960-05-20
TRIAL STUDY 134XCP|EX|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|564|||||||||||RING|SUPPOSITORY|QD||INTRAUTERINE||PARACOLIC GUTTER|UNILATERAL|FRONTAL|N|||BASELINE|1965-08-09|1967-09-20|||1964-05-22|||1960-07-05||1972-08-25
TRIAL STUDY 134XCP|EX|152147B0-6EAD-4124-8E1A-BD7707850B60|565|||||||||||M/SEC|CEMENT|Q12H||INTRAOCULAR||AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|LOWER FLEXOR SURFACE|U|||OBSERVATION|1961-01-26|1967-04-02|||1964-01-22|||1971-06-13||1967-05-08
TRIAL STUDY 134XCP|EX|3CCF019C-5663-4670-B2D1-EC01D6B58D06|566|||||||||||HOMEOPATHIC DILUTION|TABLET, MULTILAYER, EXTENDED RELEASE|Q72H||INTRA-ARTERIAL||POSTEROLATERAL SEGMENTAL ARTERY|LATERAL|VENTROLATERAL|NA|||FOLLOW-UP|1973-09-03|1966-02-05|||1964-05-26|||1966-08-11||1967-03-04
TRIAL STUDY 134XCP|EX|6599D082-A8A0-412D-BBDF-CD786C581905|567|||||||||||BQ/MG|GRAFT|Q6M||SOFT TISSUE||INTERPHALANGEAL OF THE FOOT|LEFT|PROXIMAL|Y|||LONG-TERM FOLLOW-UP|1965-05-05|1962-09-08|||1962-06-10|||1967-04-15||1962-05-08
TRIAL STUDY 134XCP|EX|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|568|||||||||||FT|PELLET|Q72H||INTRA-ARTICULAR||TENTORIUM CEREBELLI|CONTRALATERAL|NASAL|N|||WASHOUT|1970-07-22|1963-08-01|||1972-05-21|||1967-02-10||1962-07-02
TRIAL STUDY 134XCP|EX|AAC3113C-793D-43F4-87E9-111246E03003|569|||||||||||OZ EQ|ELIXIR|5 TIMES PER DAY||INTRA-AMNIOTIC||SHOULDER JOINT|IPSILATERAL|NASAL|Y|||OBSERVATION|1962-05-04|1960-04-29|||1966-01-12|||1964-04-20||1962-03-28
TRIAL STUDY 134XCP|EX|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|570|||||||||||10^4/HPF|TROCHE|Q21H||IONTOPHORESIS||SYMPATHETIC GANGLIA|UNILATERAL|SUPERIOR|U|||BLINDED TREATMENT|1968-02-05|1967-07-04|||1962-11-18|||1961-11-19||1963-07-18
TRIAL STUDY 134XCP|EX|941A9CF9-872C-42CF-A409-129BE5A88520|571|||||||||||OHM|BLOCK|Q5D||ENDOCERVICAL||SKIN AROUND THE MOUTH|RIGHT|MIDLINE|U|||TREATMENT|1972-12-08|1963-08-28|||1973-07-17|||1968-01-12||1973-03-16
TRIAL STUDY 134XCP|EX|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|572|||||||||||NSEC|INJECTION, EMULSION|Q3D||INTRATESTICULAR||ACCESSORY RENAL ARTERY|LATERAL|PROXIMAL|NA|||CONTINUATION TREATMENT|1960-09-24|1970-05-06|||1963-12-28|||1964-11-29||1966-03-10
TRIAL STUDY 134XCP|EX|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|573|||||||||||CMOL/L|INJECTION, SOLUTION|QH||INTRACARDIAC||COLON, RIGHT|UNILATERAL|SURFACE|Y|||BASELINE|1960-07-19|1970-07-05|||1967-01-09|||1973-04-22||1960-10-15
TRIAL STUDY 134XCP|EX|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|574|||||||||||MMOL/G|CAPSULE|EVERY AFTERNOON||INTRAGASTRIC||MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|SURFACE|Y|||CONTINUATION TREATMENT|1972-11-19|1962-11-05|||1970-08-11|||1965-06-08||1966-02-23
TRIAL STUDY 134XCP|EX|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|575|||||||||||GMFI|GUM, RESIN|Q21H||PHARYNGEAL||BICEPS FEMORIS MUSCLE|UNILATERAL|VENTRAL|U|||RUN-IN|1962-06-12|1961-03-03|||1965-10-15|||1966-08-08||1971-11-12
TRIAL STUDY 134XCP|EX|A4A5E66A-E65C-4234-8858-E69D04AB1593|576|||||||||||ELISA UNIT/DOSE|EMULSION|2 TIMES PER WEEK||PERCUTANEOUS||PROXIMAL PHALANX 5 OF THE HAND|RIGHT|INFERIOR|NA|||OPEN LABEL TREATMENT|1964-10-21|1969-03-08|||1971-07-19|||1961-11-30||1973-02-28
TRIAL STUDY 134XCP|EX|0EA46DA5-4291-4585-9745-08BFA60BED3F|577|||||||||||MMOL/DAY|LOTION|Q13H||INTRAMEDULLARY||MESENTERIC LYMPH NODE|UNILATERAL|MIDLINE|U|||OPEN LABEL TREATMENT|1962-11-08|1960-03-31|||1960-10-30|||1966-12-02||1964-05-18
TRIAL STUDY 134XCP|EX|F54E494F-7EC2-41E7-A969-DF7151EA08E9|578|||||||||||KAT|INJECTION, POWDER, FOR SUSPENSION|Q36H||SUBMUCOSAL||TRICUSPID VALVE, ANTERIOR CUSP|CONTRALATERAL|ANTEROTEMPORAL|U|||SCREENING|1969-12-17|1969-08-27|||1972-04-01|||1965-06-01||1969-03-20
TRIAL STUDY 134XCP|EX|3C4215F7-A7FA-4177-8B84-FD26FEB43039|579|||||||||||PMOL/10^10 CELLS|CAPSULE, GELATIN COATED|3 TIMES PER CYCLE||INTRACARTILAGINOUS||L5-S1 INTERVERTEBRAL SPACE|BILATERAL|FORE|Y|||LONG-TERM FOLLOW-UP|1970-01-05|1971-12-02|||1972-01-18|||1968-04-02||1973-07-28
TRIAL STUDY 134XCP|EX|797C71A3-375E-466E-BDA8-A2828C9C45BB|580|||||||||||MEQ/UG|PACKING|8 TIMES PER DAY||INTRAUTERINE||GUT-ASSOCIATED LYMPHOID TISSUE|CONTRALATERAL|VENTROLATERAL|Y|||FOLLOW-UP|1970-11-22|1962-09-20|||1963-05-25|||1970-03-13||1972-10-04
TRIAL STUDY 134XCP|EX|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|581|||||||||||LOG EID 50/DOSE|LIQUID, EXTENDED RELEASE|3 TIMES PER WEEK||PERIVENOUS||BRACHIAL LYMPH NODE|BILATERAL|CENTRAL|U|||OBSERVATION|1960-06-23|1961-01-03|||1960-11-07|||1968-05-14||1965-02-20
TRIAL STUDY 134XCP|EX|5617A5B9-AEE0-4118-9113-3755ED8E961A|582|||||||||||10^9 CFU/G|CAPSULE, SOFTGEL, EXTENDED RELEASE|Q5D||ENTERAL||PROCERUS MUSCLE|BILATERAL|BASAL|NA|||FOLLOW-UP|1966-01-24|1972-05-15|||1967-05-21|||1963-08-10||1972-06-02
TRIAL STUDY 134XCP|EX|7ECE0F95-910A-4FB3-9435-73805E498415|583|||||||||||OHM|INSERT|EVERY 6 WEEKS||INTRAVENOUS BOLUS||PANCREAS, BODY|BILATERAL|OCCIPITAL|NA|||BASELINE|1966-07-30|1964-02-24|||1961-07-15|||1966-12-11||1961-02-20
TRIAL STUDY 134XCP|EX|83EDB0FE-728D-453F-8DB2-7D44202EEB43|584|||||||||||PACK|SOLUTION, GEL FORMING, EXTENDED RELEASE|3 TIMES PER WEEK||TOPICAL||ANTERIOR SUPERIOR ILIAC SPINE|RIGHT|LATERAL|NA|||TREATMENT|1960-11-03|1964-07-18|||1971-05-21|||1969-11-29||1971-05-22
TRIAL STUDY 134XCP|EX|35589D89-B019-4C5E-8A4B-BFA58E894A9C|585|||||||||||HEP|CREAM, AUGMENTED|Q9H||SOFT TISSUE||PROXIMAL PHALANX 3 OF THE HAND|LEFT|ANTEROMEDIAL|N|||INDUCTION TREATMENT|1961-10-29|1963-05-03|||1968-05-07|||1968-04-22||1966-03-23
TRIAL STUDY 134XCP|EX|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|586|||||||||||CY/CM|DIAPHRAGM|8 TIMES PER DAY||CUTANEOUS||EAR, INNER|LATERAL|HIND|NA|||SCREENING|1964-11-01|1963-08-19|||1961-06-08|||1963-12-22||1967-06-01
TRIAL STUDY 134XCP|EX|21934F6E-8333-413B-931C-DF115519F394|587|||||||||||EID 50/DOSE|EXTRACT|4 TIMES PER WEEK||SUBRETINAL||INTERNAL ILIAC ARTERY|LATERAL|UPPER EXTENSOR SURFACE|U|||BASELINE|1963-01-22|1967-09-28|||1966-05-12|||1961-02-24||1966-12-06
TRIAL STUDY 134XCP|EX|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|588|||||||||||ML/ANIMAL/DAY|FOR SUSPENSION, EXTENDED RELEASE|5 TIMES PER MONTH||INTRASYNOVIAL||ETHMOID BONE|CONTRALATERAL|SUPERFICIAL|Y|||WASHOUT|1961-04-04|1966-01-21|||1966-06-08|||1968-01-20||1962-09-28
TRIAL STUDY 134XCP|EX|E31F3DEB-BCA2-4660-935D-BAEBC4238866|589|||||||||||SQU/ML|CAPSULE, HARD, EXTENDED RELEASE|Q23H||INFILTRATION||METATARSAL BONE|UNILATERAL|ANTERIOR|N|||SCREENING|1971-04-12|1962-12-02|||1968-12-07|||1960-08-25||1963-08-14
TRIAL STUDY 134XCP|EX|8310989D-82CC-456C-965A-E38AC9EA073F|590|||||||||||PG/DL|CREAM, AUGMENTED|INTERMITTENT||INTRALUMINAL||LEFT MAIN CORONARY ARTERY OSTIUM|CONTRALATERAL|LOWER|U|||WASHOUT|1973-01-26|1966-05-11|||1972-07-20|||1968-03-14||1971-05-30
TRIAL STUDY 134XCP|EX|826D8DC2-E407-481C-93D8-5169DBDF99C4|591|||||||||||AMFI|CAPSULE, SOFTGEL, EXTENDED RELEASE|Q4D||TRANSDERMAL||LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|TIP|N|||WASHOUT|1965-03-09|1961-09-20|||1963-12-29|||1963-12-31||1965-11-26
TRIAL STUDY 134XCP|EX|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|592|||||||||||NEWTON|SOLUTION, GEL FORMING / DROPS|AD LIBITUM||INTRABILIARY||LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|FORE|U|||INDUCTION TREATMENT|1968-07-09|1966-07-10|||1965-03-18|||1965-05-15||1961-03-17
TRIAL STUDY 134XCP|EX|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|593|||||||||||MG/KG/MIN|STICK|5 TIMES PER WEEK||ENTERAL||BLADDER, FUNDUS|IPSILATERAL|TEMPORAL|N|||OBSERVATION|1964-04-14|1971-06-18|||1962-05-12|||1966-01-23||1971-04-04
TRIAL STUDY 134XCP|EX|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|594|||||||||||IU/MMOL|FIBER, EXTENDED RELEASE|EVERY 5 WEEKS||INFILTRATION||EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|VENTRAL|N|||INDUCTION TREATMENT|1971-02-18|1963-01-10|||1961-04-08|||1967-08-28||1965-11-26
TRIAL STUDY 134XCP|EX|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|595|||||||||||LENS|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|7 TIMES PER WEEK||INTRACAVERNOUS||LEFT VENTRICULAR MID INFERIOR SEGMENT|RIGHT|MEDIAL|Y|||CONTINUATION TREATMENT|1962-08-22|1970-01-04|||1966-09-20|||1972-03-07||1971-01-10
TRIAL STUDY 134XCP|EX|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|596|||||||||||UG/L FEU|TINCTURE|OCCASIONAL||PERINEURAL||ENDOMETRIUM|BILATERAL|FACIAL|U|||OBSERVATION|1972-07-14|1967-05-03|||1973-07-24|||1960-05-30||1967-11-19
TRIAL STUDY 134XCP|EX|B396F12E-7BF5-47CC-AFD1-1B679066B106|597|||||||||||OHM|DIAPHRAGM|Q5D||RECTAL||HEART, RIGHT VENTRICULAR FREE WALL|BILATERAL|DORSAL|U|||WASHOUT|1961-11-17|1962-02-14|||1965-04-06|||1971-09-08||1971-04-17
TRIAL STUDY 134XCP|EX|2936B26A-9A8D-4C28-90A7-6131837F255F|598|||||||||||ML/MMHG|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|3 TIMES PER WEEK||INTERSTITIAL||SHIN|IPSILATERAL|OUTER|Y|||INDUCTION TREATMENT|1962-05-06|1967-10-15|||1964-02-06|||1968-08-16||1968-11-03
TRIAL STUDY 134XCP|EX|901A91DC-9EF3-4A20-A35D-9C426A5C640B|599|||||||||||ENZYME U/L|IMPLANT|Q9H||OROMUCOSAL||GREATER CURVATURE OF THE STOMACH|BILATERAL|UPPER FLEXOR SURFACE|Y|||FOLLOW-UP|1971-02-17|1967-08-02|||1970-12-20|||1966-05-04||1965-03-21
TRIAL STUDY 134XCP|EX|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|600|||||||||||UG/M2|FILM|Q2M||ORAL||ILEUM|RIGHT|ANTERIOR|Y|||SCREENING|1968-04-13|1967-09-20|||1965-03-26|||1965-05-16||1972-07-05
TRIAL STUDY 134XCP|EX|5A7F2C89-5398-4119-8EA0-B432FF8942A4|601|||||||||||ELISA UNIT|GUM|Q24H||INTRAMEDULLARY||COLON, RECTOSIGMOID|IPSILATERAL|SURFACE|NA|||FOLLOW-UP|1964-06-29|1971-08-22|||1963-08-31|||1967-08-03||1963-07-16
TRIAL STUDY 134XCP|EX|898FB78B-63D1-4ECE-B6B8-34750E958D93|602|||||||||||GENEQ/ML|INJECTION, POWDER, FOR SUSPENSION|8 TIMES PER DAY||URETERAL||RETROAURICULAR LYMPH NODE|CONTRALATERAL|ANTEROMEDIAL|NA|||SCREENING|1973-06-11|1973-03-07|||1966-05-15|||1964-10-04||1972-09-28
TRIAL STUDY 134XCP|EX|AF1E7141-5390-4928-9F49-94E1C7464A63|603|||||||||||MMOL/S|FILM, EXTENDED RELEASE|7 TIMES PER WEEK||TRANSMUCOSAL||PANCREAS, EXOCRINE|LEFT|ANTEROLATERAL|U|||FOLLOW-UP|1962-03-15|1962-09-15|||1970-05-25|||1972-11-21||1969-12-04
TRIAL STUDY 134XCP|EX|2188CADE-EE6F-4F14-8049-5EDD72020185|604|||||||||||U/KG/DAY|SOLUTION|EVERY 7 WEEKS||TRANSMUCOSAL||T9 VERTEBRA|UNILATERAL|DISTAL|N|||TREATMENT|1969-07-07|1967-11-18|||1973-08-19|||1960-06-05||1970-03-13
TRIAL STUDY 134XCP|EX|DFF30783-4496-4134-8201-67C727683A7D|605|||||||||||FMOL/L/SEC|FIBER, EXTENDED RELEASE|4 TIMES PER MONTH||INTRATUBULAR||AORTA|BILATERAL|LOWER|U|||LONG-TERM FOLLOW-UP|1963-04-13|1964-03-27|||1966-05-17|||1973-02-13||1961-08-29
TRIAL STUDY 134XCP|EX|970170C0-8FF0-4D24-84E8-1195272D55C0|606|||||||||||10^6/EJACULATE U|PLASTER|Q3D||OCCLUSIVE DRESSING TECHNIQUE||RIB 3|IPSILATERAL|PROXIMAL|N|||BLINDED TREATMENT|1970-02-13|1971-01-25|||1964-03-13|||1963-05-26||1973-05-03
TRIAL STUDY 134XCP|EX|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|607|||||||||||MBQ|PILL|QD||MICRODIALYSIS||LEFT MAIN CORONARY ARTERY OSTIUM|CONTRALATERAL|HIND|N|||TREATMENT|1961-07-13|1966-01-14|||1965-02-13|||1966-10-21||1967-12-31
TRIAL STUDY 134XCP|EX|69CC47A3-DA90-4919-889E-E0008ED689FA|608|||||||||||VIRTUAL PIXEL|INJECTION|EVERY 7 WEEKS||INTRABILIARY||BLOOD VESSEL|CONTRALATERAL|SUBCORTICAL|N|||FOLLOW-UP|1966-10-13|1966-06-21|||1971-05-20|||1962-01-29||1972-12-01
TRIAL STUDY 134XCP|EX|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|609|||||||||||/10^3|PELLETS, COATED, EXTENDED RELEASE|TWICE||INFILTRATION||LIP|UNILATERAL|ANTEROMEDIAL|U|||CONTINUATION TREATMENT|1969-05-13|1964-03-03|||1970-06-11|||1962-01-14||1967-01-04
TRIAL STUDY 134XCP|EX|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|610|||||||||||%|GRANULE, DELAYED RELEASE|3 TIMES PER WEEK||BUCCAL||SUBTALAR JOINT|UNILATERAL|ANTEROTEMPORAL|Y|||BASELINE|1965-02-07|1972-09-04|||1970-10-28|||1970-08-06||1973-03-23
TRIAL STUDY 134XCP|EX|0281E055-F419-4BA2-89CE-23EC7428CDA0|611|||||||||||L/MIN|GUM|10 DAYS PER MONTH||INTRAOSSEOUS||GLOTTIS|LEFT|OUTER|N|||OBSERVATION|1962-03-19|1973-04-12|||1966-05-07|||1973-01-10||1967-04-15
TRIAL STUDY 134XCP|EX|23CE1310-DBB3-4135-8E11-2A870CE42D50|612|||||||||||CFU/ML|GEL, CHEWABLE|EVERY 2 WEEKS||INTRALUMINAL||INFRATENTORIAL BRAIN|LATERAL|BASAL|U|||OBSERVATION|1960-03-18|1966-02-01|||1966-12-28|||1965-01-24||1968-07-08
TRIAL STUDY 134XCP|EX|CC80D8A2-7D71-428B-9599-C0D0312B8691|613|||||||||||U/M2/DAY|SOLUTION, FOR SLUSH|CONTINUOUS||OCCLUSIVE DRESSING TECHNIQUE||MIDDLE PHALANX 4 OF THE HAND|CONTRALATERAL|DORSAL|NA|||TREATMENT|1973-07-13|1965-05-11|||1964-03-06|||1968-09-16||1964-10-16
TRIAL STUDY 134XCP|EX|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|614|||||||||||MET*H|INJECTION, SUSPENSION, LIPOSOMAL|6 TIMES PER WEEK||DENTAL||GLENOID FOSSA|CONTRALATERAL|ROSTRAL|NA|||BASELINE|1966-02-23|1970-04-16|||1968-12-08|||1971-11-25||1965-11-04
TRIAL STUDY 134XCP|EX|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|615|||||||||||S^-1(%O2)^-1|CAPSULE, COATED, EXTENDED RELEASE|Q72H||INTRACORNEAL||LEFT ATRIOVENTRICULAR ARTERY|CONTRALATERAL|CRANIAL|U|||BASELINE|1965-07-18|1968-02-20|||1967-12-21|||1968-06-28||1963-04-28
TRIAL STUDY 134XCP|EX|3D25A735-6298-4AF4-91CC-AE8D481DF552|616|||||||||||VG/DOSE|TABLET, EFFERVESCENT|EVERY 2 WEEKS||INTRAVAGINAL||RENAL PELVIS|IPSILATERAL|ANTEROPOSTERIOR|N|||RUN-IN|1970-04-26|1964-07-17|||1965-10-24|||1961-06-14||1960-03-09
TRIAL STUDY 134XCP|EX|C249E38B-B454-47D9-8D8B-E2F6A434BA21|617|||||||||||10^9 ORGANISMS/G|SOLUTION, GEL FORMING / DROPS|PRN||SUBARACHNOID||MUSCLE|RIGHT|LOWER|NA|||RUN-IN|1971-02-24|1971-12-08|||1961-09-10|||1960-09-14||1968-09-09
TRIAL STUDY 134XCP|EX|4540D569-1DD0-4984-89DB-6F9A391397FE|618|||||||||||COAT|SUSPENSION|Q7H||OROMUCOSAL||APPENDICEAL TIP|IPSILATERAL|VENTROLATERAL|U|||OBSERVATION|1971-10-28|1965-11-03|||1973-04-08|||1962-05-19||1964-12-06
TRIAL STUDY 134XCP|EX|DC1D666E-4920-4B60-A520-D183BCDE0E85|619|||||||||||DAGU|LOTION|EVERY 3 WEEKS||INTRABILIARY||LUNG, HILUM|UNILATERAL|NASAL|U|||TREATMENT|1962-02-12|1968-08-14|||1960-06-18|||1964-01-24||1960-10-31
TRIAL STUDY 134XCP|EX|A015D12B-C03B-4371-8D1F-F03D60542BA7|620|||||||||||ML/M2/DAY|LIQUID, EXTENDED RELEASE|Q3H||INTRATHORACIC||RENAL PELVIS|UNILATERAL|APICAL|N|||OBSERVATION|1972-12-23|1970-12-13|||1960-08-03|||1960-05-02||1964-07-30
TRIAL STUDY 134XCP|EX|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|621|||||||||||PT_BR|DIAPHRAGM|EVERY 2 WEEKS||CONJUNCTIVAL||RETINAL NERVE FIBER LAYER|CONTRALATERAL|LOWER|U|||LONG-TERM FOLLOW-UP|1969-01-21|1965-10-21|||1965-10-24|||1964-12-01||1963-12-28
TRIAL STUDY 134XCP|EX|34AC7973-686F-45A2-999A-1A36C7874F91|622|||||||||||LOG10 ELISA UNIT/DOSE|PELLET|Q6D||INTRAVENOUS BOLUS||EAR|LATERAL|TIP|N|||WASHOUT|1963-08-19|1964-09-14|||1970-10-29|||1961-04-27||1973-08-31
TRIAL STUDY 134XCP|EX|5AE66AC0-ECB6-49A2-859F-871B9A15E624|623|||||||||||MAMP|BAR, CHEWABLE|BID||INTRAVENTRICULAR||TIBIOTARSAL JOINT|BILATERAL|LOWER EXTENSOR SURFACE|U|||OBSERVATION|1960-08-19|1966-02-23|||1962-07-17|||1967-04-23||1963-06-13
TRIAL STUDY 134XCP|EX|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|624|||||||||||SBE/ML|FILM, SOLUBLE|Q4M||RECTAL||FRONTAL LOBE|RIGHT|ANTEROTEMPORAL|U|||RUN-IN|1967-06-01|1965-04-17|||1965-12-31|||1961-12-17||1962-03-23
TRIAL STUDY 134XCP|EX|59A9826F-4C2F-482A-8888-F649544318BE|625|||||||||||MET*MIN|OINTMENT, AUGMENTED|QAM||INTRACAMERAL||COLON LYMPH NODE|LEFT|VOLAR|NA|||TREATMENT|1960-10-17|1963-10-01|||1963-04-26|||1963-02-22||1967-08-29
TRIAL STUDY 134XCP|EX|B6E55A62-CF0B-4BC6-84DC-038F29518909|626|||||||||||%(W/W)|GRAFT|Q4D||ENTERAL||SACROILIAC JOINT|LATERAL|UPPER FLEXOR SURFACE|Y|||BLINDED TREATMENT|1969-05-31|1961-02-24|||1963-12-01|||1970-03-27||1971-06-15
TRIAL STUDY 134XCP|EX|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|627|||||||||||OHM|LINER, DENTAL|Q13H||ORAL GAVAGE||BULBAR CONJUNCTIVA|CONTRALATERAL|INTERMEDIATE|U|||CONTINUATION TREATMENT|1964-05-01|1965-05-21|||1963-05-05|||1970-07-20||1967-10-02
TRIAL STUDY 134XCP|EX|5577E914-C90D-4CC4-A7A8-D919C29A61D1|628|||||||||||CIGAR|GAS|QD||INTRAPULMONARY||HEART, RIGHT ATRIAL APPENDAGE|LEFT|LATERAL|N|||CONTINUATION TREATMENT|1970-09-26|1962-10-20|||1961-06-02|||1967-08-03||1966-11-27
TRIAL STUDY 134XCP|EX|2DBA8940-F59E-4A0D-8858-408D71DD9753|629|||||||||||G/CM2|MOUTHWASH|Q36H||INTRACORONAL, DENTAL||INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|INNER|N|||TREATMENT|1961-12-09|1971-11-08|||1971-12-19|||1972-09-01||1963-03-21
TRIAL STUDY 134XCP|EX|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|630|||||||||||VG/ML|DIAPHRAGM|Q45MIN||SUBLINGUAL||LOWER RESPIRATORY SYSTEM|LATERAL|INTERMEDIATE|U|||RUN-IN|1960-08-24|1962-01-21|||1970-09-27|||1968-06-07||1966-10-20
TRIAL STUDY 134XCP|EX|0250EC5D-B08F-4010-9653-95E20EDD0CCA|631|||||||||||MEQ|AEROSOL, FOAM|6 TIMES PER YEAR||ENDOSINUSIAL||LEFT VENTRICULAR APICAL SEPTAL SEGMENT|UNILATERAL|ANTERIOR|NA|||TREATMENT|1970-02-23|1965-10-14|||1960-07-20|||1971-10-29||1965-02-12
TRIAL STUDY 134XCP|EX|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|632|||||||||||EU|CAPSULE, LIQUID FILLED|EVERY 2 WEEKS||INTRAGINGIVAL||AXILLARY LYMPH NODE LEVEL III|IPSILATERAL|OUTER|N|||RUN-IN|1967-08-22|1967-04-14|||1972-02-20|||1971-10-12||1966-03-01
TRIAL STUDY 134XCP|EX|140FFC83-72C9-4BD4-AA44-C98CA42147F3|633|||||||||||EID 50/ML|LOTION|BIM||LARYNGEAL||PULMONARY VALVE, LEFT CUSP|LEFT|DISTAL|U|||BLINDED TREATMENT|1968-07-19|1967-03-11|||1966-08-09|||1972-06-20||1964-10-16
TRIAL STUDY 134XCP|EX|7BAC399A-0523-476E-A294-C57309E573AF|634|||||||||||STEPS/MIN|AEROSOL, SPRAY|3 TIMES PER CYCLE||INTRACORPORUS CAVERNOSUM||PARATHYROID GLAND|IPSILATERAL|UPPER FLEXOR SURFACE|Y|||OBSERVATION|1964-01-24|1964-08-17|||1960-11-30|||1961-03-19||1973-02-20
TRIAL STUDY 134XCP|EX|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|635|||||||||||BAU/ML|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|EVERY 8 WEEKS||SUBRETINAL||THIGH|IPSILATERAL|LOWER|NA|||SCREENING|1962-12-28|1964-01-13|||1963-05-23|||1970-12-19||1969-07-17
TRIAL STUDY 134XCP|EX|0F180E62-F840-490F-8EB3-F7DDB7132401|636|||||||||||MEQ|INHALANT|Q6M||TRANSPLACENTAL||PALM|CONTRALATERAL|FACIAL|NA|||BASELINE|1969-11-02|1961-12-26|||1963-08-21|||1967-10-09||1971-11-02
TRIAL STUDY 134XCP|EX|80E7A428-CDDE-453F-B7D1-1B282A1835BF|637|||||||||||G/CM2|TAMPON|Q6H||INTRAMUSCULAR||C5 VERTEBRA|RIGHT|ANTERIOR|N|||CONTINUATION TREATMENT|1967-09-12|1968-04-10|||1967-02-09|||1965-04-11||1961-01-02
TRIAL STUDY 134XCP|EX|F1D265C4-B975-4E74-9545-122A10FE100F|638|||||||||||KALLIKREIN INHIBITOR UNIT|LOTION/SHAMPOO|INTERMITTENT||INTRAUTERINE||WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL|APICAL|N|||INDUCTION TREATMENT|1962-07-15|1960-02-11|||1966-07-25|||1963-04-10||1966-04-22
TRIAL STUDY 134XCP|EX|7A272C35-DB2C-429D-AF31-CC7386DC8F07|639|||||||||||10^5/HPF|TABLET, MODIFIED RELEASE|2 TIMES PER YEAR||ENTERAL||KIDNEY|LATERAL|CAUDAL|U|||FOLLOW-UP|1966-03-01|1967-04-21|||1965-07-14|||1972-08-05||1964-03-01
TRIAL STUDY 134XCP|EX|FBF95CF9-933D-406A-8D67-B1F643C5F554|640|||||||||||10^7 CFU|INJECTION, POWDER, FOR SOLUTION|6 TIMES PER YEAR||HEMODIALYSIS||ESOPHAGUS|LEFT|PROXIMAL|U|||INDUCTION TREATMENT|1960-01-17|1964-11-23|||1965-04-08|||1969-07-02||1969-10-14
TRIAL STUDY 134XCP|EX|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|641|||||||||||CM/MIN|EXTRACT|7 TIMES PER DAY||INTRACORONARY||LUNATE BONE|BILATERAL|ANTEROPOSTERIOR|U|||OBSERVATION|1967-08-15|1967-10-27|||1970-06-02|||1964-04-09||1963-12-11
TRIAL STUDY 134XCP|EX|391D2418-5359-457B-AEC5-6A48DE04DAFD|642|||||||||||10^7 PFU|PILL|BIM||INTRAGASTRIC||CANINE TOOTH|IPSILATERAL|INTERMEDIATE|Y|||OPEN LABEL TREATMENT|1963-03-23|1970-12-16|||1964-04-05|||1965-04-01||1969-03-02
TRIAL STUDY 134XCP|EX|68F706F0-2F0B-4D50-B15C-2DFDD186112E|643|||||||||||PL|GRANULE, FOR SUSPENSION|Q22H||ELECTRO-OSMOSIS||ANUS|RIGHT|INNER|Y|||WASHOUT|1971-03-17|1967-12-10|||1968-06-29|||1961-02-11||1971-03-23
TRIAL STUDY 134XCP|EX|E8D4AACE-0832-482D-8266-96B7423F9459|644|||||||||||DISK|PELLET, IMPLANTABLE|Q12H||INTRAPLEURAL||L2 VERTEBRA|RIGHT|CRANIAL|NA|||LONG-TERM FOLLOW-UP|1971-06-19|1973-03-14|||1966-02-27|||1963-07-15||1964-09-07
TRIAL STUDY 134XCP|EX|F358E69F-9B9A-4637-9063-B8FECFF000B2|645|||||||||||ML|INJECTION, SUSPENSION, LIPOSOMAL|Q36H||AURICULAR (OTIC)||T1 VERTEBRA|IPSILATERAL|SUPERIOR|NA|||RUN-IN|1964-09-19|1963-03-19|||1967-12-06|||1967-09-11||1960-04-23
TRIAL STUDY 134XCP|EX|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|646|||||||||||ELISA UNIT/ML|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|EVERY WEEK||SUBMUCOSAL||INTRAHEPATIC BILE DUCT|BILATERAL|OCCIPITAL|Y|||OPEN LABEL TREATMENT|1969-12-04|1970-02-21|||1969-03-23|||1970-07-14||1972-08-01
TRIAL STUDY 134XCP|EX|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|647|||||||||||LOG EID 50/DOSE|JELLY|4 TIMES PER MONTH||INTRAMANDIBULAR||VOCAL CORD|CONTRALATERAL|PROXIMAL VOLAR|N|||INDUCTION TREATMENT|1971-04-14|1962-10-05|||1962-03-25|||1965-08-10||1962-11-15
TRIAL STUDY 134XCP|EX|586B4529-9808-4205-B3D6-5C4A1DAFA922|648|||||||||||CARTRIDGE|FOR SUSPENSION|PA||NASOGASTRIC||DURAL VENOUS SINUS|RIGHT|LOWER FLEXOR SURFACE|N|||OBSERVATION|1970-11-24|1971-10-15|||1964-04-14|||1972-05-24||1963-11-10
TRIAL STUDY 134XCP|EX|54685EFC-EE92-4591-B059-24145A3E6D69|649|||||||||||UMOL/L|GUM|EVERY 16 WEEKS||SUBMUCOSAL||HEART, LEFT VENTRICLE|LEFT|PROXIMAL VOLAR|NA|||OPEN LABEL TREATMENT|1965-08-04|1971-04-08|||1964-06-17|||1973-05-03||1967-08-11
TRIAL STUDY 134XCP|EX|7BD32505-61D5-4862-8896-B3E41D3EE779|650|||||||||||G/G/DAY|PATCH|QN||OCCLUSIVE DRESSING TECHNIQUE||ISCHIAL TUBEROSITY|LATERAL|BASAL|U|||SCREENING|1969-08-10|1966-06-17|||1971-10-17|||1964-12-28||1960-10-09
TRIAL STUDY 134XCP|EX|3461C227-E30F-482B-B404-026FE0CA3549|651|||||||||||MG/KG/WEEK|SPONGE|Q2H||INTRAPERICARDIAL||PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|ROSTRAL|Y|||INDUCTION TREATMENT|1969-04-25|1973-05-06|||1970-06-22|||1969-08-09||1964-06-09
TRIAL STUDY 134XCP|EX|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|652|||||||||||BOLUS|INJECTION, LIPID COMPLEX|QID||INTRATESTICULAR||MEDIASTINUM, ANTERIOR|LATERAL|NASAL|NA|||WASHOUT|1972-03-13|1963-09-15|||1970-10-10|||1973-07-09||1969-05-03
TRIAL STUDY 134XCP|EX|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|653|||||||||||NMOL BCE/MMOL|BAR, CHEWABLE|Q7H||INTRASTOMAL||INTERNAL MAMMARY ARTERY|UNILATERAL|CENTRAL|U|||FOLLOW-UP|1971-02-24|1963-01-20|||1973-01-01|||1966-01-05||1962-01-07
TRIAL STUDY 134XCP|EX|C7C91F63-87B7-4E62-B5F3-39979F74E955|654|||||||||||TUBERCULIN UNIT|EXTRACT|EVERY WEEK||INTRAMENINGEAL||L5 VERTEBRA|CONTRALATERAL|VENTRAL|NA|||TREATMENT|1961-04-13|1969-01-14|||1970-11-28|||1968-04-10||1972-07-04
TRIAL STUDY 134XCP|EX|D6659F53-6DF6-4F88-BF9A-160E2D057028|655|||||||||||PPTH|DOUCHE|EVERY 6 WEEKS||RECTAL||EYELASH|BILATERAL|CAUDAL|N|||TREATMENT|1968-01-05|1960-02-17|||1965-06-05|||1966-09-12||1968-07-13
TRIAL STUDY 134XCP|EX|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|656|||||||||||ML/S/M2|AEROSOL|Q4H||INTRAPLEURAL||ACETABULUM|RIGHT|CAUDAL|NA|||CONTINUATION TREATMENT|1961-09-28|1970-07-28|||1964-07-30|||1973-06-28||1960-01-01
TRIAL STUDY 134XCP|EX|91B36C93-3ADF-4570-B355-BC81B097EEFC|657|||||||||||MIN|TABLET, DELAYED RELEASE|QH||INTRACORONAL, DENTAL||INTERNAL ILIAC LYMPH NODE|LEFT|OCCIPITAL|Y|||SCREENING|1960-03-31|1966-04-19|||1960-02-02|||1964-08-05||1969-04-21
TRIAL STUDY 134XCP|EX|ADD0DDE5-166F-4C20-B3C3-31B131509771|658|||||||||||MOL/MG|DOUCHE|BID||PERIDURAL||LENS|LATERAL|UPPER|NA|||OPEN LABEL TREATMENT|1964-06-03|1964-10-01|||1971-06-06|||1973-08-30||1968-02-20
TRIAL STUDY 134XCP|EX|4265CC9E-26AF-4A14-B9AA-04A246E2523C|659|||||||||||GAUSS|CONE|Q10H||SUBRETINAL||HIP ADDUCTORS|LEFT|DORSOLATERAL|U|||INDUCTION TREATMENT|1967-03-19|1964-06-30|||1964-08-31|||1963-06-19||1966-03-31
TRIAL STUDY 134XCP|EX|96F268D3-7441-415C-95C9-A6B70C1718D5|660|||||||||||MASK|DRESSING|QPM||DIETARY||STERNEBRA|BILATERAL|SUPERIOR|U|||SCREENING|1964-05-01|1967-10-12|||1966-01-13|||1968-10-15||1965-04-17
TRIAL STUDY 134XCP|EX|15D32D1F-AEE2-474C-956E-461FB087D7B0|661|||||||||||10^5/L|DRESSING|Q20H||INTRALYMPHATIC||ACUTE MARGINAL ARTERY|LATERAL|ANTEROPOSTERIOR|U|||WASHOUT|1971-08-05|1960-02-05|||1966-01-11|||1968-10-13||1961-12-17
TRIAL STUDY 134XCP|EX|DB42C81A-D644-455D-9D95-42131EF2BFE5|662|||||||||||MS/MMHG|POWDER, FOR SUSPENSION|QPM||INTRAPROSTATIC||ABDUCTOR DIGITI QUINTI MUSCLE|UNILATERAL|OUTER|N|||INDUCTION TREATMENT|1969-08-23|1967-11-25|||1967-01-01|||1966-05-24||1966-04-30
TRIAL STUDY 134XCP|EX|4B01CC59-51D3-4499-9AB1-DF446006CB8D|663|||||||||||UMOL/H/MMOL|INHALANT|1 TIME PER WEEK||EXTRACORPOREAL||EPIGASTRIC REGION|UNILATERAL|PROXIMAL|Y|||BASELINE|1961-02-04|1960-08-28|||1961-04-05|||1972-07-13||1970-11-27
TRIAL STUDY 134XCP|EX|B69774FC-1151-45DD-B329-6C21C2F29603|664|||||||||||U/DL|CAPSULE, LIQUID FILLED|QN||INTRAVENOUS||T7 VERTEBRA|IPSILATERAL|PROXIMAL VOLAR|N|||FOLLOW-UP|1963-03-16|1961-12-02|||1965-05-24|||1970-01-27||1973-05-09
TRIAL STUDY 134XCP|EX|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|665|||||||||||BAR|CAPSULE, IMMEDIATE RELEASE|4 TIMES PER MONTH||INTRAMANDIBULAR||PROXIMAL PHALANX 5 OF THE HAND|IPSILATERAL|DISTAL|U|||WASHOUT|1970-03-27|1967-08-22|||1969-11-08|||1966-01-19||1967-04-01
TRIAL STUDY 134XCP|EX|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|666|||||||||||10^6 ORGANISMS|TABLET, SOLUBLE|BID||CONJUNCTIVAL||MEDIASTINUM, SUPERIOR|RIGHT|LOWER FLEXOR SURFACE|U|||WASHOUT|1971-08-05|1966-04-18|||1967-07-10|||1960-02-28||1969-01-30
TRIAL STUDY 134XCP|EX|674B4474-6D52-4DE2-8342-EDB28F577BB5|667|||||||||||MESF|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|Q36H||INTRAVENOUS DRIP||RENAL FOSSA|CONTRALATERAL|LOWER MEDIAL|Y|||CONTINUATION TREATMENT|1969-04-07|1968-09-08|||1961-05-10|||1967-01-17||1968-08-25
TRIAL STUDY 134XCP|EX|AF634AD4-086A-47EE-A5DB-A4B6833356C7|668|||||||||||KV|CAPSULE, COATED, EXTENDED RELEASE|EVERY 8 WEEKS||ELECTRO-OSMOSIS||URETHRA, POSTERIOR|LATERAL|FRONTAL|NA|||TREATMENT|1962-10-14|1963-09-01|||1961-04-05|||1967-10-29||1962-12-08
TRIAL STUDY 134XCP|EX|89298058-EB86-4892-97D6-1B87277DF7FC|669|||||||||||MEQ|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|EVERY 3 WEEKS||INTRAVAGINAL||RADIAL NERVE|CONTRALATERAL|DISTAL|N|||RUN-IN|1966-03-10|1964-12-27|||1960-01-05|||1967-11-26||1961-05-26
TRIAL STUDY 134XCP|EX|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|670|||||||||||GLOBULE|FOR SUSPENSION, EXTENDED RELEASE|OCCASIONAL||INTRACAUDAL||METATARSOPHALANGEAL JOINT|LATERAL|ANTERIOR|N|||BLINDED TREATMENT|1965-04-08|1965-02-02|||1973-09-02|||1964-12-27||1969-12-17
TRIAL STUDY 134XCP|EX|D5235188-810B-431F-A6EF-E50DAA57F5E7|671|||||||||||/100 HPFS|TABLET, MODIFIED RELEASE|8 TIMES PER DAY||INTRAVAGINAL||LESSER TROCHANTER|BILATERAL|NASAL|U|||CONTINUATION TREATMENT|1961-10-07|1964-12-23|||1968-07-16|||1965-11-17||1966-08-15
TRIAL STUDY 134XCP|EX|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|672|||||||||||MG/DL|INJECTION, SUSPENSION, LIPOSOMAL|6 TIMES PER MONTH||DENTAL||CORRUGATOR SUPERCILII MUSCLE|BILATERAL|DISTAL VOLAR|Y|||FOLLOW-UP|1963-10-04|1967-08-17|||1972-02-02|||1960-08-20||1966-09-30
TRIAL STUDY 134XCP|EX|E3BB136E-0913-43FB-B760-CBE939F0C4D2|673|||||||||||APL U/ML|SOLUTION|Q18H||OCCLUSIVE DRESSING TECHNIQUE||WRIST JOINT FLEXOR TENDONS|LEFT|BASAL|N|||OBSERVATION|1967-11-16|1965-12-26|||1971-07-23|||1961-02-05||1961-09-22
TRIAL STUDY 134XCP|EX|60C25341-42CE-4532-8F99-25B8305C4ED5|674|||||||||||BQ/G|SOLUTION, FOR SLUSH|4 TIMES PER YEAR||INTRACORNEAL||SUPRAPUBIC REGION|RIGHT|INTERMEDIATE|N|||OPEN LABEL TREATMENT|1966-07-15|1973-01-05|||1962-11-14|||1963-08-15||1968-02-13
TRIAL STUDY 134XCP|EX|42B54D88-E5B5-4828-958B-4B64F07E34B3|675|||||||||||UG/G/H|SOLID|Q20H||INTRAMEDULLARY||ESOPHAGUS, ABDOMINAL|CONTRALATERAL|FRONTAL|NA|||FOLLOW-UP|1962-05-27|1964-12-27|||1962-05-19|||1966-03-06||1961-02-13
TRIAL STUDY 134XCP|EX|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|676|||||||||||UMOL/L|TABLET, FILM COATED|Q15H||DIETARY||SKIN OF THE THIGH|RIGHT|ROSTRAL|Y|||TREATMENT|1964-12-02|1960-01-11|||1968-12-02|||1962-09-27||1960-07-01
TRIAL STUDY 134XCP|EX|1FD985ED-A573-4A00-8902-214A7F182F28|677|||||||||||10^6/EJACULATE U|GEL, METERED|EVERY 5 YEARS||SUBTENON||FOOT DIGIT 1|RIGHT|LOWER EXTENSOR SURFACE|NA|||CONTINUATION TREATMENT|1971-10-20|1960-02-21|||1968-02-26|||1964-08-02||1972-09-01
TRIAL STUDY 134XCP|EX|A2FD338A-F994-4399-BD02-99CB299F768E|678|||||||||||DROP|GUM, CHEWING|6 TIMES PER YEAR||INTRAVENOUS DRIP||TIBIAL-CRURAL PERIPHERAL ARTERY|RIGHT|FORE|N|||LONG-TERM FOLLOW-UP|1963-04-21|1961-04-15|||1960-03-15|||1966-03-08||1966-10-05
TRIAL STUDY 134XCP|EX|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|679|||||||||||MET|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|5 TIMES PER WEEK||ENDOTRACHEAL||ESOPHAGEAL LYMPH NODE|LEFT|PARIETO-OCCIPITAL|U|||TREATMENT|1963-08-13|1961-01-11|||1971-12-07|||1966-11-14||1972-07-23
TRIAL STUDY 134XCP|EX|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|680|||||||||||PG/DL|CORE, EXTENDED RELEASE|CONTINUOUS||INTRACAVITARY||LUNATE BONE|CONTRALATERAL|ROSTRAL|N|||WASHOUT|1960-10-16|1971-05-15|||1968-05-24|||1963-10-26||1965-10-27
TRIAL STUDY 134XCP|EX|A8821AEE-49EB-4687-BB63-361BC3B8B182|681|||||||||||U/L|POWDER, FOR SUSPENSION|Q17H||INTRAVESICAL||CEREBRAL CORTEX|RIGHT|TIP|Y|||OPEN LABEL TREATMENT|1972-07-18|1960-06-23|||1965-01-23|||1962-08-16||1972-07-11
TRIAL STUDY 134XCP|EX|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|682|||||||||||LOG10 TCID 50/UL|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|INTERMITTENT||NASOGASTRIC||PROXIMAL PHALANX 4 OF THE HAND|UNILATERAL|UPPER|NA|||SCREENING|1964-11-15|1973-04-13|||1972-11-20|||1964-10-11||1965-09-09
TRIAL STUDY 134XCP|EX|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|683|||||||||||APL U/ML|SHAMPOO, SUSPENSION|QID||INTRACORNEAL||FEMORAL CONDYLE|RIGHT|INFERIOR|Y|||FOLLOW-UP|1971-06-12|1966-08-28|||1967-04-19|||1965-07-18||1966-06-28
TRIAL STUDY 134XCP|EX|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|684|||||||||||CI/UL|PELLET|5 TIMES PER WEEK||INTRASURGICAL SITE||CEREBRAL VEIN|LEFT|INNER|NA|||WASHOUT|1967-12-31|1961-11-07|||1964-07-28|||1967-09-14||1969-02-18
TRIAL STUDY 134XCP|EX|E711C534-E58F-4B41-95CC-24E938D89B61|685|||||||||||U/G|AEROSOL, METERED|4 TIMES PER MONTH||INTRASURGICAL SITE||HAMSTRING MUSCLE|BILATERAL|NASAL|NA|||OBSERVATION|1964-05-02|1963-12-08|||1961-07-21|||1966-12-30||1960-11-04
TRIAL STUDY 134XCP|EX|83938342-C01F-491A-84A7-F85D327F112D|686|||||||||||DAYS/WK|CAPSULE, LIQUID FILLED|6 TIMES PER MONTH||INTRASINAL||GASTROINTESTINAL TRACT, UPPER|UNILATERAL|DISTAL VOLAR|NA|||INDUCTION TREATMENT|1969-12-02|1969-04-16|||1964-01-31|||1965-02-20||1968-03-24
TRIAL STUDY 134XCP|EX|731665AB-4418-4943-BFC5-D78F03C8D423|687|||||||||||FEU|TAPE|6 TIMES PER MONTH||INTRAVITREAL||DISTAL FEMUR R1|IPSILATERAL|FRONTAL|U|||BASELINE|1969-12-30|1966-05-14|||1960-12-14|||1968-12-22||1970-04-18
TRIAL STUDY 134XCP|EX|3E337B9F-D718-4FE6-83D8-E05BC77CA872|688|||||||||||INHALATION|CIGARETTE|Q3M||OCCLUSIVE DRESSING TECHNIQUE||ADDUCTOR BREVIS MUSCLE|LATERAL|MIDLINE|U|||OPEN LABEL TREATMENT|1973-06-13|1960-08-09|||1970-05-08|||1967-03-08||1972-08-11
TRIAL STUDY 134XCP|EX|D5243E6E-2521-4331-ABFB-75112D06F771|689|||||||||||FL|LOTION/SHAMPOO|QD||INTRANODAL||UPPER RESPIRATORY SYSTEM|LEFT|INNER|NA|||WASHOUT|1966-09-19|1967-08-26|||1967-12-17|||1971-05-17||1965-07-21
TRIAL STUDY 134XCP|EX|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|690|||||||||||L/L|POULTICE|Q45MIN||SUBCONJUNCTIVAL||SAPHENOUS VEIN|UNILATERAL|OCCIPITAL|Y|||OBSERVATION|1969-10-02|1962-04-01|||1970-12-31|||1967-12-06||1961-06-25
TRIAL STUDY 134XCP|EX|5B3E406E-F2A5-4F25-8271-DC1FABA40138|691|||||||||||SPRAY|TAPE|QOD||INTRATUMOR||UVEA|RIGHT|CAUDAL|Y|||FOLLOW-UP|1967-04-10|1961-09-04|||1966-08-31|||1964-07-09||1967-08-29
TRIAL STUDY 134XCP|EX|D5262627-52D7-42F5-B4BA-D7E6FA243959|692|||||||||||MM/H|SUTURE|Q14H||INTRABRONCHIAL||MIDDLE PHALANX 4 OF THE HAND|BILATERAL|INTERMEDIATE|NA|||OBSERVATION|1960-06-03|1968-06-26|||1970-06-05|||1965-06-01||1960-11-12
TRIAL STUDY 134XCP|EX|C550278D-F171-42D0-8C34-D60824A3FE98|693|||||||||||M|GEL, METERED|Q18H||INTRAVENOUS BOLUS||CRANIAL CAVITY|BILATERAL|PERIPHERAL|N|||OPEN LABEL TREATMENT|1967-10-04|1972-08-31|||1963-05-07|||1960-12-24||1963-08-30
TRIAL STUDY 134XCP|EX|5E76262E-FE1E-40C9-B147-3C792F768F48|694|||||||||||G/ANIMAL|POWDER|3 TIMES PER MONTH||UNKNOWN||ACETABULUM|CONTRALATERAL|PROXIMAL VOLAR|NA|||CONTINUATION TREATMENT|1967-07-19|1972-06-12|||1972-03-25|||1969-07-02||1964-06-21
TRIAL STUDY 134XCP|EX|2F21921D-D18C-43EE-A39E-91A93B262B8C|695|||||||||||UMOL/MOL|CAPSULE, COATED, EXTENDED RELEASE|Q36H||OROPHARYNGEAL||ENDOMETRIUM|BILATERAL|LOWER EXTENSOR SURFACE|U|||TREATMENT|1960-03-24|1968-11-06|||1973-07-07|||1971-02-12||1960-03-16
TRIAL STUDY 134XCP|EX|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|696|||||||||||MEQ/DAY|DISC|2 TIMES PER WEEK||INTRATHALAMIC||TRACHEOBRONCHIAL TREE|CONTRALATERAL|VENTROLATERAL|U|||TREATMENT|1970-09-22|1971-12-17|||1966-03-20|||1973-08-10||1972-04-02
TRIAL STUDY 134XCP|EX|55985646-0224-4442-90C5-EFEDF990E88C|697|||||||||||ML|MOUTHWASH|EVERY 2 WEEKS||SUBMUCOSAL||VENA CAVA|LATERAL|SURFACE|N|||SCREENING|1961-10-26|1970-03-16|||1970-03-30|||1960-11-28||1966-10-02
TRIAL STUDY 134XCP|EX|86509C90-3C57-4755-A06F-79C620779371|698|||||||||||L/DAY|SUSPENSION|EVERY 5 WEEKS||RESPIRATORY (INHALATION)||TRICEPS BRACHII MUSCLE|IPSILATERAL|VENTRAL|NA|||TREATMENT|1962-01-22|1966-10-25|||1971-11-06|||1972-05-16||1964-09-07
TRIAL STUDY 134XCP|EX|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|699|||||||||||ABSORBANCE U/MIN|CAPSULE|Q24H||TRANSDERMAL||EAR|LEFT|ANTEROMEDIAL|Y|||FOLLOW-UP|1967-12-21|1973-07-13|||1972-01-13|||1972-01-16||1962-02-18
TRIAL STUDY 134XCP|EX|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|700|||||||||||UEQ/L|CAPSULE, DELAYED RELEASE PELLETS|Q7D||INTRASPINAL||BUCCAL LYMPH NODE|LATERAL|DISTAL|NA|||OPEN LABEL TREATMENT|1966-01-15|1968-01-19|||1962-07-26|||1964-02-11||1965-10-24
TRIAL STUDY 134XCP|EX|0FFBFF7C-7C64-411E-8D07-C959F0886023|701|||||||||||UL|TINCTURE|Q23H||URETHRAL||BUCCAL LYMPH NODE|LATERAL|LATERAL|Y|||FOLLOW-UP|1960-07-01|1972-12-15|||1961-09-27|||1967-09-22||1961-03-15
TRIAL STUDY 134XCP|EX|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|702|||||||||||BE/ML|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|QOD||INTRACORONARY||HYMENAL RING|LATERAL|APICAL|Y|||LONG-TERM FOLLOW-UP|1964-06-18|1963-08-04|||1968-10-18|||1968-06-02||1967-09-17
TRIAL STUDY 134XCP|EX|5DC5F780-264A-4EB1-BEA5-28209D416FEB|703|||||||||||CM H2O|TAMPON|EVERY EVENING||INTRAGINGIVAL||KNEE JOINT TENDONS|LATERAL|SUBCORTICAL|U|||SCREENING|1970-09-15|1965-11-05|||1971-06-10|||1972-02-20||1964-05-04
TRIAL STUDY 134XCP|EX|DDBCA084-DD05-4FA0-9083-7CD31CECA420|704|||||||||||UMOL/DAY|TABLET, COATED PARTICLES|5 TIMES PER YEAR||IONTOPHORESIS||EXTERNAL ILIAC ARTERY|BILATERAL|LOWER EXTENSOR SURFACE|NA|||CONTINUATION TREATMENT|1961-02-14|1973-08-22|||1969-07-27|||1963-11-30||1968-11-03
TRIAL STUDY 134XCP|EX|65A5AAA6-A817-45F8-9BA8-584E9627AB26|705|||||||||||SIEMENS|TROCHE|6 TIMES PER YEAR||RECTAL||HEART, BASE|BILATERAL|HIND|Y|||BASELINE|1961-04-06|1967-02-03|||1970-06-02|||1968-03-24||1970-07-09
TRIAL STUDY 134XCP|EX|854AD9A5-A869-41C7-9AF0-43383CE64B86|706|||||||||||FARAD|TABLET, COATED|Q21H||NASAL||LACRIMAL BONE|CONTRALATERAL|SUPERIOR|N|||OPEN LABEL TREATMENT|1967-02-15|1973-08-15|||1960-08-26|||1971-08-24||1971-09-18
TRIAL STUDY 134XCP|EX|008F02C8-B28A-490E-A77A-F32584DA06FA|707|||||||||||KCAL/DAY|FILM|Q45MIN||EPIDURAL||TIBIAL-CRURAL PERIPHERAL ARTERY|LATERAL|DISTAL|U|||INDUCTION TREATMENT|1973-08-08|1972-08-17|||1968-04-17|||1964-08-10||1968-10-16
TRIAL STUDY 134XCP|EX|7C06549D-596C-4C47-BD0B-119DF6CD67AC|708|||||||||||SEC|SHAMPOO, SUSPENSION|8 TIMES PER DAY||INTRAUTERINE||FIRST DIAGONAL BRANCH ARTERY|UNILATERAL|BASAL|N|||OBSERVATION|1969-12-12|1960-11-12|||1967-02-28|||1966-03-03||1963-03-09
TRIAL STUDY 134XCP|EX|39A00D93-61B9-44C5-9672-005A1F9A93EB|709|||||||||||G/L|DIAPHRAGM|EVERY WEEK||INTRACARTILAGINOUS||ADDUCTOR MAGNUS MUSCLE|LEFT|FRONTAL|Y|||OBSERVATION|1971-01-30|1961-01-13|||1962-10-01|||1966-02-01||1969-10-14
TRIAL STUDY 134XCP|EX|71B78EFA-AE7A-4248-9A59-63885131F1D1|710|||||||||||BQ/UL|PELLETS, COATED, EXTENDED RELEASE|EVERY WEEK||INTRACAVITARY||CARPOMETACARPAL JOINT 4|IPSILATERAL|CAUDAL|Y|||WASHOUT|1970-02-14|1972-12-21|||1970-01-31|||1973-04-12||1967-02-22
TRIAL STUDY 134XCP|EX|CE28B885-422E-471D-895C-DE8F41CD9FE9|711|||||||||||100 IU/ML|CAPSULE, SOFTGEL, EXTENDED RELEASE|PA||MICRODIALYSIS||CEREBRAL VEIN|UNILATERAL|PARIETO-OCCIPITAL|NA|||INDUCTION TREATMENT|1969-06-12|1967-01-27|||1966-07-30|||1967-04-09||1961-08-30
TRIAL STUDY 134XCP|EX|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|712|||||||||||NMOL|GRANULE, EFFERVESCENT|UNKNOWN||NASOGASTRIC||SCAPHOID-TRAPEZIUM JOINT|UNILATERAL|ANTEROLATERAL|N|||BASELINE|1961-12-18|1972-02-17|||1965-04-20|||1963-03-09||1965-12-14
TRIAL STUDY 134XCP|EX|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|713|||||||||||UMOL/MOL|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|EVERY 8 WEEKS||SUBARACHNOID||FASCIA|RIGHT|SUBCORTICAL|Y|||WASHOUT|1961-07-26|1962-01-24|||1967-01-28|||1970-03-24||1960-10-28
TRIAL STUDY 134XCP|EX|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|714|||||||||||UV*SEC|SPONGE|Q13H||INTRACAMERAL||CEREBRAL VEIN|CONTRALATERAL|VOLAR|N|||CONTINUATION TREATMENT|1962-04-06|1970-08-02|||1966-05-31|||1962-10-06||1960-08-27
TRIAL STUDY 134XCP|EX|3AA56307-0D09-4C82-91B6-717A7C503EFE|715|||||||||||GMFI|LIPSTICK|5 TIMES PER DAY||INTRADISCAL||HEPATIC ARTERY|BILATERAL|LOWER FLEXOR SURFACE|N|||BASELINE|1967-04-28|1966-04-28|||1973-08-18|||1964-12-24||1971-12-05
TRIAL STUDY 134XCP|EX|811AE318-625A-4913-8B18-2D318AF04EAC|716|||||||||||PIXEL|INJECTION, EMULSION|EVERY 6 WEEKS||SUBTENON||PARAPHARYNGEAL LYMPH NODE|UNILATERAL|UPPER EXTENSOR SURFACE|U|||CONTINUATION TREATMENT|1961-04-28|1968-10-04|||1969-10-31|||1963-02-08||1968-09-13
TRIAL STUDY 134XCP|EX|E8F0AF72-5DB4-41D5-814E-5E280A027E94|717|||||||||||MG/KG/DOSE|TABLET, COATED|6 TIMES PER DAY||INTRASPINAL||CORONARY ARTERY, LEFT|LATERAL|LOWER EXTENSOR SURFACE|NA|||SCREENING|1962-03-21|1965-12-25|||1969-08-02|||1968-11-08||1971-09-30
TRIAL STUDY 134XCP|EX|3B726736-01B3-4A69-ABFB-C6255E341E69|718|||||||||||ELISA UNIT/DOSE|AEROSOL, SPRAY|Q2M||TRANSTRACHEAL||L2 VERTEBRA|RIGHT|TIP|Y|||RUN-IN|1962-09-09|1961-09-29|||1968-07-27|||1968-11-05||1971-06-19
TRIAL STUDY 134XCP|EX|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|719|||||||||||ANTI-XA IU/ML|CORE, EXTENDED RELEASE|Q21H||INTRACORPORUS CAVERNOSUM||TRACHEOBRONCHIAL TREE|LATERAL|ANTEROPOSTERIOR|Y|||INDUCTION TREATMENT|1971-10-01|1971-08-07|||1960-08-05|||1970-12-16||1966-01-19
TRIAL STUDY 134XCP|EX|0535EF31-5388-4CC0-8567-44F4C20975EC|720|||||||||||NMOL/G|PILL|EVERY 8 WEEKS||INTRAHEPATIC||HEEL OF THE HAND|UNILATERAL|FACIAL|NA|||FOLLOW-UP|1961-04-18|1964-02-14|||1968-10-29|||1966-10-20||1961-05-05
TRIAL STUDY 134XCP|EX|F149BD98-0802-4C18-8599-426C5258D513|721|||||||||||CM|SPRAY|4 TIMES PER WEEK||PERINEURAL||OCCIPITAL SCALP|RIGHT|MEDIAL|NA|||LONG-TERM FOLLOW-UP|1968-01-04|1963-06-20|||1971-10-12|||1966-03-26||1971-01-18
TRIAL STUDY 134XCP|EX|5A31D035-90D2-4BD0-AE08-839862D6E0DF|722|||||||||||EVENTS|TABLET, MODIFIED RELEASE, LONG DURATION|EVERY WEEK||HEMODIALYSIS||RIB 4|BILATERAL|SURFACE|Y|||SCREENING|1972-08-05|1963-05-17|||1969-04-01|||1968-04-07||1965-11-05
TRIAL STUDY 134XCP|EX|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|723|||||||||||IU/ML|PLASTER|9 TIMES PER DAY||INTERSTITIAL||DIAPHRAGM|RIGHT|OUTER|NA|||INDUCTION TREATMENT|1965-11-22|1971-11-06|||1970-08-23|||1960-07-29||1965-10-10
TRIAL STUDY 134XCP|EX|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|724|||||||||||BAG|CEMENT|QN||INTRATYMPANIC||CAPITATE BONE|UNILATERAL|FORE|U|||RUN-IN|1961-06-07|1961-04-06|||1960-01-03|||1972-09-07||1973-07-26
TRIAL STUDY 134XCP|EX|9C9398A4-38BC-40A7-880D-4549A676F69B|725|||||||||||ML/ANIMAL/DAY|CAPSULE|3 TIMES PER CYCLE||EXTRACORPOREAL||LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|UNILATERAL|OUTER|NA|||INDUCTION TREATMENT|1969-01-21|1963-01-01|||1961-10-15|||1971-05-21||1966-05-03
TRIAL STUDY 134XCP|EX|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|726|||||||||||CIGARETTE|TABLET, COATED|Q2M||IONTOPHORESIS||RETROCRURAL LYMPH NODE|RIGHT|ANTERIOR|U|||BASELINE|1964-04-12|1962-09-25|||1973-03-15|||1971-12-04||1970-07-09
TRIAL STUDY 134XCP|EX|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|727|||||||||||DAYS/MONTH|CEMENT|4 TIMES PER YEAR||TRANSMUCOSAL||DISTAL CIRCUMFLEX ARTERY|LEFT|VENTRAL|NA|||BLINDED TREATMENT|1964-06-22|1971-01-28|||1971-09-24|||1961-09-19||1967-02-01
TRIAL STUDY 134XCP|EX|1E049F70-8E29-458F-BF37-13450BC9227E|728|||||||||||10^6 DNA COPIES/ML|ENEMA|EVERY 2 WEEKS||INTRABURSAL||LOWER JUGULAR LYMPH NODE|CONTRALATERAL|INNER|U|||BASELINE|1960-01-30|1971-02-05|||1961-04-23|||1961-09-27||1960-01-13
TRIAL STUDY 134XCP|EX|7A612F0F-943A-4283-9A11-B8E8E8D68D66|729|||||||||||MAMP|TABLET, DELAYED RELEASE|UNKNOWN||SUBARACHNOID||TRACHEOBRONCHIAL TREE|BILATERAL|DORSOLATERAL|N|||INDUCTION TREATMENT|1964-09-30|1970-09-09|||1967-05-25|||1967-04-10||1963-11-15
TRIAL STUDY 134XCP|EX|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|730|||||||||||MM/SEC|INJECTION, SUSPENSION, EXTENDED RELEASE|EVERY 2 WEEKS||INTRAVAGINAL||GLUTEUS MAXIMUS|UNILATERAL|HIND|U|||BASELINE|1967-11-12|1968-05-24|||1973-04-21|||1969-10-12||1961-04-19
TRIAL STUDY 134XCP|EX|8C86A799-2717-46E8-99C2-76D11AAB54D7|731|||||||||||DAYS|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|Q22H||INTRAOSSEOUS||VEIN|UNILATERAL|OUTER|N|||TREATMENT|1960-05-22|1969-12-07|||1972-04-18|||1973-02-20||1972-03-06
TRIAL STUDY 134XCP|EX|727807A8-A180-4589-A553-E3C82E1D3CF2|732|||||||||||ML/DAY|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|INTERMITTENT||INTRALESIONAL||HIP ADDUCTORS|UNILATERAL|APICAL|NA|||INDUCTION TREATMENT|1963-12-08|1961-02-05|||1973-03-26|||1965-06-29||1970-08-27
TRIAL STUDY 134XCP|EX|BFFB5321-5FC7-4465-8579-D75865306359|733|||||||||||UEQ|TABLET, DELAYED RELEASE|6 TIMES PER YEAR||SUBTENON||ESOPHAGUS|LEFT|LOWER MEDIAL|NA|||BASELINE|1969-04-14|1972-01-06|||1963-06-01|||1961-06-22||1964-08-28
TRIAL STUDY 134XCP|EX|12F9A745-F76D-4222-B37E-22AF93981ECE|734|||||||||||UG/ML/H|PASTE|EVERY 7 WEEKS||INTRAVENOUS||GASTROCNEMIUS MUSCLE, LATERAL HEAD|RIGHT|PERIPHERAL|U|||TREATMENT|1973-07-14|1962-01-20|||1966-09-14|||1968-06-16||1963-09-28
TRIAL STUDY 134XCP|EX|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|735|||||||||||MG/KG/WEEK|INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE|Q5D||MICRODIALYSIS||SKIN OF THE AXILLA|CONTRALATERAL|SUPERIOR|NA|||TREATMENT|1964-04-21|1964-06-08|||1971-10-12|||1960-11-15||1969-01-02
TRIAL STUDY 134XCP|EX|37693A38-D8A0-4313-A4D1-56E282579636|736|||||||||||CUP EQ|SYRUP|Q3D||INTRATYMPANIC||TEMPORAL LOBE|UNILATERAL|UPPER|Y|||TREATMENT|1962-07-04|1961-06-17|||1971-01-24|||1962-09-03||1966-06-10
TRIAL STUDY 134XCP|EX|5C48E0BB-FD52-47F5-8759-6126ECB47B80|737|||||||||||BOLUS|CAPSULE, HARD, EXTENDED RELEASE|EVERY 16 WEEKS||INTRASYNOVIAL||EYE, ANTERIOR CHAMBER|IPSILATERAL|LOWER MEDIAL|Y|||SCREENING|1973-08-17|1967-08-04|||1964-01-08|||1963-01-14||1965-07-15
TRIAL STUDY 134XCP|EX|5B420A5A-DB2C-48D2-8E9B-97639F49F182|738|||||||||||UG/G/DAY|POWDER, FOR SOLUTION|EVERY EVENING||INTRACAMERAL||SACRAL VERTEBRA|BILATERAL|LOWER|N|||CONTINUATION TREATMENT|1971-03-17|1972-09-28|||1964-06-09|||1963-09-01||1962-08-16
TRIAL STUDY 134XCP|EX|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|739|||||||||||VP/DOSE|AEROSOL, FOAM|5 TIMES PER YEAR||INTRAOVARIAN||AORTIC VALVE|LATERAL|SUPERFICIAL|NA|||FOLLOW-UP|1965-10-21|1963-08-21|||1966-10-07|||1967-02-27||1969-03-07
TRIAL STUDY 134XCP|EX|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|740|||||||||||L/H/M2|GRANULE, FOR SOLUTION|QPM||INTRA-ARTERIAL||C2 VERTEBRA|LATERAL|OCCIPITAL|NA|||FOLLOW-UP|1963-11-09|1968-01-19|||1964-05-17|||1967-05-10||1960-07-21
TRIAL STUDY 134XCP|EX|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|741|||||||||||FOZ_US|SOAP|AD LIBITUM||EPIDURAL||CORRUGATOR SUPERCILII MUSCLE|UNILATERAL|UPPER FLEXOR SURFACE|N|||BASELINE|1971-01-25|1972-05-21|||1964-06-05|||1964-08-30||1960-05-16
TRIAL STUDY 134XCP|EX|9B95CE9F-E755-463A-92EC-07A55EE8A58F|742|||||||||||DAYS/WK|SUSPENSION|EVERY 5 YEARS||UNASSIGNED||C2 VERTEBRA|BILATERAL|DORSAL|Y|||BASELINE|1972-10-22|1969-04-13|||1963-11-27|||1963-05-27||1966-11-07
TRIAL STUDY 134XCP|EX|ED388A78-3B06-4529-861A-0174E7F345C2|743|||||||||||ML/SEC/1.73M2|AEROSOL, POWDER|4 TIMES PER YEAR||TRANSMUCOSAL||PERIFACIAL LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|U|||BLINDED TREATMENT|1966-06-16|1965-08-05|||1964-07-30|||1962-12-28||1972-09-01
TRIAL STUDY 134XCP|EX|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|744|||||||||||OSM|TABLET, SOLUBLE|CONTINUOUS||INTRACARTILAGINOUS||MESENTERIC VEIN|CONTRALATERAL|DISTAL|U|||INDUCTION TREATMENT|1969-09-21|1973-08-05|||1963-05-03|||1967-03-18||1962-08-17
TRIAL STUDY 134XCP|EX|172AB680-362D-488C-9DF1-E1C8E386980D|745|||||||||||NMOL|CAPSULE, EXTENDED RELEASE|BID||INTRAMENINGEAL||ISCHIUM|LEFT|OCCIPITAL|N|||CONTINUATION TREATMENT|1963-12-21|1965-01-30|||1964-06-06|||1967-10-03||1963-06-03
TRIAL STUDY 134XCP|EX|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|746|||||||||||KV|LOTION|6 TIMES PER WEEK||TOPICAL||KIDNEY, MEDULLA|CONTRALATERAL|HIND|Y|||RUN-IN|1963-05-02|1973-06-13|||1962-06-18|||1973-03-28||1970-12-03
TRIAL STUDY 134XCP|EX|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|747|||||||||||FFU|INJECTION, POWDER, FOR SUSPENSION|Q6H||CUTANEOUS||THYMUS GLAND|CONTRALATERAL|SUPERFICIAL|NA|||FOLLOW-UP|1971-09-27|1969-04-19|||1967-07-17|||1968-08-13||1960-02-24
TRIAL STUDY 134XCP|EX|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|748|||||||||||L/S|PELLET|INTERMITTENT||INTRAJEJUNAL||SAPHENOUS VEIN|BILATERAL|OUTER|NA|||CONTINUATION TREATMENT|1964-11-10|1964-10-07|||1961-05-10|||1972-07-28||1971-03-23
TRIAL STUDY 134XCP|EX|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|749|||||||||||ML/(MIN*100ML)|PELLETS, COATED, EXTENDED RELEASE|EVERY 5 WEEKS||INTRASURGICAL SITE||TOOTH|LEFT|POSTERIOR|U|||LONG-TERM FOLLOW-UP|1963-09-05|1960-05-21|||1973-07-09|||1967-07-24||1963-11-10
TRIAL STUDY 134XCP|EX|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|750|||||||||||UM|INHALANT|3 TIMES PER CYCLE||INTRAEPIDERMAL||MALLEUS|CONTRALATERAL|OCCIPITAL|Y|||RUN-IN|1973-07-12|1969-09-05|||1969-01-09|||1960-10-16||1962-12-08
TRIAL STUDY 134XCP|EX|740D80F1-8BD5-4409-8087-E48F94363362|751|||||||||||DAYS/WK|LINIMENT|TID||ENDOCERVICAL||LUNG, RIGHT LOWER LOBE|CONTRALATERAL|PROXIMAL|NA|||TREATMENT|1971-07-23|1966-10-02|||1970-07-03|||1960-11-03||1968-03-16
TRIAL STUDY 134XCP|EX|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|752|||||||||||MG/M2/H|GUM|INTERMITTENT||INTRADUODENAL||AORTA|RIGHT|MIDLINE|N|||LONG-TERM FOLLOW-UP|1962-01-15|1969-12-26|||1963-09-27|||1968-10-04||1967-08-12
TRIAL STUDY 134XCP|EX|12AD3838-F986-4A27-8AEE-59C387988B0F|753|||||||||||SUPPOSITORY|TABLET, IMMEDIATE RELEASE|EVERY 3 WEEKS||TOPICAL||ORAL CAVITY|UNILATERAL|PROXIMAL VOLAR|NA|||INDUCTION TREATMENT|1968-10-03|1968-07-09|||1970-11-17|||1963-01-03||1971-12-08
TRIAL STUDY 134XCP|EX|441F1A21-6350-478A-9719-75B053182B78|754|||||||||||COULOMB|CAPSULE, GELATIN COATED|9 TIMES PER DAY||INTRAPERITONEAL||SKIN OF THE UPPER LIMB|BILATERAL|DORSAL|Y|||SCREENING|1967-08-20|1966-02-11|||1965-05-28|||1961-08-29||1972-08-13
TRIAL STUDY 134XCP|EX|A69520E2-01A5-4CBC-AFC9-00324531779F|755|||||||||||UMOL/L|TROCHE|Q2H||INTRATYMPANIC||SKIN OF THE THIGH|LATERAL|PERIPHERAL|Y|||INDUCTION TREATMENT|1971-07-20|1972-12-07|||1973-06-19|||1969-08-16||1971-10-26
TRIAL STUDY 134XCP|EX|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|756|||||||||||/5X10^4 WBC|UNASSIGNED|6 TIMES PER MONTH||INTRABRONCHIAL||INTERNAL MAMMARY ARTERY|BILATERAL|TIP|U|||OBSERVATION|1964-12-08|1967-09-02|||1970-04-04|||1970-12-03||1967-10-02
TRIAL STUDY 134XCP|EX|C361B153-4623-4F03-9D81-8316B1046F35|757|||||||||||/WK|AEROSOL, SPRAY|QPM||INTRASINAL||PERIFACIAL LYMPH NODE|LATERAL|SUPERFICIAL|U|||LONG-TERM FOLLOW-UP|1972-07-18|1960-12-28|||1969-08-29|||1964-08-16||1973-07-28
TRIAL STUDY 134XCP|EX|8FF0A93C-26D1-49E9-853F-B063A958FE1E|758|||||||||||EIA UNIT|FOR SUSPENSION|QH||LARYNGEAL||LAD SEPTAL PERFORATOR ARTERY|RIGHT|DORSOLATERAL|N|||SCREENING|1961-04-03|1965-01-30|||1968-10-07|||1972-09-11||1967-09-28
TRIAL STUDY 134XCP|EX|31D8814B-5542-4540-B955-24410D42F1EF|759|||||||||||EIA UNIT|SPONGE|EVERY 5 WEEKS||VAGINAL||TRICUSPID VALVE, ANTERIOR CUSP|CONTRALATERAL|CENTRAL|U|||INDUCTION TREATMENT|1962-09-24|1968-02-09|||1972-11-10|||1970-03-16||1964-05-21
TRIAL STUDY 134XCP|EX|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|760|||||||||||UMOL/MIN|GEL, METERED|QD||DIETARY||POPLITEAL LYMPH NODE|LEFT|INFERIOR|NA|||RUN-IN|1960-05-11|1963-11-15|||1961-09-01|||1965-06-26||1962-06-29
TRIAL STUDY 134XCP|EX|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|761|||||||||||CD*S/M2|TABLET, MODIFIED RELEASE|THRICE||INTRABILIARY||NOSE|LEFT|PERIPHERAL|N|||FOLLOW-UP|1969-10-05|1960-11-08|||1967-11-28|||1972-07-08||1973-03-12
TRIAL STUDY 134XCP|EX|15BFC17A-2F55-441A-AB99-76D270D62367|762|||||||||||ML/KG/H|CAPLET|EVERY 4 WEEKS||INTRACAVERNOUS||AXILLARY ARTERY|LATERAL|DEEP|U|||CONTINUATION TREATMENT|1963-05-07|1972-01-19|||1963-06-03|||1965-12-03||1960-11-06
TRIAL STUDY 134XCP|EX|CA231D77-1A1F-49F3-8172-06709A1330B7|763|||||||||||/100 HPFS|SHAMPOO, SUSPENSION|3 TIMES PER MONTH||ORAL||CORPUS STRIATUM|UNILATERAL|PERIPHERAL|U|||FOLLOW-UP|1971-12-05|1964-03-06|||1965-05-19|||1962-03-30||1964-01-31
TRIAL STUDY 134XCP|EX|7A4D6074-E870-40E8-B567-D069BCB7DA9F|764|||||||||||PG/CELL|FILM, EXTENDED RELEASE|EVERY 6 WEEKS||TRANSTRACHEAL||OCCIPITAL LOBE|BILATERAL|UPPER FLEXOR SURFACE|NA|||TREATMENT|1969-05-23|1967-10-14|||1971-12-05|||1970-01-11||1972-04-08
TRIAL STUDY 134XCP|EX|3DDD2A7E-B955-424B-B485-54E81D0E0699|765|||||||||||ML/G/DAY|GRANULE, FOR SUSPENSION, EXTENDED RELEASE|CONTINUOUS||INTRAJEJUNAL||SCAPHOID-CAPITATE JOINT|UNILATERAL|UPPER EXTENSOR SURFACE|N|||SCREENING|1969-12-01|1962-11-07|||1970-11-04|||1968-05-01||1963-04-13
TRIAL STUDY 134XCP|EX|D6757E79-3104-468E-BADC-8CCB51BFAE87|766|||||||||||U|DISC|EVERY 3 YEARS||SUBCONJUNCTIVAL||SKIN OF THE FACE|UNILATERAL|FORE|Y|||OPEN LABEL TREATMENT|1969-09-28|1970-12-28|||1969-01-07|||1970-05-21||1961-06-20
TRIAL STUDY 134XCP|EX|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|767|||||||||||ML/CM H2O|INJECTION, SUSPENSION, EXTENDED RELEASE|Q5D||INTRAHEPATIC||HEAD AND NECK|BILATERAL|HIND|Y|||SCREENING|1964-09-19|1973-07-05|||1963-01-05|||1966-12-18||1965-01-29
TRIAL STUDY 134XCP|EX|FBAA59F4-154C-40CC-B740-A87769BFEC45|768|||||||||||10^6 U|INJECTION|Q4M||INTRAVAGINAL||GASTROINTESTINAL TRACT, LOWER, WALL|LEFT|ANTEROTEMPORAL|N|||BLINDED TREATMENT|1969-09-10|1966-07-10|||1971-10-23|||1966-04-09||1962-01-17
TRIAL STUDY 134XCP|EX|9A9E638B-426B-4F3E-8363-50DC2617FD63|769|||||||||||PM|SOLUTION, GEL FORMING, EXTENDED RELEASE|EVERY EVENING||NASAL||LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|LOWER MEDIAL|U|||INDUCTION TREATMENT|1968-12-04|1968-03-11|||1969-03-11|||1966-12-28||1970-08-06
TRIAL STUDY 134XCP|EX|9995CD08-2650-4711-8F04-E41183E28B21|770|||||||||||L/H|POWDER, DENTIFRICE|Q45MIN||INFILTRATION||REGIONAL LYMPH NODE|RIGHT|PROXIMAL|N|||SCREENING|1960-11-15|1967-04-15|||1969-09-29|||1970-12-26||1960-09-20
TRIAL STUDY 134XCP|EX|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|771|||||||||||CMHG|BEAD, IMPLANT, EXTENDED RELEASE|Q4D||INTRAVASCULAR||FINGER FLEXOR TENDONS|BILATERAL|UPPER|U|||LONG-TERM FOLLOW-UP|1960-07-04|1964-03-17|||1970-07-01|||1961-08-04||1965-03-13
TRIAL STUDY 134XCP|EX|DE805225-C632-46E6-B673-DA0D864D47F7|772|||||||||||GENEQ/ML|SOLUTION, FOR SLUSH|Q7H||ORAL GAVAGE||DISTAL PHALANX 5 OF THE HAND|CONTRALATERAL|VOLAR|NA|||INDUCTION TREATMENT|1968-01-28|1963-03-23|||1971-04-05|||1960-01-22||1970-10-19
TRIAL STUDY 134XCP|EX|9C921E89-706F-46E8-ADE3-A806289D43A5|773|||||||||||LX|SUSPENSION, EXTENDED RELEASE|4 TIMES PER YEAR||INTRACAUDAL||ELBOW JOINT|UNILATERAL|FRONTAL|Y|||LONG-TERM FOLLOW-UP|1963-08-24|1970-06-09|||1960-10-11|||1966-08-07||1961-11-13
TRIAL STUDY 134XCP|EX|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|774|||||||||||1/(S*KPA)|CREAM, AUGMENTED|Q9H||INTRACAVERNOUS||SUBTALAR JOINT|LEFT|PROXIMAL|U|||SCREENING|1971-09-28|1963-02-25|||1972-11-28|||1961-11-27||1964-12-16
TRIAL STUDY 134XCP|EX|17C2A52E-1232-4CBB-A809-9DC2C863366A|775|||||||||||CARTRIDGE|TABLET, COATED PARTICLES|EVERY 6 WEEKS||INTRAMEDULLARY||THYROID GLAND, LEFT LOBE|RIGHT|LOWER MEDIAL|N|||FOLLOW-UP|1969-07-30|1962-03-30|||1970-07-31|||1964-03-23||1972-08-24
TRIAL STUDY 134XCP|EX|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|776|||||||||||UKAT/L|TABLET, CHEWABLE|EVERY WEEK||INTRATESTICULAR||LEG SKIN|BILATERAL|PERIVENTRICULAR|U|||WASHOUT|1964-07-19|1973-03-28|||1965-08-08|||1970-07-04||1968-02-27
TRIAL STUDY 134XCP|EX|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|777|||||||||||STRIP|TABLET, SUGAR COATED|QD||OPHTHALMIC||AORTOCAVAL LYMPH NODE|CONTRALATERAL|UPPER FLEXOR SURFACE|N|||BASELINE|1969-02-18|1972-08-25|||1968-11-17|||1972-11-30||1964-06-29
TRIAL STUDY 134XCP|EX|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|778|||||||||||UG/MOL|ELIXIR|PA||INTRAGINGIVAL||TRUNK|RIGHT|PARIETO-OCCIPITAL|NA|||WASHOUT|1970-01-26|1968-01-02|||1964-06-19|||1963-03-12||1961-03-11
TRIAL STUDY 134XCP|EX|585A17D7-12A3-40C8-811F-339497B9D09C|779|||||||||||10^12 IU/L|MOUTHWASH|Q5D||NASAL||TIBIAL-CRURAL PERIPHERAL ARTERY|IPSILATERAL|CRANIAL|U|||LONG-TERM FOLLOW-UP|1962-09-03|1970-09-14|||1963-06-13|||1969-08-29||1971-11-21
TRIAL STUDY 134XCP|EX|D777661E-DF03-4221-88CC-34EB805EF5DB|780|||||||||||MCI|POWDER, DENTIFRICE|QOD||URETERAL||SPINAL ACCESSORY NERVE|LEFT|UPPER EXTENSOR SURFACE|U|||INDUCTION TREATMENT|1969-12-09|1960-06-27|||1963-09-30|||1972-11-14||1967-10-28
TRIAL STUDY 134XCP|EX|67828FC5-94DE-4A68-83DE-F86AA8F86D72|781|||||||||||MEQ/MMOL|POULTICE|QH||INTRASURGICAL SITE||MID-LAD ARTERY|LEFT|SUBCORTICAL|N|||CONTINUATION TREATMENT|1968-05-07|1961-11-15|||1971-02-21|||1972-03-20||1966-03-04
TRIAL STUDY 134XCP|EX|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|782|||||||||||LOG10 PFU/ML|RINSE|6 TIMES PER YEAR||INTRA-ABDOMINAL||THIGH|LATERAL|PERIPHERAL|U|||BLINDED TREATMENT|1964-05-30|1966-12-12|||1966-11-18|||1965-08-08||1968-04-24
TRIAL STUDY 134XCP|EX|650E5DFA-08CC-413C-B43D-070E61353E6E|783|||||||||||NG/DAY|IRRIGANT|Q6H||INTRAMEDULLARY||ASCENDING AORTA, AORTIC ROOT|LEFT|BASAL|U|||OPEN LABEL TREATMENT|1972-06-11|1960-02-02|||1966-03-07|||1972-08-16||1972-03-02
TRIAL STUDY 134XCP|EX|71716F05-3ABE-4A2A-B9DD-2201A63087ED|784|||||||||||10^8 PFU|INJECTABLE, LIPOSOMAL|EVERY 12 WEEKS||INTERSTITIAL||GASTROINTESTINAL TRACT, WALL|CONTRALATERAL|VENTRAL|NA|||BLINDED TREATMENT|1960-07-27|1969-07-06|||1968-07-16|||1963-11-06||1970-05-14
TRIAL STUDY 134XCP|EX|EF9208B0-4DF0-4029-AB67-8F87662D3E90|785|||||||||||KV|SOLUTION, CONCENTRATE|Q5H||INTRASTOMAL||RIB 10|RIGHT|SURFACE|Y|||BLINDED TREATMENT|1971-09-17|1970-08-09|||1973-05-23|||1971-07-16||1965-04-01
TRIAL STUDY 134XCP|EX|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|786|||||||||||KPA/L/SEC|JELLY|QD||INTRAVESICAL||HYPOPHARYNX|RIGHT|LOWER|Y|||BLINDED TREATMENT|1969-12-13|1971-02-16|||1961-04-20|||1971-12-25||1962-11-19
TRIAL STUDY 134XCP|EX|25580765-CB09-4BE3-8DED-C0068C69E9C4|787|||||||||||UL/ML|CIGARETTE|Q15H||INTRAPLEURAL||GLOSSOPHARYNGEAL NERVE|BILATERAL|LATERAL|N|||WASHOUT|1961-10-14|1970-07-23|||1967-10-17|||1971-08-27||1970-03-15
TRIAL STUDY 134XCP|EX|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|788|||||||||||ML/H|JELLY|UNKNOWN||INTRACARDIAC||CELIAC ARTERY|UNILATERAL|BASAL|N|||BLINDED TREATMENT|1961-03-07|1960-12-16|||1961-11-23|||1966-02-21||1972-02-22
TRIAL STUDY 134XCP|EX|A902F087-3BF4-4387-80F9-DDCDDCE1813E|789|||||||||||10^6 IU/ML|GRANULE|10 DAYS PER MONTH||MICRODIALYSIS||RADIUS|LATERAL|ANTERIOR|U|||RUN-IN|1970-03-14|1973-03-06|||1966-03-09|||1964-10-01||1971-11-16
TRIAL STUDY 134XCP|EX|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|790|||||||||||SUPPOSITORY|GRANULE, EFFERVESCENT|EVERY EVENING||TRANSMUCOSAL||LUNG, RIGHT MIDDLE LOBE|RIGHT|DISTAL VOLAR|Y|||RUN-IN|1970-03-06|1968-11-29|||1972-06-27|||1966-04-29||1966-09-21
TRIAL STUDY 134XCP|EX|415F9206-A793-437C-B227-BD245DBF40AB|791|||||||||||CI/L|SUPPOSITORY|4 TIMES PER MONTH||INTRADURAL||CLAW|LATERAL|HIND|U|||TREATMENT|1961-12-22|1966-07-26|||1968-06-12|||1964-12-25||1968-04-19
TRIAL STUDY 134XCP|EX|C580BA02-D031-4875-AC02-347AA65C4C6C|792|||||||||||MMOL/KG|GRANULE, DELAYED RELEASE|QN||INTRA-ABDOMINAL||OVARIAN FOLLICLE|IPSILATERAL|ANTEROPOSTERIOR|Y|||RUN-IN|1967-11-27|1967-03-10|||1972-04-29|||1960-04-20||1971-05-20
TRIAL STUDY 134XCP|EX|4DD6944D-662E-4C9A-A663-601B657BCF5E|793|||||||||||10^6/HPF|PATCH|QH||INTRATUMOR||EAR|BILATERAL|BASAL|N|||BASELINE|1960-08-21|1960-06-08|||1969-09-13|||1966-07-23||1970-01-15
TRIAL STUDY 134XCP|EX|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|794|||||||||||U/M2|TABLET, MULTILAYER, EXTENDED RELEASE|EVERY 7 WEEKS||INTRADURAL||SINUS|LEFT|PERIPHERAL|Y|||BLINDED TREATMENT|1970-12-03|1968-10-11|||1971-10-03|||1962-05-20||1965-08-08
TRIAL STUDY 134XCP|EX|69A130F1-44A1-4091-BF0C-FF8087CC9940|795|||||||||||APL U|INTRAUTERINE DEVICE|EVERY 8 WEEKS||INTRATUBULAR||SUPERFICIAL LYMPH NODE|LEFT|DEEP|N|||CONTINUATION TREATMENT|1967-10-22|1965-03-15|||1962-12-09|||1973-02-07||1966-03-17
TRIAL STUDY 134XCP|EX|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|796|||||||||||CMH2O*S2/ML|CAPSULE, EXTENDED RELEASE|EVERY 3 YEARS||INTRACAMERAL||SPLENIC VEIN|CONTRALATERAL|UPPER|NA|||WASHOUT|1961-01-16|1971-09-04|||1967-04-26|||1962-01-26||1969-08-05
TRIAL STUDY 134XCP|EX|96C60715-2EDE-40FD-B41C-ECD1E5065C81|797|||||||||||UIU/DL|TROCHE|CONTINUOUS||INTRAPALATAL||PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|SURFACE|N|||BASELINE|1966-01-16|1966-05-27|||1966-01-16|||1967-07-05||1961-09-29
TRIAL STUDY 134XCP|EX|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|798|||||||||||CCID 50/DOSE|TABLET, IMMEDIATE RELEASE|Q3M||INTRATYMPANIC||INTERPHALANGEAL JOINT 4|RIGHT|ANTEROPOSTERIOR|N|||LONG-TERM FOLLOW-UP|1965-09-23|1971-10-03|||1971-01-07|||1966-01-01||1963-08-11
TRIAL STUDY 134XCP|EX|8452DD7A-4DC9-4BDF-B670-AE5B49292805|799|||||||||||CPM|GAS|Q6D||INTRACARDIAC||GREAT TROCHANTER|LATERAL|PARIETO-OCCIPITAL|N|||SCREENING|1966-06-05|1969-02-25|||1972-10-15|||1963-12-26||1965-06-26
TRIAL STUDY 134XCP|EX|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|800|||||||||||FFU|RING|3 TIMES PER WEEK||INTRAPERITONEAL||GLOTTIS|RIGHT|PROXIMAL|NA|||RUN-IN|1970-10-01|1961-01-01|||1963-12-01|||1972-05-30||1963-11-21
TRIAL STUDY 134XCP|EX|30108497-140B-499E-8924-8BFCDC57457A|801|||||||||||WEBER|TAPE|6 TIMES PER WEEK||INTRAESOPHAGEAL||MESENTERIC VEIN|BILATERAL|INNER|N|||SCREENING|1973-02-02|1967-07-26|||1962-09-18|||1960-10-22||1972-11-04
TRIAL STUDY 134XCP|EX|5FFEF358-5014-497F-A091-6EF27A1BCF7D|802|||||||||||TRANSDUCING UNIT/ML|SPONGE|QD||INTRA-ARTERIAL||PALPEBRAL CONJUNCTIVA|RIGHT|LOWER MEDIAL|N|||OPEN LABEL TREATMENT|1971-01-04|1965-04-07|||1960-09-06|||1969-10-03||1965-07-30
TRIAL STUDY 134XCP|EX|9DFBE459-22E4-4BA7-A993-AC06D6644562|803|||||||||||SCM|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|UNKNOWN||INTRASINAL||ILEUM|RIGHT|CRANIAL|U|||FOLLOW-UP|1969-08-27|1967-09-17|||1965-03-12|||1960-06-11||1970-07-20
TRIAL STUDY 134XCP|EX|850B35FA-69C7-44AD-A471-964C59C4CFD8|804|||||||||||POUCH|SUPPOSITORY, EXTENDED RELEASE|Q4M||INTRA-ABDOMINAL||DISTAL PHALANX 5 OF THE HAND|LEFT|HIND|N|||WASHOUT|1972-11-02|1963-01-24|||1971-03-18|||1961-11-20||1964-12-24
TRIAL STUDY 134XCP|EX|981B890E-1257-4F04-A974-6006401F78CC|805|||||||||||M2|SYRUP|7 TIMES PER DAY||INTRATHORACIC||LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|BILATERAL|OCCIPITAL|N|||CONTINUATION TREATMENT|1969-12-22|1968-01-27|||1970-02-07|||1962-01-20||1973-05-22
TRIAL STUDY 134XCP|EX|52FF8D96-64AD-498D-8B28-3DDD015796E3|806|||||||||||CG|UNKNOWN|EVERY 3 YEARS||INTRAVENOUS DRIP||LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|CONTRALATERAL|FACIAL|U|||BASELINE|1965-12-05|1970-08-18|||1962-09-23|||1962-05-05||1968-07-10
TRIAL STUDY 134XCP|EX|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|807|||||||||||10^6 RNA COPIES/ML|SPRAY, SUSPENSION|EVERY 12 WEEKS||RETROBULBAR||NASAL BONE|RIGHT|UPPER|N|||INDUCTION TREATMENT|1962-07-30|1970-11-20|||1972-03-29|||1971-05-14||1963-09-01
TRIAL STUDY 134XCP|EX|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|808|||||||||||NL|CAPSULE, GELATIN COATED|9 TIMES PER DAY||NASAL||CAUDATE NUCLEUS|UNILATERAL|VOLAR|N|||FOLLOW-UP|1970-04-15|1970-08-15|||1961-10-10|||1973-03-10||1970-01-30
TRIAL STUDY 134XCP|EX|CD65CBB8-D056-4738-93A8-FF465534961B|809|||||||||||M|TINCTURE|Q6D||INTRAPERITONEAL||DISTAL PHALANX 2 OF THE HAND|BILATERAL|ROSTRAL|U|||OPEN LABEL TREATMENT|1960-11-28|1969-03-02|||1970-06-29|||1961-09-02||1963-02-09
TRIAL STUDY 134XCP|EX|7F014394-ABE2-45F8-891F-2DE808762532|810|||||||||||UV|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|Q4M||INTRADISCAL||THYROID GLAND, RIGHT LOBE|LATERAL|TEMPORAL|U|||WASHOUT|1971-07-13|1961-01-21|||1970-02-02|||1964-10-03||1972-12-23
TRIAL STUDY 134XCP|EX|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|811|||||||||||G/KG/DAY|GAS|Q7H||PHARYNGEAL||ASCENDING AORTA|RIGHT|PERIPHERAL|N|||BLINDED TREATMENT|1960-04-14|1969-05-30|||1964-03-31|||1968-12-22||1967-01-18
TRIAL STUDY 134XCP|EX|FB781158-BB8A-4A75-BD55-00D6A5C72720|812|||||||||||YEARS|GEL, METERED|Q5D||SUPRACHOROIDAL||PROXIMAL PHALANX 2 OF THE HAND|LATERAL|LATERAL|U|||LONG-TERM FOLLOW-UP|1966-08-14|1967-04-05|||1964-11-29|||1965-12-25||1970-04-17
TRIAL STUDY 134XCP|EX|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|813|||||||||||V/V|GRANULE, FOR SUSPENSION|BIM||INTRATHECAL||TIBIOTARSAL JOINT|LATERAL|INNER|NA|||CONTINUATION TREATMENT|1969-06-26|1972-08-22|||1970-07-02|||1967-04-28||1972-09-27
TRIAL STUDY 134XCP|EX|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|814|||||||||||FOZ_BR|AEROSOL|Q24H||INTRAUTERINE||DISTAL PHALANX 4 OF THE HAND|LEFT|FORE|N|||INDUCTION TREATMENT|1968-08-18|1970-08-12|||1968-04-19|||1964-04-02||1967-11-20
TRIAL STUDY 134XCP|EX|505A1BB6-135A-4839-BB9E-6DD37F49DC45|815|||||||||||/5X10^4 WBC|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|Q8H||ORAL GAVAGE||WALDEYER'S TONSILLAR RING|RIGHT|SUPERIOR|Y|||SCREENING|1966-03-10|1968-01-31|||1964-06-20|||1965-12-18||1960-11-01
TRIAL STUDY 134XCP|EX|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|816|||||||||||KBQ/UL|PELLET, IMPLANTABLE|Q13H||SUBCONJUNCTIVAL||CALCANEAL TUBEROSITY|CONTRALATERAL|FACIAL|Y|||TREATMENT|1965-03-31|1963-10-16|||1967-05-21|||1971-06-02||1972-10-09
TRIAL STUDY 134XCP|EX|16F375DC-DC27-461B-969E-1269DC53F4D9|817|||||||||||CG|GAS|9 TIMES PER DAY||INTRAVESICAL||THIRD RIGHT POSTEROLATERAL ARTERY|UNILATERAL|ROSTRAL|NA|||INDUCTION TREATMENT|1973-05-22|1964-07-02|||1965-02-11|||1971-06-27||1970-09-24
TRIAL STUDY 134XCP|EX|17BF9A68-265F-4FCC-A499-615A1B71A8D6|818|||||||||||UMOL/L/H|LINER, DENTAL|Q11H||INTRACORONARY||ANAL VERGE|UNILATERAL|SUBCORTICAL|U|||WASHOUT|1965-10-10|1965-04-25|||1963-04-09|||1964-07-18||1966-12-04
TRIAL STUDY 134XCP|EX|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|819|||||||||||BOWL|TABLET, CHEWABLE|QM||INTRADUODENAL||EXTERNAL ILIAC LYMPH NODE|UNILATERAL|ROSTRAL|NA|||FOLLOW-UP|1966-01-23|1962-12-31|||1971-05-09|||1971-11-27||1971-05-29
TRIAL STUDY 134XCP|EX|B842981B-AD7A-4A03-8E84-D5FC887BAD60|820|||||||||||GY/H|TABLET, MODIFIED RELEASE, SHORT DURATION|THRICE||ENDOCERVICAL||SUBCARINAL LYMPH NODE|RIGHT|OUTER|N|||INDUCTION TREATMENT|1972-01-31|1968-09-20|||1971-05-20|||1964-11-01||1965-01-10
TRIAL STUDY 134XCP|EX|07F7C4E7-7722-4916-AB89-46EF540E2BD7|821|||||||||||ML/MMHG|TABLET, DELAYED RELEASE PARTICLES|QM||INTRACAVERNOUS||LOCUS CERULEUS|LATERAL|SUBCORTICAL|U|||SCREENING|1963-04-04|1963-11-07|||1964-07-23|||1967-04-11||1961-02-22
TRIAL STUDY 134XCP|EX|58661394-906E-43F3-8935-150DF240A04C|822|||||||||||DIP|LOZENGE|Q22H||INTRAPROSTATIC||EARLOBE|UNILATERAL|LOWER|NA|||SCREENING|1969-10-10|1963-03-26|||1960-01-06|||1967-02-22||1969-08-16
TRIAL STUDY 134XCP|EX|B70F3694-B764-4B39-BFB9-B1281ED091B8|823|||||||||||GY/MIN|TABLET, COATED|4 TIMES PER MONTH||INTRAPARENCHYMAL||FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|UNILATERAL|UPPER FLEXOR SURFACE|N|||WASHOUT|1972-10-16|1960-10-03|||1962-09-25|||1965-04-27||1965-10-11
TRIAL STUDY 134XCP|EX|5B2471DB-807A-44F8-9529-D2319CCFE017|824|||||||||||NKAT/G HB|EXTRACT|QOD||URETERAL||UVEA|UNILATERAL|ANTEROTEMPORAL|Y|||WASHOUT|1971-12-26|1961-06-17|||1967-01-18|||1971-10-19||1963-12-24
TRIAL STUDY 134XCP|EX|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|825|||||||||||IU/DAY|PLASTER|Q20H||INTRAOCULAR||PUPIL|LATERAL|OUTER|U|||RUN-IN|1961-04-19|1966-04-15|||1965-06-18|||1963-11-11||1962-08-16
TRIAL STUDY 134XCP|EX|A6E00A2C-7DBC-4577-8873-C780F5A6B400|826|||||||||||DPM/0.5 ML|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|THRICE||INTRACEREBRAL||FINGERNAIL|LATERAL|FORE|Y|||BASELINE|1962-12-16|1960-12-14|||1970-12-13|||1963-03-26||1965-06-22
TRIAL STUDY 134XCP|EX|06611015-E99C-466B-B0B3-EBE10EA9E627|827|||||||||||PMOL/G|CULTURE|8 TIMES PER DAY||ENDOSINUSIAL||MEDIASTINUM, MIDDLE|UNILATERAL|FACIAL|N|||OBSERVATION|1967-12-09|1964-04-11|||1967-07-24|||1964-12-26||1972-04-05
TRIAL STUDY 134XCP|EX|5AF91C46-87FC-4714-B956-A4ECFC87C30A|828|||||||||||MM/MIN|TABLET, IMMEDIATE RELEASE|QID||VAGINAL||HEART, BASE|LATERAL|ROSTRAL|Y|||LONG-TERM FOLLOW-UP|1963-05-21|1964-02-05|||1960-04-23|||1960-11-28||1970-12-16
TRIAL STUDY 134XCP|EX|3DEA7E00-77B9-4710-A37E-577F925BFBD8|829|||||||||||IU/DL|WAFER|6 TIMES PER WEEK||INTRATYMPANIC||COSTOCHONDRAL JOINT 1|LEFT|SUPERFICIAL|NA|||FOLLOW-UP|1968-11-13|1963-02-04|||1961-10-18|||1969-02-25||1969-07-31
TRIAL STUDY 134XCP|EX|DC79E350-1B89-4518-8B42-5858F5270928|830|||||||||||MMAL|SOLUTION, GEL FORMING / DROPS|Q13H||PERIODONTAL||NOSTRIL|CONTRALATERAL|FORE|N|||OBSERVATION|1965-03-02|1972-05-26|||1966-01-15|||1961-02-09||1961-04-28
TRIAL STUDY 134XCP|EX|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|831|||||||||||CI/KG|TABLET, COATED|EVERY 5 WEEKS||INTRACARTILAGINOUS||FEMUR|BILATERAL|ANTEROTEMPORAL|U|||OBSERVATION|1968-07-29|1969-02-07|||1961-08-21|||1971-02-05||1962-04-26
TRIAL STUDY 134XCP|EX|7F51014D-D2B5-4956-9DD6-52676EB66ED7|832|||||||||||UG/L DDU|TABLET, FOR SUSPENSION|7 TIMES PER WEEK||INTRA-AMNIOTIC||LEFT VENTRICULAR APICAL LATERAL SEGMENT|RIGHT|UPPER FLEXOR SURFACE|U|||BASELINE|1972-09-16|1960-11-11|||1966-03-04|||1960-12-01||1966-09-27
TRIAL STUDY 134XCP|EX|0568B2DD-3184-472D-89C6-66A5CE8AE00F|833|||||||||||NCI|BEAD, IMPLANT, EXTENDED RELEASE|3 TIMES PER WEEK||TRANSMAMMARY||METATARSOPHALANGEAL JOINT 1|CONTRALATERAL|OUTER|N|||CONTINUATION TREATMENT|1964-05-21|1964-07-31|||1972-01-25|||1962-02-23||1967-04-24
TRIAL STUDY 134XCP|EX|275DC6A6-598C-4997-A442-4A3916AC42BD|834|||||||||||MG/M2|CAPLET|8 TIMES PER DAY||INTRASURGICAL SITE||BICEPS BRACHII MUSCLE|LATERAL|ANTEROMEDIAL|NA|||WASHOUT|1961-02-28|1968-02-03|||1963-08-25|||1963-05-10||1965-03-25
TRIAL STUDY 134XCP|EX|B949F90F-524D-4494-A63C-A05F56421EA1|835|||||||||||CFU/G|BEAD|INTERMITTENT||OCCLUSIVE DRESSING TECHNIQUE||LATERAL RAMUS INTERMEDIUS ARTERY|IPSILATERAL|MEDIAL|Y|||LONG-TERM FOLLOW-UP|1966-01-15|1964-11-12|||1972-08-23|||1966-11-19||1971-03-11
TRIAL STUDY 134XCP|EX|152411EA-E7DA-4230-A8A6-163C8A8C0A58|836|||||||||||ML/H|INJECTION, SUSPENSION, SONICATED|4 TIMES PER YEAR||TRANSMAMMARY||SKIN OF THE CHIN|RIGHT|DORSAL|NA|||BLINDED TREATMENT|1966-12-28|1973-04-12|||1971-02-02|||1969-01-28||1967-10-21
TRIAL STUDY 134XCP|EX|AB78662C-F90A-4193-9AC7-5621B497A18F|837|||||||||||PACKET|POWDER|Q8H||OPHTHALMIC||T1 VERTEBRA|CONTRALATERAL|ANTEROTEMPORAL|U|||SCREENING|1962-09-07|1962-09-03|||1964-01-09|||1966-07-01||1971-07-02
TRIAL STUDY 134XCP|EX|84CD31FD-BCB9-4439-84F7-11C63D578108|838|||||||||||IU/G|AEROSOL|5 TIMES PER YEAR||INTRAPERITONEAL||METATARSOPHALANGEAL JOINT 1|UNILATERAL|MEDIAL|NA|||OPEN LABEL TREATMENT|1972-10-01|1971-01-21|||1962-05-18|||1963-05-14||1972-05-28
TRIAL STUDY 134XCP|EX|BB9A976D-48AC-4618-9BA1-683D97240F2B|839|||||||||||GENEQ/ML|CAPSULE, FILM COATED, EXTENDED RELEASE|Q3D||INTRACEREBRAL||HEEL OF THE HAND|IPSILATERAL|FRONTAL|U|||RUN-IN|1968-03-27|1965-04-08|||1964-04-06|||1973-02-05||1966-05-28
TRIAL STUDY 134XCP|EX|FA440C9B-0D7A-4656-BF17-D46289567FB0|840|||||||||||U/10^12 RBC|TABLET, MULTILAYER, EXTENDED RELEASE|Q7H||INTRAVENTRICULAR||DISTAL PHALANX 5 OF THE HAND|LATERAL|POSTERIOR|U|||OBSERVATION|1966-01-22|1969-10-14|||1961-12-29|||1963-08-19||1963-10-03
TRIAL STUDY 134XCP|EX|1706BA4E-D2AB-4877-974A-17BDBD834FFF|841|||||||||||BAU/ML|INJECTION, EMULSION|EVERY 3 WEEKS||INTRAHEPATIC||GLUTEAL MUSCLE|LATERAL|CENTRAL|U|||TREATMENT|1970-09-01|1972-04-17|||1961-10-01|||1965-04-03||1971-06-30
TRIAL STUDY 134XCP|EX|15E3DD06-7F28-499B-9CF5-6EE5875095B5|842|||||||||||NEBULE|DRESSING|Q6H||RETROBULBAR||GONAD|UNILATERAL|FACIAL|Y|||BASELINE|1968-05-21|1969-02-06|||1963-02-02|||1964-02-15||1966-06-19
TRIAL STUDY 134XCP|EX|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|843|||||||||||UGEQ/L|SPRAY, METERED|THRICE||OROMUCOSAL||SCAPHOID-CAPITATE JOINT|UNILATERAL|UPPER FLEXOR SURFACE|NA|||CONTINUATION TREATMENT|1968-08-13|1966-10-01|||1973-06-26|||1972-10-07||1960-03-24
TRIAL STUDY 134XCP|EX|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|844|||||||||||KIU|AEROSOL|Q7D||TRANSMAMMARY||LEFT MAIN CORONARY ARTERY BODY|LATERAL|DORSAL|Y|||INDUCTION TREATMENT|1964-07-12|1970-09-02|||1971-04-09|||1970-11-17||1969-02-06
TRIAL STUDY 134XCP|EX|87ED1C08-AF47-4827-A897-E8FC24A69ECC|845|||||||||||NMOL/ML/MIN|TABLET|QOD||UNASSIGNED||ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|BILATERAL|ANTERIOR|Y|||OBSERVATION|1972-07-11|1962-10-24|||1964-06-23|||1969-04-01||1972-08-27
TRIAL STUDY 134XCP|EX|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|846|||||||||||MG/M2/DAY|PLASTER|1 TIME PER WEEK||INTRACAMERAL||TOE|LATERAL|VENTROLATERAL|NA|||OPEN LABEL TREATMENT|1962-07-24|1966-11-29|||1967-01-30|||1969-08-10||1963-07-27
TRIAL STUDY 134XCP|EX|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|847|||||||||||UIU/DL|SPRAY, METERED|OCCASIONAL||TRANSTYMPANIC||SKIN AROUND THE EYE|UNILATERAL|UPPER|N|||FOLLOW-UP|1960-04-27|1968-10-01|||1972-09-01|||1961-02-17||1963-05-16
TRIAL STUDY 134XCP|EX|C817A043-1331-47AB-A627-D85893F9D61A|848|||||||||||/10^4|TABLET, DELAYED RELEASE PARTICLES|6 TIMES PER MONTH||UNASSIGNED||PROFUNDA FEMORIS ARTERY|LEFT|ANTERIOR|Y|||TREATMENT|1971-04-01|1961-03-02|||1967-05-31|||1962-12-14||1963-01-23
TRIAL STUDY 134XCP|EX|DDD6F5D1-AE97-412C-A161-869C4178223A|849|||||||||||TRACE|SOLUTION, GEL FORMING, EXTENDED RELEASE|Q2M||INTRATHALAMIC||CEREBRAL VEIN|UNILATERAL|ANTEROLATERAL|NA|||TREATMENT|1963-06-11|1960-05-14|||1971-08-09|||1969-08-26||1961-01-31
TRIAL STUDY 134XCP|EX|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|850|||||||||||FIU|LINIMENT|Q10H||INTRASURGICAL SITE||DISTAL PHALANX 5 OF THE HAND|CONTRALATERAL|LOWER FLEXOR SURFACE|NA|||INDUCTION TREATMENT|1973-07-19|1967-01-21|||1962-08-15|||1973-01-07||1962-05-08
TRIAL STUDY 134XCP|EX|25FB07EA-3CB8-430D-B775-CA0E9918C069|851|||||||||||MV*MIN|TABLET, MULTILAYER|EVERY WEEK||INTRA-ARTERIAL||WRIST JOINT FLEXOR MUSCLES|IPSILATERAL|OCCIPITAL|U|||INDUCTION TREATMENT|1960-11-04|1972-12-18|||1967-12-01|||1960-10-31||1961-09-09
TRIAL STUDY 134XCP|EX|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|852|||||||||||UL/KG/DAY|INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION|EVERY 6 WEEKS||INTRADERMAL||OLFACTORY BULB|RIGHT|FORE|Y|||BLINDED TREATMENT|1960-03-10|1960-09-13|||1966-02-28|||1967-08-02||1968-02-13
TRIAL STUDY 134XCP|EX|B49B9695-9815-4B7B-9F96-4EE6A4432062|853|||||||||||GPL U/ML|INJECTION, SOLUTION, CONCENTRATE|Q45MIN||OCCLUSIVE DRESSING TECHNIQUE||ILIUM|RIGHT|TIP|Y|||WASHOUT|1964-02-10|1961-02-11|||1966-02-07|||1967-05-06||1971-03-17
TRIAL STUDY 134XCP|EX|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|854|||||||||||BP|PACKING|4 TIMES PER WEEK||INTRALUMINAL||POSTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT|LOWER FLEXOR SURFACE|Y|||BLINDED TREATMENT|1969-10-07|1965-08-03|||1964-06-30|||1968-04-07||1963-07-10
TRIAL STUDY 134XCP|EX|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|855|||||||||||NKAT|AEROSOL, POWDER|QID||INTRALUMINAL||POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|IPSILATERAL|VENTRAL|U|||BLINDED TREATMENT|1966-08-25|1962-09-07|||1971-11-01|||1967-01-31||1965-08-07
TRIAL STUDY 134XCP|EX|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|856|||||||||||UG/G/H|GRANULE|OCCASIONAL||CONJUNCTIVAL||INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|TIP|N|||RUN-IN|1962-06-30|1968-09-21|||1965-05-27|||1966-02-03||1967-08-26
TRIAL STUDY 134XCP|EX|07A934C8-0237-4B37-9FDD-503B8BF94357|857|||||||||||TSP EQ|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|UNKNOWN||INTRAOCULAR||AXILLARY LYMPH NODE LEVEL III|RIGHT|UPPER EXTENSOR SURFACE|U|||FOLLOW-UP|1971-09-17|1961-11-09|||1969-01-23|||1962-09-19||1970-01-30
TRIAL STUDY 134XCP|EX|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|858|||||||||||PMOL/L/H|PASTE, DENTIFRICE|3 TIMES PER MONTH||EXTRACORPOREAL||FUNDUS OF THE STOMACH|RIGHT|LATERAL|U|||OBSERVATION|1970-03-29|1972-02-27|||1965-10-03|||1966-06-14||1966-11-28
TRIAL STUDY 134XCP|EX|10E1249E-10AC-45E8-9896-84C7B0F548BC|859|||||||||||MBQ/UL|FOR SUSPENSION, EXTENDED RELEASE|6 TIMES PER WEEK||PERIVENOUS||METATARSOPHALANGEAL JOINT 1|RIGHT|VENTRAL|NA|||TREATMENT|1970-12-09|1966-10-31|||1968-11-06|||1962-06-08||1971-08-14
TRIAL STUDY 134XCP|EX|6CA97CE0-D120-4E14-A82F-4799D2699110|860|||||||||||AMU|SPRAY, METERED|5 TIMES PER MONTH||PHARYNGEAL||TIBIALIS ANTERIOR MUSCLE|BILATERAL|FACIAL|NA|||OPEN LABEL TREATMENT|1967-04-30|1962-09-02|||1961-08-31|||1970-01-30||1973-03-11
TRIAL STUDY 134XCP|EX|D807C3F6-0955-4742-A29B-815682559530|861|||||||||||CYLINDER|SOLUTION, GEL FORMING / DROPS|Q6M||CONJUNCTIVAL||BLADDER, NECK|UNILATERAL|SUBCORTICAL|Y|||SCREENING|1968-12-23|1970-05-25|||1971-09-09|||1972-01-13||1964-09-02
TRIAL STUDY 134XCP|EX|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|862|||||||||||NG/DAY|MOUTHWASH|Q5D||TRANSMAMMARY||ASCENDING AORTA|BILATERAL|CENTRAL|Y|||FOLLOW-UP|1963-09-25|1968-01-04|||1968-04-26|||1965-10-04||1967-02-16
TRIAL STUDY 134XCP|EX|38C36B22-EC60-4D40-A1B6-71B17F8C8625|863|||||||||||UGEQ/L|INJECTION, SOLUTION, CONCENTRATE|BIM||CUTANEOUS||OPHTHALMIC ARTERY|LATERAL|INTERMEDIATE|Y|||LONG-TERM FOLLOW-UP|1960-04-30|1970-03-30|||1968-12-08|||1967-12-14||1960-11-16
TRIAL STUDY 134XCP|EX|E2F4144C-543D-4F55-A94E-58F244FB21D1|864|||||||||||UKAT/10^12 RBC|GRANULE, FOR SUSPENSION|Q19H||OPHTHALMIC||CELIAC LYMPH NODE|CONTRALATERAL|PROXIMAL|Y|||BASELINE|1961-08-16|1965-01-09|||1970-04-09|||1961-07-23||1971-07-19
TRIAL STUDY 134XCP|EX|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|865|||||||||||IU/ML|TABLET, DELAYED RELEASE|Q15H||INTRATESTICULAR||AXILLARY LYMPH NODE LEVEL III|BILATERAL|SURFACE|U|||WASHOUT|1971-12-29|1966-11-20|||1967-08-01|||1962-08-26||1964-03-04
TRIAL STUDY 134XCP|EX|49B857CF-22F2-406F-A269-54944B23C236|866|||||||||||UG/MIN|ENEMA|Q2M||INTRADURAL||PENIS, BODY|RIGHT|OCCIPITAL|N|||CONTINUATION TREATMENT|1966-08-08|1960-03-29|||1967-06-08|||1967-11-09||1961-10-21
TRIAL STUDY 134XCP|EX|E09B394B-9E48-4132-B430-991DF1953A81|867|||||||||||UG/L|SHAMPOO, SUSPENSION|Q2M||EXTRACORPOREAL||ACHILLES TENDON|LEFT|MIDLINE|N|||SCREENING|1967-04-30|1964-10-02|||1964-05-11|||1967-06-25||1972-04-09
TRIAL STUDY 134XCP|EX|5FB65CB2-DB12-4D00-818E-C51992DC7273|868|||||||||||ML/M2|CAPSULE, IMMEDIATE RELEASE|Q11H||URETERAL||THIGH|CONTRALATERAL|TEMPORAL|Y|||CONTINUATION TREATMENT|1972-05-21|1960-10-22|||1964-09-21|||1961-06-13||1963-06-25
TRIAL STUDY 134XCP|EX|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|869|||||||||||MMHG*MIN/L|TABLET, EFFERVESCENT|Q6H||INTRAVENOUS||INTERTROCHANTERIC REGION|UNILATERAL|DISTAL VOLAR|Y|||SCREENING|1970-12-08|1960-05-24|||1963-10-17|||1965-10-24||1970-03-29
TRIAL STUDY 134XCP|EX|CB6A1101-1EF8-476D-BD15-B60EF323D740|870|||||||||||MM/MIN|FIBER, EXTENDED RELEASE|Q6H||NASOGASTRIC||T11 VERTEBRA|UNILATERAL|ANTEROLATERAL|N|||OBSERVATION|1961-05-03|1965-11-15|||1965-05-22|||1972-06-03||1962-05-14
TRIAL STUDY 134XCP|EX|3AED1654-6D9A-40EE-A560-99F51C469D63|871|||||||||||GPS U|SOAP|AD LIBITUM||INTRABILIARY||SUBCLAVIAN VEIN|RIGHT|SUPERIOR|NA|||SCREENING|1963-06-29|1964-02-24|||1964-09-09|||1970-02-21||1966-04-02
TRIAL STUDY 134XCP|EX|4C13FD80-8950-4194-B76C-F46B643BED82|872|||||||||||G/G/DAY|CAPSULE, DELAYED RELEASE|EVERY 5 WEEKS||INTRAEPIDERMAL||FLOOR OF MOUTH|UNILATERAL|INTERMEDIATE|N|||TREATMENT|1971-07-12|1968-11-17|||1973-09-08|||1968-08-19||1966-03-21
TRIAL STUDY 134XCP|EX|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|873|||||||||||MOL/DAY|BAR, CHEWABLE|2 TIMES PER CYCLE||CONJUNCTIVAL||DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|POSTERIOR|NA|||WASHOUT|1971-03-25|1972-01-08|||1973-05-08|||1973-02-01||1971-12-14
TRIAL STUDY 134XCP|EX|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|874|||||||||||ANTIBODY UNIT|SUPPOSITORY, EXTENDED RELEASE|THRICE||INTRAMEDULLARY||LEFT VENTRICULAR APEX SEGMENT|LEFT|DORSOLATERAL|Y|||WASHOUT|1971-08-21|1962-06-14|||1965-03-29|||1969-07-14||1969-06-30
TRIAL STUDY 134XCP|EX|CFFA0003-098B-486E-82DB-30838F6541DD|875|||||||||||%(V/V)|INJECTION, SUSPENSION|Q2H||INTRAPERITONEAL||INFERIOR VENA CAVA|LEFT|ANTERIOR|NA|||CONTINUATION TREATMENT|1965-05-09|1961-02-25|||1960-09-19|||1972-03-03||1973-05-20
TRIAL STUDY 134XCP|EX|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|876|||||||||||FFU|CAPSULE, GELATIN COATED|Q72H||INTRAGINGIVAL||HAIR ROOT|BILATERAL|TEMPORAL|NA|||SCREENING|1969-05-14|1965-06-03|||1962-10-24|||1964-09-26||1969-12-26
TRIAL STUDY 134XCP|EX|3F29184F-1963-4EC7-881A-61C9DEF95D2D|877|||||||||||KHZ|SPRAY, SUSPENSION|OCCASIONAL||INTRAPERICARDIAL||OSTIOMEATAL COMPLEX|BILATERAL|POSTERIOR|U|||TREATMENT|1960-07-26|1964-12-06|||1973-01-06|||1970-07-29||1961-05-28
TRIAL STUDY 134XCP|EX|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|878|||||||||||MGEQ|GRANULE, FOR SUSPENSION|Q17H||INTRACAMERAL||NAVICULAR BONE|LATERAL|DORSOLATERAL|N|||LONG-TERM FOLLOW-UP|1973-05-14|1963-06-29|||1960-02-23|||1964-06-13||1965-10-17
TRIAL STUDY 134XCP|EX|D9C32CF1-51C7-412D-A030-682B2860F89D|879|||||||||||10^6 DNA COPIES/ML|MOUTHWASH|1 TIME PER WEEK||INTRAVENTRICULAR||WALDEYER'S TONSILLAR RING|LATERAL|SUPERFICIAL|U|||BASELINE|1961-10-11|1960-10-11|||1965-07-15|||1971-12-17||1965-03-11
TRIAL STUDY 134XCP|EX|102F6B51-5A86-497B-A36D-13FB77928C39|880|||||||||||TRACE|CAPSULE, DELAYED RELEASE|AD LIBITUM||INTRACARTILAGINOUS||PARASPINAL REGION|IPSILATERAL|UPPER EXTENSOR SURFACE|NA|||WASHOUT|1962-01-06|1970-04-21|||1962-11-20|||1965-09-21||1963-03-16
TRIAL STUDY 134XCP|EX|C123D04C-1AA4-418D-B68C-EC9D410376F0|881|||||||||||TSP EQ|INSERT|BIM||INTRAPLEURAL||PROXIMAL PHALANX 3 OF THE HAND|UNILATERAL|SUBCORTICAL|Y|||WASHOUT|1961-04-09|1964-04-13|||1965-04-17|||1967-10-06||1963-04-14
TRIAL STUDY 134XCP|EX|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|882|||||||||||VP/DOSE|CAPSULE, HARD, EXTENDED RELEASE|4 TIMES PER YEAR||INTRAPERICARDIAL||MEDIAN OR LOWER CERVICAL LYMPH NODE|LEFT|PROXIMAL VOLAR|N|||BLINDED TREATMENT|1960-05-09|1967-04-12|||1970-08-20|||1966-02-11||1966-01-20
TRIAL STUDY 134XCP|EX|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|883|||||||||||LM|GUM, RESIN|EVERY EVENING||INTRATESTICULAR||FORELIMB|CONTRALATERAL|PERIVENTRICULAR|NA|||BASELINE|1960-02-29|1971-09-26|||1970-10-18|||1971-01-21||1973-06-04
TRIAL STUDY 134XCP|EX|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|884|||||||||||FT|INJECTION, LIPID COMPLEX|EVERY 12 WEEKS||INTRABURSAL||FOREHEAD|RIGHT|DORSOLATERAL|N|||FOLLOW-UP|1962-02-02|1971-02-18|||1972-05-11|||1963-12-23||1967-01-25
TRIAL STUDY 134XCP|EX|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|885|||||||||||ANSON U|INJECTION, SUSPENSION, SONICATED|Q3D||PERCUTANEOUS||STOMACH|RIGHT|INTERMEDIATE|NA|||FOLLOW-UP|1963-12-07|1973-08-19|||1967-09-28|||1960-04-18||1968-03-28
TRIAL STUDY 134XCP|EX|E3310689-5727-4970-A675-A58931E406FA|886|||||||||||CUP EQ|PILL|TID||INTRA-ABDOMINAL||LOWER JUGULAR LYMPH NODE|RIGHT|PROXIMAL|N|||RUN-IN|1965-01-08|1962-05-11|||1965-10-05|||1973-06-07||1968-09-03
TRIAL STUDY 134XCP|EX|D5359BBA-960E-4392-996A-BCDD8637894A|887|||||||||||TITER|GENERATOR|Q19H||ENDOCERVICAL||HIP|LATERAL|PROXIMAL VOLAR|NA|||OBSERVATION|1965-07-12|1971-06-27|||1972-09-26|||1970-03-30||1966-08-28
TRIAL STUDY 134XCP|EX|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|888|||||||||||UG/M2|INSERT, EXTENDED RELEASE|QPM||INTRAPLEURAL||TESTIS|CONTRALATERAL|PROXIMAL|Y|||CONTINUATION TREATMENT|1964-01-27|1969-08-18|||1973-09-04|||1971-03-14||1967-10-13
TRIAL STUDY 134XCP|EX|EED3F55E-892E-46C6-8B0A-30D2E1112072|889|||||||||||MU/G|LIQUID, EXTENDED RELEASE|QN||INTRAMANDIBULAR||PORTA HEPATIS LYMPH NODE|IPSILATERAL|ROSTRAL|Y|||WASHOUT|1962-09-30|1973-09-04|||1961-09-11|||1972-03-03||1960-08-27
TRIAL STUDY 134XCP|EX|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|890|||||||||||UL|PASTE, DENTIFRICE|Q23H||SUBTENON||PANCREAS|BILATERAL|LOWER FLEXOR SURFACE|NA|||WASHOUT|1961-07-05|1972-12-21|||1972-02-20|||1968-11-13||1964-03-13
TRIAL STUDY 134XCP|EX|B865DADD-9A4E-4521-A2E8-104D709F4144|891|||||||||||UMOL/MG/MIN|TABLET, DELAYED RELEASE|EVERY 7 WEEKS||DENTAL||STERNUM|IPSILATERAL|ROSTRAL|U|||TREATMENT|1960-12-03|1961-03-12|||1973-02-21|||1969-01-22||1966-03-29
TRIAL STUDY 134XCP|EX|D8C78860-7893-4239-8F29-A0EE98C90310|892|||||||||||UG/KG/MIN|TAPE|8 TIMES PER DAY||NOT APPLICABLE||SINUS|LATERAL|ANTEROPOSTERIOR|NA|||SCREENING|1961-05-14|1965-03-08|||1972-06-25|||1971-03-22||1961-06-07
TRIAL STUDY 134XCP|EX|841D0118-C3F9-4169-B43E-D88CEB2795BA|893|||||||||||MV/SEC|SPONGE|QPM||SUBTENON||BASILIC VEIN|LATERAL|VENTROLATERAL|Y|||FOLLOW-UP|1970-01-26|1966-04-23|||1967-04-27|||1960-01-13||1964-12-17
TRIAL STUDY 134XCP|EX|9C3C0334-F7A4-4530-A6D3-574C039979E7|894|||||||||||PPB|INSERT, EXTENDED RELEASE|QM||INTRACEREBRAL||LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|DEEP|U|||RUN-IN|1969-10-05|1962-02-04|||1970-10-01|||1969-12-09||1970-12-10
TRIAL STUDY 134XCP|EX|FE955CB9-9992-4521-8788-7597AF40F214|895|||||||||||10^5/HPF|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|Q22H||TRANSTYMPANIC||BRONCHUS|IPSILATERAL|PROXIMAL VOLAR|Y|||RUN-IN|1973-05-22|1969-03-05|||1970-03-06|||1963-09-16||1967-11-01
TRIAL STUDY 134XCP|EX|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|896|||||||||||AU/ML|CAPSULE, EXTENDED RELEASE|Q16H||INTRATHORACIC||SECOND OBTUSE MARGINAL BRANCH ARTERY|LEFT|BASAL|U|||TREATMENT|1971-06-22|1967-04-20|||1969-05-22|||1971-08-16||1960-06-01
TRIAL STUDY 134XCP|EX|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|897|||||||||||GAUSS|PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED|Q6D||INTRAESOPHAGEAL||JEJUNUM|IPSILATERAL|POSTERIOR|U|||TREATMENT|1972-07-20|1968-07-14|||1968-04-03|||1968-06-14||1965-10-19
TRIAL STUDY 134XCP|EX|28B6CF51-A007-4CED-8247-37BD468F41C5|898|||||||||||U/10^12 RBC|CAPSULE, LIQUID FILLED|EVERY 3 YEARS||SUBLINGUAL||POSTERIOR CINGULATE CORTEX|LEFT|LATERAL|NA|||OBSERVATION|1967-11-01|1960-01-10|||1965-11-21|||1965-08-30||1961-05-12
TRIAL STUDY 134XCP|EX|4E600C41-1B27-4042-B48E-B60489701D2D|899|||||||||||/MS|CAPSULE, SOFTGEL, EXTENDED RELEASE|EVERY 6 WEEKS||RECTAL||PANCREAS, BODY|RIGHT|DORSAL|Y|||SCREENING|1961-03-22|1968-05-15|||1966-07-12|||1973-09-05||1967-02-18
TRIAL STUDY 134XCP|EX|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|900|||||||||||PM|SHAMPOO|Q21H||INTRACAUDAL||GASTROINTESTINAL TRACT, UPPER|LEFT|LOWER EXTENSOR SURFACE|Y|||LONG-TERM FOLLOW-UP|1971-03-29|1971-10-12|||1964-02-02|||1968-10-26||1963-11-04
TRIAL STUDY 134XCP|EX|00D760E7-DC21-41A8-AD28-FF48A5C21E83|901|||||||||||MG/M2/H|FOR SUSPENSION, EXTENDED RELEASE|EVERY 3 WEEKS||INTRATUBULAR||LUNG, LEFT UPPER LOBE|LATERAL|ANTERIOR|NA|||LONG-TERM FOLLOW-UP|1963-01-04|1963-02-22|||1968-09-22|||1966-09-29||1963-04-02
TRIAL STUDY 134XCP|EX|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|902|||||||||||ML/MMHG|POWDER, METERED|Q5H||LARYNGEAL||PERICARDIAL WALL|CONTRALATERAL|POSTERIOR|NA|||SCREENING|1960-09-18|1966-10-10|||1965-07-10|||1961-02-01||1963-09-30
TRIAL STUDY 134XCP|EX|4EC25C9E-F259-405B-8B7D-3C9640FB9748|903|||||||||||BOTTLE|PATCH|Q18H||PERIARTICULAR||HYPOPHARYNX|LATERAL|SURFACE|NA|||FOLLOW-UP|1966-11-28|1972-12-24|||1969-03-19|||1973-04-06||1967-06-20
TRIAL STUDY 134XCP|EX|FF1CC617-040D-42E9-AD31-32E7B8DAED24|904|||||||||||PMOL/10^9 CELLS|INJECTION, SUSPENSION, LIPOSOMAL|Q5H||INTRASTOMAL||HEART, BASE|BILATERAL|CAUDAL|N|||CONTINUATION TREATMENT|1972-06-12|1969-03-22|||1965-02-27|||1970-04-09||1966-06-12
TRIAL STUDY 134XCP|EX|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|905|||||||||||NG/MOL|LIQUID|Q19H||DIETARY||ATRIOVENTRICULAR VALVE|CONTRALATERAL|ANTEROLATERAL|U|||TREATMENT|1961-08-15|1971-08-09|||1961-10-21|||1962-03-15||1969-08-14
TRIAL STUDY 134XCP|EX|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|906|||||||||||KHZ|POWDER, DENTIFRICE|EVERY AFTERNOON||INTRAPALATAL||THYROID GLAND, LEFT LOBE|UNILATERAL|POSTERIOR|Y|||TREATMENT|1970-10-28|1960-11-02|||1961-11-28|||1962-05-13||1965-11-27
TRIAL STUDY 134XCP|EX|BFA83769-F31F-49AE-8C43-49046C719D69|907|||||||||||UL|ELIXIR|Q4D||HEMODIALYSIS||CHEEK|LEFT|VOLAR|U|||FOLLOW-UP|1962-08-14|1969-06-24|||1968-05-02|||1964-06-06||1964-08-27
TRIAL STUDY 134XCP|EX|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|908|||||||||||GTT|LIQUID, EXTENDED RELEASE|7 TIMES PER DAY||INTRACARDIAC||ULNAR NERVE|UNILATERAL|PERIVENTRICULAR|N|||FOLLOW-UP|1961-09-30|1971-12-15|||1961-11-10|||1964-12-29||1972-02-09
TRIAL STUDY 134XCP|EX|91838668-D463-4728-A581-2E1987592885|909|||||||||||CM/MIN|GAS|EVERY WEEK||INTRAPERITONEAL||FOREARM|CONTRALATERAL|VENTRAL|Y|||BASELINE|1969-06-20|1972-01-13|||1972-04-09|||1973-01-20||1968-02-12
TRIAL STUDY 134XCP|EX|DE440A90-82D5-4269-A48B-47E2F5495440|910|||||||||||U/G/DAY|SOLUTION, GEL FORMING, EXTENDED RELEASE|Q16H||INTRAPERICARDIAL||SARTORIUS MUSCLE|LEFT|PROXIMAL VOLAR|Y|||TREATMENT|1965-07-21|1966-02-19|||1966-02-02|||1972-02-24||1968-06-11
TRIAL STUDY 134XCP|EX|74CA3A61-3179-43F1-8721-2582F50C44EF|911|||||||||||CM H2O|CEMENT|Q7H||INTRADURAL||POPLITEAL ARTERY ABOVE KNEE|RIGHT|FACIAL|Y|||FOLLOW-UP|1962-09-23|1965-07-03|||1972-08-11|||1968-08-20||1960-10-10
TRIAL STUDY 134XCP|EX|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|912|||||||||||RFU|CAPSULE, EXTENDED RELEASE|EVERY 16 WEEKS||HEMODIALYSIS||EAR, OUTER|RIGHT|VENTRAL|N|||OBSERVATION|1969-02-25|1961-05-12|||1964-06-02|||1971-03-30||1967-11-30
TRIAL STUDY 134XCP|EX|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|913|||||||||||10^6/EJACULATE U|CAPSULE, HARD, EXTENDED RELEASE|Q2H||INTRASYNOVIAL||LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|LEFT|UPPER|N|||WASHOUT|1965-06-25|1961-09-10|||1971-04-05|||1971-02-26||1966-08-10
TRIAL STUDY 134XCP|EX|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|914|||||||||||UG/DOSE|BEAD|4 TIMES PER WEEK||INTRACAVITARY||SKIN OF THE UPPER LIMB|CONTRALATERAL|DORSAL|N|||INDUCTION TREATMENT|1967-02-20|1963-05-04|||1967-01-26|||1962-07-11||1968-09-01
TRIAL STUDY 134XCP|EX|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|915|||||||||||GBQ/UG|OINTMENT, AUGMENTED|Q3M||OROMUCOSAL||INTERPHALANGEAL JOINT 4|BILATERAL|VOLAR|N|||OPEN LABEL TREATMENT|1960-03-01|1971-10-13|||1973-01-10|||1972-02-22||1967-12-15
TRIAL STUDY 134XCP|EX|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|916|||||||||||FOZ_BR|TABLET, FILM COATED|6 TIMES PER YEAR||ENDOTRACHEAL||SUBMANDIBULAR LYMPH NODE|UNILATERAL|CAUDAL|NA|||WASHOUT|1964-02-19|1960-10-28|||1965-10-25|||1971-06-08||1970-03-15
TRIAL STUDY 134XCP|EX|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|917|||||||||||PIXELS/IN|PACKING|Q12H||TRANSMAMMARY||COMMON ILIAC ARTERY|RIGHT|HIND|N|||BASELINE|1962-08-14|1971-07-23|||1970-11-28|||1963-02-16||1963-07-08
TRIAL STUDY 134XCP|EX|687E56D1-7E45-4598-819A-A0D8D770F406|918|||||||||||EID 50/ML|STICK|5 TIMES PER DAY||INTRATHORACIC||ORBICULARIS OCULI MUSCLE|CONTRALATERAL|DISTAL|NA|||FOLLOW-UP|1971-03-29|1971-02-23|||1973-05-23|||1969-09-15||1961-04-16
TRIAL STUDY 134XCP|EX|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|919|||||||||||UGEQ|CRYSTAL|Q22H||HEMODIALYSIS||SKIN OF THE TRUNK|BILATERAL|SUBCORTICAL|N|||SCREENING|1960-12-06|1968-06-27|||1962-07-22|||1960-03-08||1964-07-17
TRIAL STUDY 134XCP|EX|F536FDD9-881B-41AD-B863-FE8AB14062A1|920|||||||||||1/(S*KPA)|TABLET, MODIFIED RELEASE, LONG DURATION|ONCE||HEMODIALYSIS||MOTOR CORTEX|UNILATERAL|LOWER EXTENSOR SURFACE|NA|||LONG-TERM FOLLOW-UP|1962-09-22|1960-02-23|||1967-11-17|||1962-12-13||1970-06-22
TRIAL STUDY 134XCP|EX|CB726766-A812-45B3-95CA-D1AD8F697FD3|921|||||||||||/MS|CAPSULE|3 TIMES PER WEEK||SUBRETINAL||BRAIN VENTRICLE, LATERAL|LEFT|HIND|N|||WASHOUT|1963-03-28|1972-09-26|||1973-08-26|||1963-04-22||1962-12-12
TRIAL STUDY 134XCP|EX|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|922|||||||||||UU/L|SUPPOSITORY|6 TIMES PER MONTH||INTRAMENINGEAL||ULNAR ARTERY|BILATERAL|HIND|NA|||BASELINE|1961-06-02|1973-08-04|||1965-01-29|||1964-01-16||1961-01-10
TRIAL STUDY 134XCP|EX|20DC654F-595C-410D-A340-465A23434D42|923|||||||||||CCID 50/ML|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|ONCE||ELECTRO-OSMOSIS||NERVE|IPSILATERAL|INFERIOR|N|||OPEN LABEL TREATMENT|1968-09-02|1963-03-17|||1965-12-27|||1969-11-06||1971-05-02
TRIAL STUDY 134XCP|EX|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|924|||||||||||U/KG/H|ENEMA|Q3D||INTRATUBULAR||PARAMETRIUM|RIGHT|ANTEROLATERAL|NA|||INDUCTION TREATMENT|1963-02-17|1969-12-26|||1964-03-26|||1966-07-05||1973-07-17
TRIAL STUDY 134XCP|EX|4EA8DC88-09C8-4954-A469-D8E12F01CB56|925|||||||||||MG/CM2|FOR SOLUTION|Q9H||INTRACORPORUS CAVERNOSUM||EAR, OUTER|RIGHT|POSTERIOR|Y|||BASELINE|1971-10-24|1961-12-05|||1961-11-27|||1972-05-03||1962-08-10
TRIAL STUDY 134XCP|EX|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|926|||||||||||DRAM|PASTE|Q6M||TRANSPLACENTAL||PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|DISTAL|N|||CONTINUATION TREATMENT|1972-12-07|1961-02-13|||1963-09-03|||1971-10-07||1970-11-15
TRIAL STUDY 134XCP|EX|521B1614-9092-4F89-A47F-728C66E01B23|927|||||||||||L/H/M2|BEAD, IMPLANT, EXTENDED RELEASE|THRICE||ENTERAL||SCAPULA|IPSILATERAL|LATERAL|Y|||OBSERVATION|1968-06-10|1967-12-25|||1966-12-23|||1960-07-16||1964-04-19
TRIAL STUDY 134XCP|EX|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|928|||||||||||ML/KG/MIN|POWDER|BIM||RETROBULBAR||SACRAL TUBEROSITY|LEFT|PROXIMAL|N|||SCREENING|1960-03-29|1960-05-15|||1962-03-30|||1962-03-15||1963-05-14
TRIAL STUDY 134XCP|EX|FF6B8B49-3C82-459D-A35D-61136FC594D2|929|||||||||||UMOL/L/MIN|INSERT, EXTENDED RELEASE|PA||URETHRAL||DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|APICAL|N|||OBSERVATION|1962-03-27|1965-10-25|||1968-08-27|||1970-06-18||1969-12-12
TRIAL STUDY 134XCP|EX|2196D9F4-937A-4662-B24B-AC9D472E0393|930|||||||||||MS2|TABLET, FOR SOLUTION|TWICE||ENDOCERVICAL||FLEXOR CARPI RADIALIS MUSCLE|UNILATERAL|HIND|U|||BASELINE|1964-01-03|1962-12-29|||1972-11-06|||1970-05-07||1972-04-24
TRIAL STUDY 134XCP|EX|F192452A-4088-46AA-9DD1-8D14809E18F6|931|||||||||||/KG|GENERATOR|EVERY EVENING||DIETARY||GLOBUS PALLIDUS|UNILATERAL|DEEP|Y|||SCREENING|1963-12-17|1960-09-19|||1968-08-26|||1961-06-24||1968-07-03
TRIAL STUDY 134XCP|EX|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|932|||||||||||10^6/HPF|DISC|Q4H||RESPIRATORY (INHALATION)||HAND DIGIT 1|LEFT|ROSTRAL|NA|||INDUCTION TREATMENT|1972-08-27|1971-11-04|||1967-08-01|||1961-09-27||1963-09-20
TRIAL STUDY 134XCP|EX|0D51A87E-2597-4B2D-A7B5-E533790E917D|933|||||||||||HENRY|TABLET, MODIFIED RELEASE, SHORT DURATION|Q16H||SUBTENON||DORSAL MOTOR NUCLEUS|LEFT|FRONTAL|NA|||SCREENING|1966-03-19|1966-07-29|||1971-01-07|||1962-10-10||1965-08-08
TRIAL STUDY 134XCP|EX|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|934|||||||||||/10^4|CEMENT|Q18H||INTRADUCTAL||LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL|MEDIAL|N|||RUN-IN|1967-09-11|1963-12-17|||1970-01-12|||1967-03-05||1960-06-17
TRIAL STUDY 134XCP|EX|16075684-F04D-4CB8-970A-0819378790EB|935|||||||||||UM/DAY|TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE|4 TIMES PER YEAR||INTRABURSAL||COLON, DESCENDING|BILATERAL|DISTAL VOLAR|Y|||BASELINE|1970-10-21|1961-05-25|||1962-11-24|||1973-03-26||1960-06-27
TRIAL STUDY 134XCP|EX|3527E844-D4D5-480A-B6D6-04C5DC0A3380|936|||||||||||%(V/V)|SPRAY, METERED|EVERY 5 YEARS||UNASSIGNED||L2-L3 INTERVERTEBRAL SPACE|UNILATERAL|OUTER|U|||LONG-TERM FOLLOW-UP|1973-08-11|1966-09-11|||1964-10-21|||1962-04-29||1968-12-12
TRIAL STUDY 134XCP|EX|DFB0DF52-4D95-4A26-B28F-071774D78426|937|||||||||||CMH2O/ML|AEROSOL, METERED|Q17H||INTRATUMOR||INFERIOR PUBIC RAMUS|IPSILATERAL|POSTERIOR|U|||INDUCTION TREATMENT|1963-11-05|1966-08-02|||1961-01-14|||1961-02-07||1960-08-19
TRIAL STUDY 134XCP|EX|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|938|||||||||||MMHG/SEC|GRANULE, FOR SUSPENSION|Q11H||INTRALYMPHATIC||HEART, BASE|LEFT|OUTER|Y|||OBSERVATION|1972-01-14|1966-02-13|||1971-01-15|||1973-01-11||1968-06-23
TRIAL STUDY 134XCP|EX|CFF20837-0091-467E-ABDE-72645BAFC849|939|||||||||||PPTR|TROCHE|8 TIMES PER DAY||PERINEURAL||METACARPOPHALANGEAL JOINT 4|LEFT|ANTERIOR|Y|||BLINDED TREATMENT|1967-02-03|1972-04-29|||1970-01-18|||1966-05-08||1972-12-06
TRIAL STUDY 134XCP|EX|C79756C8-8601-4770-8BC2-7A530428BA82|940|||||||||||10^6 IU/ML|TABLET, EXTENDED RELEASE|BID||SUPRACHOROIDAL||POPLITEAL VEIN|UNILATERAL|BASAL|U|||LONG-TERM FOLLOW-UP|1968-09-03|1963-11-15|||1964-10-12|||1961-08-18||1961-09-07
TRIAL STUDY 134XCP|EX|5533A669-828B-4CA3-BEC3-849CE7384167|941|||||||||||H/WK|OINTMENT|QD||INTRAPLEURAL||OBTURATOR MUSCLE|RIGHT|DORSAL|NA|||TREATMENT|1972-03-12|1963-10-07|||1966-08-01|||1969-06-29||1972-10-12
TRIAL STUDY 134XCP|EX|C711ADD3-F398-4161-BE13-B75BEDF91402|942|||||||||||CL|SUSPENSION, EXTENDED RELEASE|CONTINUOUS||INTRANODAL||CALCANEAL TUBEROSITY|CONTRALATERAL|UPPER FLEXOR SURFACE|N|||OPEN LABEL TREATMENT|1964-07-27|1966-04-30|||1965-12-26|||1966-11-01||1960-12-20
TRIAL STUDY 134XCP|EX|2CD70FFA-5977-4718-961B-6D67368F99B8|943|||||||||||KEV|TABLET, FOR SUSPENSION|Q6D||INTRA-ARTERIAL||CHEST WALL|UNILATERAL|ROSTRAL|NA|||BASELINE|1965-01-14|1965-04-04|||1961-03-04|||1965-03-06||1961-08-05
TRIAL STUDY 134XCP|EX|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|944|||||||||||EP U|POWDER|Q2H||SUBMUCOSAL||HAND DIGIT 5|LEFT|ANTERIOR|Y|||BASELINE|1967-08-03|1969-11-28|||1973-01-05|||1963-10-07||1969-10-15
TRIAL STUDY 134XCP|EX|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|945|||||||||||PPM|AEROSOL, METERED|6 TIMES PER MONTH||INTRAVAGINAL||SKIN OF THE ELBOW|CONTRALATERAL|PROXIMAL VOLAR|N|||CONTINUATION TREATMENT|1969-04-19|1966-02-12|||1972-05-30|||1969-11-18||1962-07-29
TRIAL STUDY 134XCP|EX|43E00B7D-684F-4BAC-A135-E65C22B191AD|946|||||||||||BQ/UL|IRRIGANT|7 TIMES PER WEEK||INTRACORONAL, DENTAL||ILIAC CREST|IPSILATERAL|POSTERIOR|Y|||BASELINE|1960-05-29|1970-10-13|||1969-11-06|||1969-07-16||1960-07-12
TRIAL STUDY 134XCP|EX|25680BE0-7CE5-4B76-A48E-2D977A07E749|947|||||||||||PKAT/L|PASTILLE|QID||INTRAOSSEOUS||JUGULAR VEIN|BILATERAL|TEMPORAL|U|||OBSERVATION|1961-12-13|1968-09-03|||1968-07-02|||1969-08-08||1972-03-05
TRIAL STUDY 134XCP|EX|67CA2619-351F-493E-93B2-5CDC9AF99C8B|948|||||||||||L/H/M2|IRRIGANT|EVERY EVENING||INTRAGINGIVAL||PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|FACIAL|U|||SCREENING|1971-08-09|1966-08-16|||1961-08-18|||1967-05-13||1968-09-17
TRIAL STUDY 134XCP|EX|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|949|||||||||||K|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|OCCASIONAL||INTRAMEDULLARY||CARPOMETACARPAL JOINT 1|LATERAL|UPPER FLEXOR SURFACE|U|||INDUCTION TREATMENT|1960-09-11|1972-01-02|||1961-03-17|||1972-05-29||1972-01-07
TRIAL STUDY 134XCP|EX|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|950|||||||||||VG/DOSE|CAPSULE, GELATIN COATED|Q2M||EXTRACORPOREAL||PERITONEAL CAVITY|RIGHT|CAUDAL|Y|||TREATMENT|1960-07-30|1969-01-29|||1965-08-24|||1966-03-25||1972-12-03
TRIAL STUDY 134XCP|EX|51B01BE3-230D-4AE0-A229-81EF519EA932|951|||||||||||10^7 TCID 50/DOSE|LINER, DENTAL|EVERY 16 WEEKS||RECTAL||EYE, ANTERIOR CHAMBER|LEFT|NASAL|U|||RUN-IN|1970-05-26|1967-09-12|||1970-11-10|||1971-10-13||1965-03-14
TRIAL STUDY 134XCP|EX|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|952|||||||||||MOL/G|TAMPON|Q4H||INTRAVENOUS||RIB 5|BILATERAL|SURFACE|Y|||RUN-IN|1967-11-01|1972-12-26|||1968-01-24|||1964-03-10||1965-07-07
TRIAL STUDY 134XCP|EX|01FD66DA-C67B-48A7-9320-F29C6C226155|953|||||||||||L/KG|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE|7 TIMES PER DAY||DENTAL||FOOT DIGIT 1|CONTRALATERAL|NASAL|U|||LONG-TERM FOLLOW-UP|1971-01-14|1967-09-12|||1968-09-16|||1967-10-22||1969-10-01
TRIAL STUDY 134XCP|EX|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|954|||||||||||U|SOAP|Q22H||NASOGASTRIC||LEFT POSTERIOR DESCENDING ARTERY|LEFT|DISTAL|NA|||INDUCTION TREATMENT|1962-09-07|1961-10-25|||1971-09-17|||1965-12-04||1968-01-28
TRIAL STUDY 134XCP|EX|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|955|||||||||||BAG|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|Q2M||DENTAL||INFRATENTORIAL BRAIN|CONTRALATERAL|LOWER FLEXOR SURFACE|Y|||OBSERVATION|1965-07-10|1970-07-07|||1965-11-16|||1965-09-24||1966-11-03
TRIAL STUDY 134XCP|EX|81E3641F-6145-4B3C-9E26-8DEC1200509D|956|||||||||||KPA/L/SEC|TABLET, MULTILAYER|EVERY AFTERNOON||INTRAMANDIBULAR||ILIOTIBIAL BAND|UNILATERAL|SUBCORTICAL|U|||FOLLOW-UP|1962-01-24|1962-07-05|||1962-09-03|||1967-06-25||1972-07-27
TRIAL STUDY 134XCP|EX|8F3D0A71-FD09-4E43-BC54-0562AF99306E|957|||||||||||G/L|INJECTION, SOLUTION, CONCENTRATE|4 TIMES PER WEEK||INTRAJEJUNAL||CALCARINE SULCUS|BILATERAL|OCCIPITAL|N|||SCREENING|1964-08-01|1962-07-21|||1960-08-02|||1964-10-11||1971-10-20
TRIAL STUDY 134XCP|EX|BE750F04-5992-42B5-A084-A33D6FBBFD2E|958|||||||||||NGEQ/L|KIT|EVERY 3 YEARS||NASOGASTRIC||MAXILLARY SINUS|CONTRALATERAL|LOWER|NA|||SCREENING|1962-12-14|1971-10-29|||1973-03-01|||1960-09-02||1967-05-29
TRIAL STUDY 134XCP|EX|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|959|||||||||||NG|OIL|10 DAYS PER MONTH||INTRAPERITONEAL||FOOT|IPSILATERAL|PERIVENTRICULAR|N|||RUN-IN|1961-07-02|1970-02-20|||1960-11-29|||1966-08-17||1973-07-18
TRIAL STUDY 134XCP|EX|8417B146-336C-4777-A566-C1D086F39430|960|||||||||||MEQ/G|BAR, CHEWABLE|QID||INTRAOVARIAN||THORAX|IPSILATERAL|FORE|U|||RUN-IN|1968-07-08|1962-09-30|||1965-03-08|||1971-06-02||1963-12-23
TRIAL STUDY 134XCP|EX|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|961|||||||||||L|POWDER, FOR SUSPENSION|4 TIMES PER WEEK||TRANSMAMMARY||SHOULDER JOINT TENDONS|UNILATERAL|INFERIOR|NA|||OBSERVATION|1968-03-30|1971-06-07|||1960-09-19|||1964-11-16||1962-08-17
TRIAL STUDY 134XCP|EX|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|962|||||||||||AMOL|TABLET, COATED|2 TIMES PER CYCLE||NOT APPLICABLE||ETHMOID BONE|CONTRALATERAL|INNER|U|||OBSERVATION|1972-12-11|1962-09-26|||1968-02-19|||1968-09-12||1972-05-31
TRIAL STUDY 134XCP|EX|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|963|||||||||||BU/ML|IMPLANT|OCCASIONAL||INTRASINAL||GANGLION|UNILATERAL|DEEP|U|||CONTINUATION TREATMENT|1965-03-11|1970-07-21|||1973-01-20|||1970-03-10||1962-11-16
TRIAL STUDY 134XCP|EX|2926D795-9C17-4440-8411-68525E93E78D|964|||||||||||UMOL/MIN|CAPSULE, EXTENDED RELEASE|CONTINUOUS||SUBCONJUNCTIVAL||TRICUSPID VALVE, SEPTAL CUSP|BILATERAL|PROXIMAL|Y|||BLINDED TREATMENT|1972-01-04|1962-05-09|||1972-10-22|||1973-08-16||1962-11-14
TRIAL STUDY 134XCP|EX|BA3378F3-C308-469F-9818-9AD811086548|965|||||||||||GY/MIN|SUPPOSITORY|Q24H||INTRAPERITONEAL||PROXIMAL RIGHT CORONARY ARTERY CONDUIT|BILATERAL|PERIPHERAL|N|||FOLLOW-UP|1962-02-10|1971-08-14|||1962-03-22|||1962-09-28||1972-01-15
TRIAL STUDY 134XCP|EX|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|966|||||||||||MEQ/ML|OINTMENT|2 TIMES PER CYCLE||OROMUCOSAL||PULMONARY VALVE, ANTERIOR CUSP|LEFT|VOLAR|Y|||BASELINE|1969-02-11|1972-01-10|||1961-01-26|||1971-12-29||1970-07-06
TRIAL STUDY 134XCP|EX|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|967|||||||||||10^3 ORGANISMS|EXTRACT|Q6D||INTRATHALAMIC||PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|FACIAL|U|||CONTINUATION TREATMENT|1967-01-09|1965-12-03|||1969-01-29|||1968-11-16||1968-09-18
TRIAL STUDY 134XCP|EX|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|968|||||||||||MS2|GRANULE, FOR SOLUTION|Q8H||SUBCONJUNCTIVAL||SKIN OF THE EAR|LATERAL|ROSTRAL|NA|||BASELINE|1966-11-15|1961-12-14|||1966-08-11|||1968-08-16||1969-12-19
TRIAL STUDY 134XCP|EX|15594D4E-1DAE-449F-AA52-9B0A926D9985|969|||||||||||VIRTUAL PIXEL|SOLUTION, CONCENTRATE|2 TIMES PER WEEK||UNKNOWN||FINGER FLEXOR TENDONS|IPSILATERAL|FRONTAL|Y|||BLINDED TREATMENT|1967-05-16|1964-08-23|||1972-05-10|||1971-04-06||1960-12-05
TRIAL STUDY 134XCP|EX|079DEA7B-A617-4787-9872-025F4248ABFF|970|||||||||||PT_US|SUSPENSION|Q8H||RECTAL||INFRATENTORIAL BRAIN|RIGHT|CRANIAL|N|||OBSERVATION|1969-09-11|1972-10-27|||1963-03-16|||1970-04-04||1967-06-12
TRIAL STUDY 134XCP|EX|3178AE30-9653-4470-84E4-FB0E4587DF6B|971|||||||||||PPTR|DRUG DELIVERY SYSTEM|QN||TRANSDERMAL||BREAST|UNILATERAL|VOLAR|NA|||TREATMENT|1972-03-07|1971-02-24|||1966-04-11|||1969-08-29||1966-10-08
TRIAL STUDY 134XCP|EX|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|972|||||||||||ML/DL|GLOBULE|UNKNOWN||INTRALUMINAL||PROFUNDA FEMORIS VEIN|LATERAL|FRONTAL|NA|||BLINDED TREATMENT|1973-03-24|1972-10-26|||1962-01-22|||1967-03-01||1970-11-30
TRIAL STUDY 134XCP|EX|D274C760-A607-4DA8-ACD3-346EF6E191D2|973|||||||||||ANTIBODY UNIT|SOLUTION, CONCENTRATE|EVERY 3 WEEKS||URETHRAL||GENITALIA|RIGHT|FRONTAL|NA|||RUN-IN|1966-04-17|1972-10-30|||1970-08-23|||1969-07-17||1963-06-07
TRIAL STUDY 134XCP|EX|F5B7E82D-49AD-422E-9C38-5681105094AA|974|||||||||||JAR|GRANULE, FOR SUSPENSION|5 TIMES PER DAY||INTRACAUDAL||CEPHALIC VEIN|LATERAL|UPPER EXTENSOR SURFACE|Y|||SCREENING|1966-06-28|1971-07-27|||1960-07-07|||1968-11-23||1970-05-19
TRIAL STUDY 134XCP|EX|AF8D32B4-B2CC-4EE3-A612-179814C691B8|975|||||||||||JAR|TABLET, FOR SOLUTION|Q7D||NOT APPLICABLE||ANTERIOR SUPERIOR ILIAC SPINE|LATERAL|HIND|NA|||RUN-IN|1967-11-03|1962-03-31|||1961-10-24|||1961-10-27||1962-11-15
TRIAL STUDY 134XCP|EX|64153B43-9DDC-473D-97E1-0E2E8C3E8116|976|||||||||||AGU/ML|TABLET, EXTENDED RELEASE|EVERY 5 WEEKS||TRANSPLACENTAL||CEREBRAL VEIN|IPSILATERAL|VENTRAL|U|||OBSERVATION|1972-10-04|1970-01-26|||1966-06-24|||1965-04-19||1961-01-02
TRIAL STUDY 134XCP|EX|0F5775AD-1D20-4B59-8558-8A41C12E03D0|977|||||||||||10^9 ORGANISMS/G|OIL|EVERY 3 WEEKS||ORAL GAVAGE||GLUTEAL MUSCLE|LEFT|ANTEROTEMPORAL|N|||BASELINE|1961-03-12|1961-07-13|||1965-09-06|||1972-01-10||1972-08-14
TRIAL STUDY 134XCP|EX|DF533087-690C-489A-9163-9D4503B7BCC9|978|||||||||||CD/M2|INJECTION, POWDER, FOR SUSPENSION|QN||INTRASURGICAL SITE||CORPUS STRIATUM|RIGHT|VOLAR|U|||TREATMENT|1961-08-22|1967-05-12|||1966-06-27|||1971-01-23||1972-10-17
TRIAL STUDY 134XCP|EX|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|979|||||||||||LOZENGE|GEL|4 TIMES PER MONTH||PERIDURAL||MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|SUPERIOR|U|||SCREENING|1966-09-30|1961-04-21|||1969-08-18|||1966-08-03||1960-05-05
TRIAL STUDY 134XCP|EX|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|980|||||||||||EJACULATE U|AEROSOL|INTERMITTENT||SOFT TISSUE||FRONTAL LOBE|CONTRALATERAL|POSTERIOR|Y|||CONTINUATION TREATMENT|1972-03-22|1968-07-11|||1966-10-14|||1963-05-15||1965-09-08
TRIAL STUDY 134XCP|EX|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|981|||||||||||/10^3|INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION|EVERY 5 WEEKS||INTRAOSSEOUS||HUMERUS|BILATERAL|LOWER FLEXOR SURFACE|U|||FOLLOW-UP|1963-08-19|1965-10-20|||1967-12-04|||1973-05-27||1971-05-16
TRIAL STUDY 134XCP|EX|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|982|||||||||||MM/MIN|GEL, METERED|4 TIMES PER YEAR||INTRAOVARIAN||HEART, SEPTUM|BILATERAL|DISTAL VOLAR|N|||SCREENING|1963-09-08|1970-07-26|||1965-11-28|||1970-07-15||1962-08-15
TRIAL STUDY 134XCP|EX|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|983|||||||||||MESF|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|Q17H||INTRADURAL||HEART, LEFT VENTRICULAR OUTFLOW TRACT|LEFT|ANTEROLATERAL|N|||SCREENING|1960-07-15|1962-05-12|||1963-09-14|||1963-02-04||1963-03-28
TRIAL STUDY 134XCP|EX|219A70B2-48A6-407C-B901-9847583DB5F4|984|||||||||||IU/DL|CULTURE|Q21H||INTRA-ABDOMINAL||JUGULAR VEIN|RIGHT|OCCIPITAL|N|||BLINDED TREATMENT|1967-10-23|1963-04-16|||1963-12-15|||1961-12-17||1962-02-25
TRIAL STUDY 134XCP|EX|CF3AC42D-DFBA-448E-A688-46A87D6264EB|985|||||||||||AMPULE|INSERT, EXTENDED RELEASE|PA||IRRIGATION||PUPIL|IPSILATERAL|ANTEROLATERAL|NA|||TREATMENT|1962-06-18|1970-02-18|||1965-05-12|||1966-10-02||1966-06-18
TRIAL STUDY 134XCP|EX|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|986|||||||||||MMOL2/L2|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|Q3H||ELECTRO-OSMOSIS||CARPOMETACARPAL JOINT 4|RIGHT|SUBCORTICAL|N|||BLINDED TREATMENT|1970-10-20|1962-10-20|||1971-06-04|||1970-02-19||1972-11-11
TRIAL STUDY 134XCP|EX|D19D43A5-DFE6-415D-86B7-6A767A357BC9|987|||||||||||YEARS|TABLET, IMMEDIATE RELEASE, SOLID DISPERSION|OCCASIONAL||INTRANODAL||SYNOVIAL FLUID|CONTRALATERAL|UPPER|N|||OBSERVATION|1961-03-31|1961-02-26|||1966-05-04|||1967-09-22||1966-08-21
TRIAL STUDY 134XCP|EX|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|988|||||||||||PMOL|CIGARETTE|Q14H||INTRAPERICARDIAL||PUPIL|RIGHT|SURFACE|N|||SCREENING|1970-03-09|1960-09-29|||1964-11-29|||1960-05-16||1964-12-05
TRIAL STUDY 134XCP|EX|7D307F63-4A25-4E7D-9980-16764AE5C4A4|989|||||||||||/MS|INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION|EVERY 3 WEEKS||INTRAPALATAL||ABDUCTOR POLLICIS BREVIS MUSCLE|CONTRALATERAL|ANTEROMEDIAL|Y|||BASELINE|1964-01-19|1961-03-29|||1963-06-01|||1961-10-31||1967-12-15
TRIAL STUDY 134XCP|EX|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|990|||||||||||PUFF|INJECTION, LIPID COMPLEX|Q72H||INTRASURGICAL SITE||CARPOMETACARPAL JOINT 2|IPSILATERAL|MIDLINE|U|||BLINDED TREATMENT|1967-03-17|1972-02-15|||1971-03-06|||1968-01-11||1965-09-09
TRIAL STUDY 134XCP|EX|F4718E0D-4DD9-442E-8907-076551C83AEE|991|||||||||||NG/DL|LOTION, AUGMENTED|Q23H||SUBTENON||LATERAL THIRD DIAGONAL BRANCH ARTERY|BILATERAL|LOWER EXTENSOR SURFACE|NA|||RUN-IN|1972-10-12|1963-02-26|||1971-02-09|||1970-04-12||1963-03-18
TRIAL STUDY 134XCP|EX|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|992|||||||||||USEC|RING|AD LIBITUM||INTRAOVARIAN||MEDIAN BASILIC VEIN|LEFT|ROSTRAL|Y|||BLINDED TREATMENT|1964-05-12|1966-01-04|||1964-05-25|||1971-12-22||1965-01-26
TRIAL STUDY 134XCP|EX|E86F996D-3A96-4C36-82B2-1AC4B4906F49|993|||||||||||KG/CM2|TABLET, COATED PARTICLES|Q4D||AURICULAR (OTIC)||OPTIC NERVE|IPSILATERAL|VOLAR|U|||OBSERVATION|1967-04-14|1969-01-15|||1964-11-18|||1967-12-10||1961-11-03
TRIAL STUDY 134XCP|EX|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|994|||||||||||UIU/L|TABLET, DELAYED RELEASE PARTICLES|Q23H||SUPRACHOROIDAL||DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|LOWER MEDIAL|N|||LONG-TERM FOLLOW-UP|1973-03-13|1968-02-03|||1966-09-18|||1968-12-20||1962-12-12
TRIAL STUDY 134XCP|EX|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|995|||||||||||G/U|BEAD|1 TIME PER WEEK||UNKNOWN||LUNATE BONE|LEFT|PARIETO-OCCIPITAL|NA|||OPEN LABEL TREATMENT|1960-05-25|1963-03-26|||1968-11-06|||1969-02-05||1973-01-29
TRIAL STUDY 134XCP|EX|28E9B15E-4757-42F5-8AE7-2C868904F88B|996|||||||||||RPM|LOTION/SHAMPOO|2 TIMES PER YEAR||INTRALESIONAL||ASCENDING AORTA, SINOTUBULAR JUNCTION|LEFT|SUPERFICIAL|Y|||CONTINUATION TREATMENT|1968-12-25|1966-05-06|||1968-08-03|||1973-08-13||1972-08-31
TRIAL STUDY 134XCP|EX|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|997|||||||||||IN2|POWDER|7 TIMES PER WEEK||INTRALUMINAL||RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|CONTRALATERAL|DEEP|NA|||RUN-IN|1961-03-19|1964-09-02|||1970-07-27|||1961-10-25||1971-09-25
TRIAL STUDY 134XCP|EX|2E1011F1-A091-4E7E-B661-477A1F6DD39A|998|||||||||||MM2|BEAD, IMPLANT, EXTENDED RELEASE|Q4H||INTRASINAL||VERTEBRA|LATERAL|SURFACE|N|||TREATMENT|1963-11-22|1964-12-25|||1961-02-13|||1965-01-16||1969-03-20
TRIAL STUDY 134XCP|EX|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|999|||||||||||LOG10 TCID 50/ML|BAR, CHEWABLE|PA||INTRASURGICAL SITE||METACARPOPHALANGEAL JOINT 1|RIGHT|ANTEROTEMPORAL|N|||FOLLOW-UP|1965-06-30|1972-12-04|||1963-12-15|||1966-02-01||1961-01-15
TRIAL STUDY 134XCP|EX|176B6882-0C9E-435E-9842-FF8714BC9CAF|1000|||||||||||PSEC|INJECTION, SOLUTION, CONCENTRATE|Q6M||INTRATHORACIC||LENS|LATERAL|FORE|NA|||WASHOUT|1964-09-15|1972-02-17|||1973-01-23|||1967-03-02||1968-05-20
